| 1 |
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). Clin Cancer Res. 2008 Jul 1;14(13):4192-9.
|
| 2 |
Aspirin FDA Label
|
| 3 |
ClinicalTrials.gov (NCT03827044) Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer (POLEM). U.S. National Institutes of Health.
|
| 4 |
Colon cancer. Crit Rev Oncol Hematol. 2010 May;74(2):106-33.
|
| 5 |
Bortezomib FDA Label
|
| 6 |
Capecitabine FDA Label
|
| 7 |
Celecoxib FDA Label
|
| 8 |
Citalopram FDA Label
|
| 9 |
Eflornithine FDA Label
|
| 10 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4920).
|
| 11 |
Everolimus FDA Label
|
| 12 |
Floxuridine FDA Label
|
| 13 |
Fludarabine FDA Label
|
| 14 |
Fluorouracil FDA Label
|
| 15 |
Gefitinib FDA Label
|
| 16 |
Gemcitabine FDA Label
|
| 17 |
Hydroxychloroquine FDA Label
|
| 18 |
Irinotecan FDA Label
|
| 19 |
Lenalidomide FDA Label
|
| 20 |
Leucovorin FDA Label
|
| 21 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7210).
|
| 22 |
Levoleucovorin FDA Label
|
| 23 |
Mitomycin FDA Label
|
| 24 |
Oxaliplatin FDA Label
|
| 25 |
Rosuvastatin FDA Label
|
| 26 |
Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators. J Med Chem. 1998 Nov 19;41(24):4800-18.
|
| 27 |
ClinicalTrials.gov (NCT03157128) A Study of LOXO-292 in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001). U.S. National Institutes of Health.
|
| 28 |
Sulindac FDA Label
|
| 29 |
Thalidomide FDA Label
|
| 30 |
Trifluridine FDA Label
|
| 31 |
Design and synthesis of bile acid derivatives and their activity against colon cancer. RSC Med Chem. 2022 Aug 19;13(11):1391-1409.
|
| 32 |
Vidarabine FDA Label
|
| 33 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 34 |
ClinicalTrials.gov (NCT03013712) A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
|
| 35 |
Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jul;27(7):753-761.
|
| 36 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024569)
|
| 37 |
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. Nat Rev Drug Discov. 2021 Apr;20(4):265-286.
|
| 38 |
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest. 2009 Dec;119(12):3613-25.
|
| 39 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002548)
|
| 40 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 41 |
Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
|
| 42 |
Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapy.Oncol Lett. 2019 Jun;17(6):5572-5580. doi: 10.3892/ol.2019.10234. Epub 2019 Apr 9.
|
| 43 |
Effect of overexpression of - and -actin isoforms on actin cytoskeleton organization and migration of human colon cancer cells.Histochem Cell Biol. 2014 Sep;142(3):307-22. doi: 10.1007/s00418-014-1199-9. Epub 2014 Feb 28.
|
| 44 |
Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells.Hum Pathol. 2010 Nov;41(11):1550-7. doi: 10.1016/j.humpath.2010.04.008.
|
| 45 |
Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease.Adv Exp Med Biol. 2018;1032:173-202. doi: 10.1007/978-3-319-98788-0_13.
|
| 46 |
Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers. Nat Commun. 2018 Sep 26;9(1):3931.
|
| 47 |
Immunohistochemistry for annexin A10 can distinguish sporadic from Lynch syndrome-associated microsatellite-unstable colorectal carcinoma.Am J Surg Pathol. 2014 Apr;38(4):518-25. doi: 10.1097/PAS.0000000000000148.
|
| 48 |
Combined pharmacological administration of AQP1 ion channel blocker AqB011 and water channel blocker Bacopaside II amplifies inhibition of colon cancer cell migration.Sci Rep. 2019 Sep 2;9(1):12635. doi: 10.1038/s41598-019-49045-9.
|
| 49 |
Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells.Oncotarget. 2018 Mar 30;9(24):17066-17077. doi: 10.18632/oncotarget.24899. eCollection 2018 Mar 30.
|
| 50 |
Silica Nanoparticles Provoke Cell Death Independent of p53 and BAX in Human Colon Cancer Cells.Nanomaterials (Basel). 2019 Aug 16;9(8):1172. doi: 10.3390/nano9081172.
|
| 51 |
Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-B signal transduction.Mol Cell Biochem. 2018 Dec;449(1-2):285-294. doi: 10.1007/s11010-018-3365-1. Epub 2018 May 14.
|
| 52 |
BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature.BMC Med Genet. 2019 May 7;20(1):75. doi: 10.1186/s12881-019-0812-0.
|
| 53 |
Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.Int J Cancer. 2006 Dec 15;119(12):2724-32. doi: 10.1002/ijc.22207.
|
| 54 |
Molecular imaging of T cell co-regulator factor B7-H3 with (89)Zr-DS-5573a.Theranostics. 2018 Jul 30;8(15):4199-4209. doi: 10.7150/thno.25575. eCollection 2018.
|
| 55 |
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.Nat Commun. 2019 May 14;10(1):2154. doi: 10.1038/s41467-019-09775-w.
|
| 56 |
Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.J Hum Genet. 2014 Jul;59(7):381-6. doi: 10.1038/jhg.2014.38. Epub 2014 May 15.
|
| 57 |
The phosphatidic acid phosphatase lipin-1 facilitates inflammation-driven colon carcinogenesis.JCI Insight. 2018 Sep 20;3(18):e97506. doi: 10.1172/jci.insight.97506. eCollection 2018 Sep 20.
|
| 58 |
Interleukin genes and associations with colon and rectal cancer risk and overall survival.Int J Cancer. 2013 Feb 15;132(4):905-15. doi: 10.1002/ijc.27660. Epub 2012 Jun 26.
|
| 59 |
Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer.Cancer Lett. 2019 Feb 28;443:1-12. doi: 10.1016/j.canlet.2018.11.017. Epub 2018 Nov 24.
|
| 60 |
Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer.Mol Cell Endocrinol. 2011 Dec 5;347(1-2):70-9. doi: 10.1016/j.mce.2011.07.022. Epub 2011 Jul 27.
|
| 61 |
Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.Cancer Res. 2006 Aug 1;66(15):7571-7. doi: 10.1158/0008-5472.CAN-06-1067.
|
| 62 |
Vitamin D enhances the efficacy of irinotecan through miR-627-mediated inhibition of intratumoral drug metabolism. Mol Cancer Ther. 2016 Sep;15(9):2086-95.
|
| 63 |
The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.Oncogene. 2017 Jun 1;36(22):3080-3093. doi: 10.1038/onc.2016.449. Epub 2016 Dec 12.
|
| 64 |
Dicer regulates non-homologous end joining and is associated with chemosensitivity in colon cancer patients.Carcinogenesis. 2017 Sep 1;38(9):873-882. doi: 10.1093/carcin/bgx059.
|
| 65 |
5-Aza-CdR Regulates RASSF1A By Inhibiting DNMT1 To Affect Colon Cancer Cell Proliferation, Migration And Apoptosis.Cancer Manag Res. 2019 Nov 8;11:9517-9528. doi: 10.2147/CMAR.S229726. eCollection 2019.
|
| 66 |
Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells.Sci Rep. 2019 Mar 1;9(1):3210. doi: 10.1038/s41598-019-39547-x.
|
| 67 |
Pulsed SILAC-based proteomic analysis unveils hypoxia- and serum starvation-induced de novo protein synthesis with PHD finger protein 14 (PHF14) as a hypoxia sensitive epigenetic regulator in cell cycle progression.Oncotarget. 2019 Mar 15;10(22):2136-2150. doi: 10.18632/oncotarget.26669. eCollection 2019 Mar 15.
|
| 68 |
The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer.Biomolecules. 2019 Sep 9;9(9):464. doi: 10.3390/biom9090464.
|
| 69 |
Loss-of-function uORF mutations in human malignancies.Sci Rep. 2018 Feb 5;8(1):2395. doi: 10.1038/s41598-018-19201-8.
|
| 70 |
Chimeric Antigen Receptor-modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model.J Immunother. 2019 Feb/Mar;42(2):33-42. doi: 10.1097/CJI.0000000000000251.
|
| 71 |
Estrogen Receptor as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps.Pathol Oncol Res. 2018 Jul;24(3):533-540. doi: 10.1007/s12253-017-0268-5. Epub 2017 Jul 5.
|
| 72 |
Identification of Estrogen-Related Receptor Agonists in the Tox21 Compound Library.Endocrinology. 2018 Feb 1;159(2):744-753. doi: 10.1210/en.2017-00658.
|
| 73 |
Proteomic characterization of peroxisome proliferator-activated receptor- (PPAR) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.Mol Oncol. 2016 Oct;10(8):1344-62. doi: 10.1016/j.molonc.2016.07.006. Epub 2016 Jul 25.
|
| 74 |
Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-B signaling pathways.Cancer Invest. 2013 Jan;31(1):7-16. doi: 10.3109/07357907.2012.743556. Epub 2012 Nov 21.
|
| 75 |
Fibroblast growth factor 18 promotes proliferation and migration of H460 cells via the ERK and p38 signaling pathways.Oncol Rep. 2017 Feb;37(2):1235-1242. doi: 10.3892/or.2016.5301. Epub 2016 Dec 7.
|
| 76 |
FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7.Cancer Sci. 2015 Oct;106(10):1278-87. doi: 10.1111/cas.12745. Epub 2015 Sep 4.
|
| 77 |
Dual targeting system by supramolecular complex of folate-conjugated methyl--cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.Int J Biol Macromol. 2018 Jul 1;113:386-394. doi: 10.1016/j.ijbiomac.2018.02.149. Epub 2018 Feb 24.
|
| 78 |
Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol. 2003 Jun;162(6):1961-74.
|
| 79 |
A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.Hum Genet. 2016 Jul;135(7):675-84. doi: 10.1007/s00439-016-1659-5. Epub 2016 Mar 29.
|
| 80 |
Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells.Int J Mol Sci. 2019 Sep 8;20(18):4421. doi: 10.3390/ijms20184421.
|
| 81 |
Identification of recurrent fusion genes across multiple cancer types.Sci Rep. 2019 Jan 31;9(1):1074. doi: 10.1038/s41598-019-38550-6.
|
| 82 |
Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression.Mol Carcinog. 2003 May;37(1):5-15. doi: 10.1002/mc.10117.
|
| 83 |
Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial?mesenchymal transition via the AKT/GSK?/Snail signaling pathway.Mol Med Rep. 2019 Sep;20(3):2783-2795. doi: 10.3892/mmr.2019.10528. Epub 2019 Jul 25.
|
| 84 |
Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.J Immunother Cancer. 2019 Apr 23;7(1):104. doi: 10.1186/s40425-019-0576-2.
|
| 85 |
Effect of butyrate and Lactobacillus GG on a butyrate receptor and transporter during Campylobacter jejuni exposure.FEMS Microbiol Lett. 2017 Mar 1;364(6):fnx046. doi: 10.1093/femsle/fnx046.
|
| 86 |
Sumoylation of HDAC2 promotes NF-B-dependent gene expression.Oncotarget. 2015 Mar 30;6(9):7123-35. doi: 10.18632/oncotarget.3344.
|
| 87 |
Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines.BMC Cancer. 2011 Feb 1;11:51. doi: 10.1186/1471-2407-11-51.
|
| 88 |
Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth.Cancer Gene Ther. 2020 Apr;27(3-4):235-245. doi: 10.1038/s41417-019-0089-7. Epub 2019 Mar 1.
|
| 89 |
Downregulated IGFBP7 facilitates liver metastasis by modulating epithelialmesenchymal transition in colon cancer.Oncol Rep. 2019 Nov;42(5):1935-1945. doi: 10.3892/or.2019.7303. Epub 2019 Sep 6.
|
| 90 |
Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1/PI3K/NF- pathway in human colon cancer cell.Cancer Manag Res. 2017 Oct 9;9:481-493. doi: 10.2147/CMAR.S147699. eCollection 2017.
|
| 91 |
IL-23 in inflammatory bowel diseases and colon cancer.Cytokine Growth Factor Rev. 2019 Feb;45:1-8. doi: 10.1016/j.cytogfr.2018.12.002. Epub 2018 Dec 12.
|
| 92 |
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.Carcinogenesis. 2011 Nov;32(11):1660-7. doi: 10.1093/carcin/bgr189. Epub 2011 Aug 22.
|
| 93 |
Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.Mol Cell Biol. 2015 Mar;35(6):988-1000. doi: 10.1128/MCB.01242-14. Epub 2015 Jan 12.
|
| 94 |
Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.PLoS One. 2017 Nov 9;12(11):e0187200. doi: 10.1371/journal.pone.0187200. eCollection 2017.
|
| 95 |
n-6 Linoleic Acid Induces Epigenetics Alterations Associated with Colonic Inflammation and Cancer.Nutrients. 2019 Jan 15;11(1):171. doi: 10.3390/nu11010171.
|
| 96 |
p27Kip1, PCAF and PAX5 cooperate in the transcriptional regulation of specific target genes.Nucleic Acids Res. 2017 May 19;45(9):5086-5099. doi: 10.1093/nar/gkx075.
|
| 97 |
Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.Oncotarget. 2019 Feb 15;10(14):1399-1406. doi: 10.18632/oncotarget.26659. eCollection 2019 Feb 15.
|
| 98 |
Leptin induces SIRT1 expression through activation of NF-E2-related factor 2: Implications for obesity-associated colon carcinogenesis.Biochem Pharmacol. 2018 Jul;153:282-291. doi: 10.1016/j.bcp.2018.02.001. Epub 2018 Feb 7.
|
| 99 |
Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways.Biochem Cell Biol. 2017 Feb;95(1):99-109. doi: 10.1139/bcb-2016-0094. Epub 2016 Nov 30.
|
| 100 |
MAP kinase genes and colon and rectal cancer.Carcinogenesis. 2012 Dec;33(12):2398-408. doi: 10.1093/carcin/bgs305. Epub 2012 Oct 1.
|
| 101 |
MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.Oncotarget. 2016 Jun 7;7(23):34322-40. doi: 10.18632/oncotarget.9107.
|
| 102 |
Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.Curr Mol Pharmacol. 2018;11(3):184-190. doi: 10.2174/1874467211666180119115828.
|
| 103 |
Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.J Biol Chem. 2019 May 24;294(21):8529-8542. doi: 10.1074/jbc.RA118.004361. Epub 2019 Apr 9.
|
| 104 |
Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.BMC Cancer. 2018 Aug 10;18(1):809. doi: 10.1186/s12885-018-4704-z.
|
| 105 |
A TGF--MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.Oncogene. 2020 Mar;39(10):2125-2139. doi: 10.1038/s41388-019-1132-8. Epub 2019 Dec 6.
|
| 106 |
AEG-1 knockdown in colon cancer cell lines inhibits radiation-enhanced migration and invasion in vitro and in a novel in vivo zebrafish model.Oncotarget. 2016 Dec 6;7(49):81634-81644. doi: 10.18632/oncotarget.13155.
|
| 107 |
Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon Cancer.Cancer Immunol Res. 2020 Feb;8(2):167-178. doi: 10.1158/2326-6066.CIR-19-0514. Epub 2019 Dec 12.
|
| 108 |
MUC17, a novel membrane-tethered mucin.Biochem Biophys Res Commun. 2002 Mar 1;291(3):466-75. doi: 10.1006/bbrc.2002.6475.
|
| 109 |
Contribution of drugs acting on the TLRs/MyD88 signaling pathway on colitis-associated cancer.Pharmazie. 2018 Jul 1;73(7):363-368. doi: 10.1691/ph.2018.8388.
|
| 110 |
The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans.Acta Histochem. 2012 Dec;114(8):827-35. doi: 10.1016/j.acthis.2012.02.004. Epub 2012 Mar 13.
|
| 111 |
Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation.Mol Cancer. 2010 Oct 15;9:276. doi: 10.1186/1476-4598-9-276.
|
| 112 |
Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor.Eur J Med Chem. 2019 Sep 1;177:386-400. doi: 10.1016/j.ejmech.2019.05.068. Epub 2019 May 25.
|
| 113 |
Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.Mol Cancer Res. 2013 Feb;11(2):109-21. doi: 10.1158/1541-7786.MCR-12-0466. Epub 2012 Dec 10.
|
| 114 |
Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase.Front Pharmacol. 2019 Oct 22;10:1248. doi: 10.3389/fphar.2019.01248. eCollection 2019.
|
| 115 |
The plasminogen activator inhibitor system in colon cancer cell lines is influenced by the CO2 pneumoperitoneum.Int J Colorectal Dis. 2011 Jan;26(1):37-43. doi: 10.1007/s00384-010-1062-y. Epub 2010 Oct 8.
|
| 116 |
The Roles of EP4 Prostanoid Receptors in Cancer Malignancy Signaling.Biol Pharm Bull. 2016;39(2):149-55. doi: 10.1248/bpb.b15-00840.
|
| 117 |
MicroRNA? suppresses human colon cancer invasion and proliferation by targeting the expression of focal adhesion kinase.Mol Med Rep. 2016 Feb;13(2):1297-303. doi: 10.3892/mmr.2015.4643. Epub 2015 Dec 4.
|
| 118 |
Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.Mol Cancer Res. 2016 Jun;14(6):563-73. doi: 10.1158/1541-7786.MCR-15-0450. Epub 2016 Mar 16.
|
| 119 |
Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.PLoS One. 2017 May 31;12(5):e0177964. doi: 10.1371/journal.pone.0177964. eCollection 2017.
|
| 120 |
RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy.Cell Death Dis. 2018 Nov 19;9(12):1148. doi: 10.1038/s41419-018-1113-9.
|
| 121 |
Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.J Cell Physiol. 2007 Oct;213(1):65-9. doi: 10.1002/jcp.21089.
|
| 122 |
ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).Anticancer Res. 2019 Mar;39(3):1267-1273. doi: 10.21873/anticanres.13237.
|
| 123 |
Curcumin induces apoptosis and cell cycle arrest via the activation of reactive oxygen species-independent mitochondrial apoptotic pathway in Smad4 and p53 mutated colon adenocarcinoma HT29 cells.Nutr Res. 2018 Mar;51:67-81. doi: 10.1016/j.nutres.2017.12.011. Epub 2018 Jan 6.
|
| 124 |
Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.PLoS One. 2015 Apr 16;10(4):e0122391. doi: 10.1371/journal.pone.0122391. eCollection 2015.
|
| 125 |
Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9.Adv Sci (Weinh). 2019 Jul 22;6(18):1901278. doi: 10.1002/advs.201901278. eCollection 2019 Sep 18.
|
| 126 |
Stability of the N-Terminal Helix and Its Role in Amyloid Formation of Serum Amyloid A.ACS Omega. 2018 Nov 30;3(11):16184-16190. doi: 10.1021/acsomega.8b02377. Epub 2018 Nov 29.
|
| 127 |
Inflammatory hypoxia induces syndecan-2 expression through IL-1-mediated FOXO3a activation in colonic epithelia.FASEB J. 2017 Apr;31(4):1516-1530. doi: 10.1096/fj.201601098R. Epub 2016 Dec 28.
|
| 128 |
Serpin B5 is a CEA-interacting biomarker for colorectal cancer.Int J Cancer. 2014 Apr 1;134(7):1595-604. doi: 10.1002/ijc.28494. Epub 2013 Oct 11.
|
| 129 |
Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy.PLoS Genet. 2019 May 6;15(5):e1007687. doi: 10.1371/journal.pgen.1007687. eCollection 2019 May.
|
| 130 |
Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo.Oncol Rep. 2019 Oct;42(4):1355-1364. doi: 10.3892/or.2019.7267. Epub 2019 Aug 7.
|
| 131 |
Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras.Cancer Lett. 2000 Jun 30;154(2):137-42. doi: 10.1016/s0304-3835(00)00354-2.
|
| 132 |
Sirtuin 3 silencing improves oxaliplatin efficacy through acetylation of MnSOD in colon cancer.J Cell Physiol. 2018 Aug;233(8):6067-6076. doi: 10.1002/jcp.26443. Epub 2018 Mar 6.
|
| 133 |
Sphingosine kinase1 promotes the metastasis of colorectal cancer by inducing the epithelialmesenchymal transition mediated by the FAK/AKT/MMPs axis.Int J Oncol. 2019 Jan;54(1):41-52. doi: 10.3892/ijo.2018.4607. Epub 2018 Oct 25.
|
| 134 |
SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-B pathway activation.BMC Cancer. 2019 Jul 12;19(1):685. doi: 10.1186/s12885-019-5904-x.
|
| 135 |
Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.Gastroenterology. 2019 Apr;156(5):1455-1466. doi: 10.1053/j.gastro.2018.11.066. Epub 2018 Dec 6.
|
| 136 |
PHD2 exerts anti-cancer and anti-inflammatory effects in colon cancer xenografts mice via attenuating NF-B activity.Life Sci. 2020 Feb 1;242:117167. doi: 10.1016/j.lfs.2019.117167. Epub 2019 Dec 12.
|
| 137 |
LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.Cancer Res. 2017 Apr 15;77(8):1880-1891. doi: 10.1158/0008-5472.CAN-16-1655. Epub 2017 Mar 1.
|
| 138 |
Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.J Exp Clin Cancer Res. 2016 Mar 31;35:56. doi: 10.1186/s13046-016-0335-x.
|
| 139 |
Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.Int J Oncol. 2018 Oct;53(4):1481-1492. doi: 10.3892/ijo.2018.4502. Epub 2018 Jul 25.
|
| 140 |
Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer.Cancer Lett. 2018 Jan 1;412:46-58. doi: 10.1016/j.canlet.2017.10.006. Epub 2017 Oct 13.
|
| 141 |
Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy.Onco Targets Ther. 2019 Jan 15;12:609-617. doi: 10.2147/OTT.S182806. eCollection 2019.
|
| 142 |
DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis.Cancer Med. 2018 Jun;7(6):2339-2349. doi: 10.1002/cam4.1480. Epub 2018 Apr 19.
|
| 143 |
Insulin promotes progression of colon cancer by upregulation of ACAT1.Lipids Health Dis. 2018 May 24;17(1):122. doi: 10.1186/s12944-018-0773-x.
|
| 144 |
Predictors of readmission and reoperation in patients with colorectal cancer.Support Care Cancer. 2020 May;28(5):2339-2350. doi: 10.1007/s00520-019-05050-2. Epub 2019 Sep 4.
|
| 145 |
Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues.Cancer Res. 1998 Nov 1;58(21):4802-4.
|
| 146 |
Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation.World J Gastroenterol. 2014 Jun 7;20(21):6560-72. doi: 10.3748/wjg.v20.i21.6560.
|
| 147 |
Expression of cellular FLICE-inhibitory protein and its association with p53 mutation in colon cancer.World J Gastroenterol. 2005 Apr 28;11(16):2482-5. doi: 10.3748/wjg.v11.i16.2482.
|
| 148 |
Mirk regulates the exit of colon cancer cells from quiescence.J Biol Chem. 2009 Aug 21;284(34):22916-25. doi: 10.1074/jbc.M109.035519. Epub 2009 Jun 19.
|
| 149 |
Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and chemotaxis of colon cancer cell line SW620.Oncol Rep. 2015 Jun;33(6):2681-8. doi: 10.3892/or.2015.3897. Epub 2015 Apr 3.
|
| 150 |
Therapeutic adenoviral gene transfer of a glycosyltransferase for prevention of peritoneal dissemination and metastasis of gastric cancer.Cancer Gene Ther. 2014 Oct;21(10):427-33. doi: 10.1038/cgt.2014.46. Epub 2014 Sep 12.
|
| 151 |
In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases.J Mol Cell Biol. 2016 Apr;8(2):157-73. doi: 10.1093/jmcb/mjv034. Epub 2015 Jun 1.
|
| 152 |
Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.Ann Surg Oncol. 2016 Mar;23(3):908-17. doi: 10.1245/s10434-015-4967-4. Epub 2015 Nov 17.
|
| 153 |
Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.Br J Cancer. 2008 Feb 12;98(3):587-95. doi: 10.1038/sj.bjc.6604184. Epub 2008 Jan 22.
|
| 154 |
Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway.PLoS One. 2010 Nov 16;5(11):e14018. doi: 10.1371/journal.pone.0014018.
|
| 155 |
Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.PLoS One. 2016 May 12;11(5):e0155660. doi: 10.1371/journal.pone.0155660. eCollection 2016.
|
| 156 |
ACLY facilitates colon cancer cell metastasis by CTNNB1.J Exp Clin Cancer Res. 2019 Sep 12;38(1):401. doi: 10.1186/s13046-019-1391-9.
|
| 157 |
Downregulation of Activin A Receptor Type 2A Is Associated with Metastatic Potential and Poor Prognosis of Colon Cancer.J Cancer. 2018 Sep 8;9(19):3626-3633. doi: 10.7150/jca.26790. eCollection 2018.
|
| 158 |
Functional Characterization of Colon Cancer-Associated Mutations in ADAM17: Modifications in the Pro-Domain Interfere with Trafficking and Maturation.Int J Mol Sci. 2019 May 4;20(9):2198. doi: 10.3390/ijms20092198.
|
| 159 |
ALKBH5 Holds Prognostic Values and Inhibits the Metastasis of Colon Cancer.Pathol Oncol Res. 2020 Jul;26(3):1615-1623. doi: 10.1007/s12253-019-00737-7. Epub 2019 Sep 10.
|
| 160 |
MicroRNA?5/ATXN3 interaction regulates human colon cancer cell growth and migration.Mol Med Rep. 2019 May;19(5):4213-4221. doi: 10.3892/mmr.2019.10090. Epub 2019 Mar 27.
|
| 161 |
Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1.Gastroenterology. 2019 Feb;156(3):662-675.e7. doi: 10.1053/j.gastro.2018.10.030. Epub 2018 Oct 17.
|
| 162 |
Structural Mechanism of the Oxygenase JMJD6 Recognition by the Extraterminal (ET) Domain of BRD4.Sci Rep. 2017 Nov 24;7(1):16272. doi: 10.1038/s41598-017-16588-8.
|
| 163 |
Bone Morphogenetic Protein 1 Targeting COL1A1 and COL1A2 to Regulate the Epithelial-Mesenchymal Transition Process of Colon Cancer SW620 Cells.J Nanosci Nanotechnol. 2020 Mar 1;20(3):1366-1374. doi: 10.1166/jnn.2020.17362.
|
| 164 |
Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53. Cancer Biol Ther. 2008 Aug;7(8):1305-12. doi: 10.4161/cbt.7.8.6302. Epub 2008 Aug 16.
|
| 165 |
The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.Anticancer Res. 2018 Jan;38(1):313-320. doi: 10.21873/anticanres.12224.
|
| 166 |
Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction.Cancer Lett. 2019 Jun 1;451:79-91. doi: 10.1016/j.canlet.2019.02.050. Epub 2019 Mar 11.
|
| 167 |
Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.Neoplasia. 2017 Oct;19(10):830-841. doi: 10.1016/j.neo.2017.08.002. Epub 2017 Sep 6.
|
| 168 |
Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.Oncotarget. 2015 Oct 27;6(33):34389-401. doi: 10.18632/oncotarget.5360.
|
| 169 |
Genetic analysis of hsCRP in American Indians: The Strong Heart Family Study.PLoS One. 2019 Oct 17;14(10):e0223574. doi: 10.1371/journal.pone.0223574. eCollection 2019.
|
| 170 |
DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.Carcinogenesis. 2020 May 14;41(3):303-312. doi: 10.1093/carcin/bgz157.
|
| 171 |
miR-590-3p promotes colon cancer cell proliferation via Wnt/-catenin signaling pathway by inhibiting WIF1 and DKK1.Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4844-4852.
|
| 172 |
FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer.Nucleic Acids Res. 2019 Feb 28;47(4):1692-1705. doi: 10.1093/nar/gky1230.
|
| 173 |
MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR).Cancer Lett. 2018 May 1;421:145-151. doi: 10.1016/j.canlet.2018.02.026. Epub 2018 Feb 20.
|
| 174 |
Functional Interaction of Hypoxia-Inducible Factor 2-Alpha and Autophagy Mediates Drug Resistance in Colon Cancer Cells.Cancers (Basel). 2019 May 30;11(6):755. doi: 10.3390/cancers11060755.
|
| 175 |
Knockdown of IRE1 suppresses metastatic potential of colon cancer cells through inhibiting FN1-Src/FAK-GTPases signaling.Int J Biochem Cell Biol. 2019 Sep;114:105572. doi: 10.1016/j.biocel.2019.105572. Epub 2019 Jul 18.
|
| 176 |
KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.Clin Epigenetics. 2018 Apr 4;10:44. doi: 10.1186/s13148-018-0473-4. eCollection 2018.
|
| 177 |
The concentrations of EGFR, LRG1, ITIH4, and F5 in serum correlate with the number of colonic adenomas in ApcPirc/+ rats.Cancer Prev Res (Phila). 2014 Nov;7(11):1160-9. doi: 10.1158/1940-6207.CAPR-14-0056. Epub 2014 Sep 8.
|
| 178 |
Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer.Cancers (Basel). 2019 Feb 8;11(2):199. doi: 10.3390/cancers11020199.
|
| 179 |
The role of lymph node size and FOXP3+ regulatory T cells in node-negative colon cancer.J Clin Pathol. 2017 May;70(5):443-447. doi: 10.1136/jclinpath-2016-203978. Epub 2016 Nov 22.
|
| 180 |
MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2).Front Oncol. 2019 Jun 12;9:495. doi: 10.3389/fonc.2019.00495. eCollection 2019.
|
| 181 |
Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15.Aging Cell. 2019 Dec;18(6):e13013. doi: 10.1111/acel.13013. Epub 2019 Aug 6.
|
| 182 |
HDAC inhibitors show differential epigenetic regulation and cell survival strategies on p53 mutant colon cancer cells.J Biomol Struct Dyn. 2018 Mar;36(4):938-955. doi: 10.1080/07391102.2017.1302820. Epub 2017 Mar 28.
|
| 183 |
AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-B, HIF1, MMP2, and MMP9 upregulation.Cell Signal. 2019 Jun;58:99-110. doi: 10.1016/j.cellsig.2019.03.011. Epub 2019 Mar 12.
|
| 184 |
H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1.Int J Oncol. 2017 May;50(5):1801-1809. doi: 10.3892/ijo.2017.3941. Epub 2017 Mar 29.
|
| 185 |
Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway.Mol Cancer Ther. 2020 Jan;19(1):135-146. doi: 10.1158/1535-7163.MCT-19-0413. Epub 2019 Sep 25.
|
| 186 |
HMGCS2 enhances invasion and metastasis via direct interaction with PPAR to activate Src signaling in colorectal cancer and oral cancer.Oncotarget. 2017 Apr 4;8(14):22460-22476. doi: 10.18632/oncotarget.13006.
|
| 187 |
AQP5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells.Tumour Biol. 2014 Jul;35(7):7035-45. doi: 10.1007/s13277-014-1956-3. Epub 2014 Apr 23.
|
| 188 |
BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.Mol Carcinog. 2018 Feb;57(2):284-294. doi: 10.1002/mc.22755. Epub 2017 Nov 14.
|
| 189 |
MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27.Cell Mol Biol Lett. 2019 Mar 14;24:22. doi: 10.1186/s11658-019-0143-3. eCollection 2019.
|
| 190 |
Cancer therapy with major histocompatibility complex-deficient and interferon -producing myeloid cells derived from allogeneic embryonic stem cells.Cancer Sci. 2019 Oct;110(10):3027-3037. doi: 10.1111/cas.14144. Epub 2019 Aug 7.
|
| 191 |
Cell-Based IL-15:IL-15R Secreting Vaccine as an Effective Therapy for CT26 Colon Cancer in Mice.Mol Cells. 2019 Dec 31;42(12):869-883. doi: 10.14348/molcells.2019.0188.
|
| 192 |
Integrated bioinformatics analysis of key genes involved in progress of colon cancer.Mol Genet Genomic Med. 2019 Apr;7(4):e00588. doi: 10.1002/mgg3.588. Epub 2019 Feb 11.
|
| 193 |
A Transcriptomic Insight into the Impact of Colon Cancer Cells on Mast Cells.Int J Mol Sci. 2019 Apr 4;20(7):1689. doi: 10.3390/ijms20071689.
|
| 194 |
Has_circ_0055625 from circRNA profile increases colon cancer cell growth by sponging miR-106b-5p.J Cell Biochem. 2019 Mar;120(3):3027-3037. doi: 10.1002/jcb.27355. Epub 2018 Dec 5.
|
| 195 |
MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.Oncogene. 2018 Feb 22;37(8):1031-1040. doi: 10.1038/onc.2017.396. Epub 2017 Oct 30.
|
| 196 |
Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression.BMC Genomics. 2006 Jun 13;7:148. doi: 10.1186/1471-2164-7-148.
|
| 197 |
L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.Sci Rep. 2017 Nov 3;7(1):14979. doi: 10.1038/s41598-017-15135-9.
|
| 198 |
Cloning, expression of the truncation of recombinant peroxidase derived from millet bran and its reversal effects on 5-Fu resistance in colorectal cancer.Int J Biol Macromol. 2019 Jul 1;132:871-879. doi: 10.1016/j.ijbiomac.2019.03.111. Epub 2019 Mar 19.
|
| 199 |
miRNA-766 induces apoptosis of human colon cancer cells through the p53/Bax signaling pathway by MDM4.Exp Ther Med. 2019 May;17(5):4100-4108. doi: 10.3892/etm.2019.7436. Epub 2019 Mar 26.
|
| 200 |
Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors.Bioorg Med Chem. 2019 Apr 1;27(7):1211-1225. doi: 10.1016/j.bmc.2019.02.007. Epub 2019 Feb 2.
|
| 201 |
MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells.Oncol Rep. 2019 Nov;42(5):1915-1923. doi: 10.3892/or.2019.7292. Epub 2019 Aug 23.
|
| 202 |
Dynamin controls extracellular level of Awd/Nme1 metastasis suppressor protein.Naunyn Schmiedebergs Arch Pharmacol. 2016 Nov;389(11):1171-1182. doi: 10.1007/s00210-016-1268-9. Epub 2016 Jul 22.
|
| 203 |
Construing the Biochemical and Molecular Mechanism Underlying the In Vivo and In Vitro Chemotherapeutic Efficacy of Ruthenium-Baicalein Complex in Colon Cancer.Int J Biol Sci. 2019 Apr 22;15(5):1052-1071. doi: 10.7150/ijbs.31143. eCollection 2019.
|
| 204 |
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.Int J Oncol. 2016 Aug;49(2):639-45. doi: 10.3892/ijo.2016.3550. Epub 2016 Jun 1.
|
| 205 |
The nuclear orphan receptor NR4A1 regulates 1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.Mol Carcinog. 2017 Sep;56(9):2066-2075. doi: 10.1002/mc.22662. Epub 2017 May 9.
|
| 206 |
Methylation of OSMR gene is frequently observed in non-invasive colorectal cancer.Anticancer Res. 2011 Apr;31(4):1293-5.
|
| 207 |
Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis.Cancer Sci. 2007 Mar;98(3):321-8. doi: 10.1111/j.1349-7006.2007.00390.x.
|
| 208 |
Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice.Cancer Res. 2013 May 1;73(9):2806-16. doi: 10.1158/0008-5472.CAN-12-2374. Epub 2013 Jan 29.
|
| 209 |
Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.Oncogene. 2019 Feb;38(8):1309-1323. doi: 10.1038/s41388-018-0527-2. Epub 2018 Oct 10.
|
| 210 |
Shikonin-induced Apoptosis of Colon Cancer Cells Is Reduced by Peroxiredoxin V Expression.Anticancer Res. 2019 Nov;39(11):6115-6123. doi: 10.21873/anticanres.13819.
|
| 211 |
Modulating PKC Activity to Target Wnt/-Catenin Signaling in Colon Cancer.Cancers (Basel). 2019 May 18;11(5):693. doi: 10.3390/cancers11050693.
|
| 212 |
Protein kinase C beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival.Oncotarget. 2016 Apr 12;7(15):20919-33. doi: 10.18632/oncotarget.8062.
|
| 213 |
Role and mechanism of circ-PRKCI in hepatocellular carcinoma.World J Gastroenterol. 2019 Apr 28;25(16):1964-1974. doi: 10.3748/wjg.v25.i16.1964.
|
| 214 |
PKC Phosphorylates SIRT6 to Mediate Fatty Acid -Oxidation in Colon Cancer Cells.Neoplasia. 2019 Jan;21(1):61-73. doi: 10.1016/j.neo.2018.11.008. Epub 2018 Nov 30.
|
| 215 |
Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.Oncol Rep. 2019 Mar;41(3):1691-1699. doi: 10.3892/or.2018.6938. Epub 2018 Dec 18.
|
| 216 |
PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.Biomed Pharmacother. 2018 Dec;108:194-200. doi: 10.1016/j.biopha.2018.09.031. Epub 2018 Sep 13.
|
| 217 |
DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells. J Cancer Res Clin Oncol. 2009 Dec;135(12):1791-8. doi: 10.1007/s00432-009-0627-z. Epub 2009 Jun 24.
|
| 218 |
Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition.Onco Targets Ther. 2019 Jul 16;12:5713-5728. doi: 10.2147/OTT.S208738. eCollection 2019.
|
| 219 |
The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis.Sci Rep. 2019 Dec 6;9(1):18557. doi: 10.1038/s41598-019-54931-3.
|
| 220 |
Ribosomal Protein L15 is involved in Colon Carcinogenesis.Int J Med Sci. 2019 Aug 6;16(8):1132-1141. doi: 10.7150/ijms.34386. eCollection 2019.
|
| 221 |
3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2.Cancer Lett. 2019 Apr 28;448:20-30. doi: 10.1016/j.canlet.2019.01.031. Epub 2019 Feb 1.
|
| 222 |
Overexpression of Chimeric RNA by Retroviral Transduction.Methods Mol Biol. 2020;2079:155-166. doi: 10.1007/978-1-4939-9904-0_12.
|
| 223 |
Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression.Cancer Lett. 2019 Apr 28;448:40-51. doi: 10.1016/j.canlet.2019.01.039. Epub 2019 Feb 8.
|
| 224 |
Discovery of common and rare genetic risk variants for colorectal cancer.Nat Genet. 2019 Jan;51(1):76-87. doi: 10.1038/s41588-018-0286-6. Epub 2018 Dec 3.
|
| 225 |
Novel Common Genetic Susceptibility Loci for Colorectal Cancer.J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099.
|
| 226 |
Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location.EBioMedicine. 2019 Dec;50:211-223. doi: 10.1016/j.ebiom.2019.11.003. Epub 2019 Nov 18.
|
| 227 |
Deficiency in STAT1 Signaling Predisposes Gut Inflammation and Prompts Colorectal Cancer Development.Cancers (Basel). 2018 Sep 19;10(9):341. doi: 10.3390/cancers10090341.
|
| 228 |
SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion.Cancer Immunol Res. 2019 Mar;7(3):414-427. doi: 10.1158/2326-6066.CIR-18-0126. Epub 2019 Jan 4.
|
| 229 |
Transforming growth factor alpha promotes tumorigenesis and regulates epithelial-mesenchymal transition modulation in colon cancer.Biochem Biophys Res Commun. 2018 Dec 2;506(4):901-906. doi: 10.1016/j.bbrc.2018.10.137. Epub 2018 Nov 2.
|
| 230 |
TGF-2, catalase activity, H(2)O(2) output and metastatic potential of diverse types of tumour.Free Radic Biol Med. 2019 Apr;134:282-287. doi: 10.1016/j.freeradbiomed.2019.01.010. Epub 2019 Jan 9.
|
| 231 |
Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway.Carcinogenesis. 2014 Feb;35(2):324-32. doi: 10.1093/carcin/bgt332. Epub 2013 Oct 1.
|
| 232 |
Overexpression of TrpC5 promotes tumor metastasis via the HIF-1-Twist signaling pathway in colon cancer.Clin Sci (Lond). 2017 Sep 22;131(19):2439-2450. doi: 10.1042/CS20171069. Print 2017 Oct 1.
|
| 233 |
Inhibition of TRPM7 suppresses cell proliferation of colon adenocarcinoma in vitro and induces hypomagnesemia in vivo without affecting azoxymethane-induced early colon cancer in mice.Cell Commun Signal. 2017 Aug 15;15(1):30. doi: 10.1186/s12964-017-0187-9.
|
| 234 |
Microarraybased analysis of COL11A1 and TWIST1 as important differentiallyexpressed pathogenic genes between left and rightsided colon cancer.Mol Med Rep. 2019 Nov;20(5):4202-4214. doi: 10.3892/mmr.2019.10667. Epub 2019 Sep 10.
|
| 235 |
Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer.BMC Cancer. 2008 Jul 25;8:210. doi: 10.1186/1471-2407-8-210.
|
| 236 |
Succinylation-dependent mitochondrial translocation of PKM2 promotes cell survival in response to nutritional stress.Cell Death Dis. 2019 Feb 20;10(3):170. doi: 10.1038/s41419-018-1271-9.
|
| 237 |
XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation.Oncogene. 2019 Feb;38(9):1448-1460. doi: 10.1038/s41388-018-0513-8. Epub 2018 Oct 1.
|
| 238 |
Traditional Chinese Medicine Curcumin Sensitizes Human Colon Cancer to Radiation by Altering the Expression of DNA Repair-related Genes.Anticancer Res. 2018 Jan;38(1):131-136. doi: 10.21873/anticanres.12200.
|
| 239 |
Novel association between heterozygous genotype of single nucleotide polymorphism C218T in drug transporter ABCC1 gene and increased risk of colon cancer.Saudi Med J. 2019 Mar;40(3):224-229. doi: 10.15537/smj.2019.3.23650.
|
| 240 |
Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.Cancer Lett. 2019 Feb 1;442:104-112. doi: 10.1016/j.canlet.2018.10.032. Epub 2018 Oct 28.
|
| 241 |
G protein-coupled receptor LGR6 is an independent risk factor for colon adenocarcinoma.Front Med. 2019 Aug;13(4):482-491. doi: 10.1007/s11684-018-0633-0. Epub 2018 Jul 4.
|
| 242 |
Recent studies on the identification of proliferative abnormalities and of oncogenic potential of cutaneous cells in individuals at increased risk of colon cancer.Semin Oncol. 1976 Dec;3(4):369-72.
|
| 243 |
TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production.Mol Cell Biochem. 2017 Jan;425(1-2):191-202. doi: 10.1007/s11010-016-2873-0. Epub 2016 Nov 12.
|
| 244 |
miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.Oncol Rep. 2017 Jan;37(1):123-130. doi: 10.3892/or.2016.5259. Epub 2016 Nov 18.
|
| 245 |
Differential coupling of the PAC1 SV1 splice variant on human colonic tumors to the activation of intracellular cAMP but not intracellular Ca2+ does not activate tumor proliferation.J Mol Neurosci. 2004;22(1-2):83-92. doi: 10.1385/JMN:22:1-2:83.
|
| 246 |
Adiponectin and colon cancer: evidence for inhibitory effects on viability and migration of human colorectal cell lines.Mol Cell Biochem. 2018 Nov;448(1-2):125-135. doi: 10.1007/s11010-018-3319-7. Epub 2018 Feb 14.
|
| 247 |
Small molecules related to adrenomedullin reduce tumor burden in a mouse model of colitis-associated colon cancer.Sci Rep. 2017 Dec 13;7(1):17488. doi: 10.1038/s41598-017-17573-x.
|
| 248 |
AGR2 is a target of canonical Wnt/-catenin signaling and is important for stemness maintenance in colorectal cancer stem cells.Biochem Biophys Res Commun. 2019 Aug 6;515(4):600-606. doi: 10.1016/j.bbrc.2019.05.154. Epub 2019 Jun 6.
|
| 249 |
Digital transcript profile analysis with aRNA-LongSAGE validates FERMT1 as a potential novel prognostic marker for colon cancer.Clin Cancer Res. 2011 May 1;17(9):2908-18. doi: 10.1158/1078-0432.CCR-10-2552. Epub 2011 Jan 10.
|
| 250 |
Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer.Int J Cancer. 2015 Aug 15;137(4):911-20. doi: 10.1002/ijc.29448. Epub 2015 Feb 5.
|
| 251 |
In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cells.Cancer Med. 2019 Sep;8(12):5662-5672. doi: 10.1002/cam4.2409. Epub 2019 Jul 31.
|
| 252 |
Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers. Chem Biol Interact. 2013 Feb 25;202(1-3):234-42.
|
| 253 |
SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.Gastroenterology. 2011 Jul;141(1):279-91, 291.e1-5. doi: 10.1053/j.gastro.2011.04.008. Epub 2011 Apr 16.
|
| 254 |
15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.FASEB J. 2015 Jun;29(6):2359-70. doi: 10.1096/fj.14-264515. Epub 2015 Feb 24.
|
| 255 |
Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor.Vascul Pharmacol. 2017 Feb;89:19-30. doi: 10.1016/j.vph.2016.10.004. Epub 2016 Oct 4.
|
| 256 |
Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism.Oncol Rep. 2017 Jan;37(1):601-607. doi: 10.3892/or.2016.5231. Epub 2016 Nov 8.
|
| 257 |
Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines.Oncol Rep. 2012 May;27(5):1541-7. doi: 10.3892/or.2012.1672. Epub 2012 Feb 3.
|
| 258 |
Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway.Cancer Manag Res. 2019 Oct 29;11:9057-9066. doi: 10.2147/CMAR.S185766. eCollection 2019.
|
| 259 |
Antitumour effect of glucooligosaccharides obtained via hydrolysis of -(1?)-glucan from Fomitopsis betulina.Mol Biol Rep. 2019 Dec;46(6):5977-5982. doi: 10.1007/s11033-019-05032-x. Epub 2019 Aug 22.
|
| 260 |
Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.PLoS One. 2013 Jul 1;8(7):e68072. doi: 10.1371/journal.pone.0068072. Print 2013.
|
| 261 |
Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population.J Appl Genet. 2010;51(3):343-52. doi: 10.1007/BF03208865.
|
| 262 |
Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819849068. doi: 10.1177/1533033819849068.
|
| 263 |
Upregulation of ASAP3 contributes to colorectal carcinogenesis and indicates poor survival outcome.Cancer Sci. 2017 Aug;108(8):1544-1555. doi: 10.1111/cas.13281. Epub 2017 Jun 14.
|
| 264 |
Prognostic value of humbug gene overexpression in stage II colon cancer.Hum Pathol. 2007 Jan;38(1):17-25. doi: 10.1016/j.humpath.2006.07.009. Epub 2006 Oct 3.
|
| 265 |
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.J Biol Chem. 2014 Sep 5;289(36):25306-16. doi: 10.1074/jbc.M114.557546. Epub 2014 Jul 18.
|
| 266 |
Genetic disruption of tubulin acetyltransferase, TAT1, inhibits proliferation and invasion of colon cancer cells through decreases in Wnt1/-catenin signaling.Biochem Biophys Res Commun. 2017 Jan 1;482(1):8-14. doi: 10.1016/j.bbrc.2016.11.039. Epub 2016 Nov 9.
|
| 267 |
Activating transcription factor 3 promotes colon cancer metastasis.Tumour Biol. 2014 Aug;35(8):8329-34. doi: 10.1007/s13277-014-2044-4. Epub 2014 May 24.
|
| 268 |
Alterations in the ATP2A2 gene in correlation with colon and lung cancer.Cancer Genet Cytogenet. 2006 Dec;171(2):105-11. doi: 10.1016/j.cancergencyto.2006.06.016.
|
| 269 |
A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.Cancer. 2018 Mar 1;124(5):1070-1082. doi: 10.1002/cncr.31136. Epub 2017 Nov 30.
|
| 270 |
Survivin-induced Aurora-B kinase activation: A mechanism by which APC mutations contribute to increased mitoses during colon cancer development.Am J Pathol. 2010 Dec;177(6):2816-26. doi: 10.2353/ajpath.2010.100047. Epub 2010 Nov 5.
|
| 271 |
Zinc--2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population.Int J Mol Sci. 2014 Dec 30;16(1):691-703. doi: 10.3390/ijms16010691.
|
| 272 |
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial.Br J Cancer. 2012 Mar 13;106(6):1239-45. doi: 10.1038/bjc.2012.53. Epub 2012 Feb 21.
|
| 273 |
Identification of a novel aspartic-like protease differentially expressed in human breast cancer cell lines.Biochim Biophys Acta. 2000 Jun 15;1501(2-3):125-37. doi: 10.1016/s0925-4439(00)00014-4.
|
| 274 |
BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.Biomed Pharmacother. 2016 Dec;84:191-198. doi: 10.1016/j.biopha.2016.09.021. Epub 2016 Sep 19.
|
| 275 |
Malignant transformation of normal enterocytes following downregulation of Bak expression.Digestion. 2008;77(1):48-56. doi: 10.1159/000121411. Epub 2008 Mar 18.
|
| 276 |
BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.PLoS One. 2019 Feb 4;14(2):e0211507. doi: 10.1371/journal.pone.0211507. eCollection 2019.
|
| 277 |
Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3/NF-B signaling pathway.Cancer Gene Ther. 2020 May;27(5):368-377. doi: 10.1038/s41417-019-0098-6. Epub 2019 Jun 11.
|
| 278 |
Targeted delivery of phycocyanin for the prevention of colon cancer using electrospun fibers.Food Funct. 2019 Apr 17;10(4):1816-1825. doi: 10.1039/c8fo02447b.
|
| 279 |
Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines.Anticancer Res. 1997 Nov-Dec;17(6D):4619-22.
|
| 280 |
MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA.J Cell Physiol. 2015 Mar;230(3):535-45. doi: 10.1002/jcp.24366.
|
| 281 |
Effects of Beclin 1 overexpression on aggressive phenotypes of colon cancer cells.Oncol Lett. 2019 Feb;17(2):2441-2450. doi: 10.3892/ol.2018.9817. Epub 2018 Dec 10.
|
| 282 |
gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res. 2009 Jan 15;69(2):573-82. doi: 10.1158/0008-5472.CAN-08-2088.
|
| 283 |
Effect of RNAi-mediated silencing of Livin gene on biological properties of colon cancer cell line LoVo.Genet Mol Res. 2014 May 16;13(2):3832-41. doi: 10.4238/2014.May.16.8.
|
| 284 |
Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of -catenin in colon cancer stem cells.Mol Carcinog. 2018 May;57(5):664-677. doi: 10.1002/mc.22791. Epub 2018 Mar 14.
|
| 285 |
Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.Int J Oncol. 2018 Nov;53(5):2091-2101. doi: 10.3892/ijo.2018.4527. Epub 2018 Aug 16.
|
| 286 |
A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival.J Natl Cancer Inst. 2015 Jun 13;107(9):djv160. doi: 10.1093/jnci/djv160. Print 2015 Sep.
|
| 287 |
BRCA2 Deletion Induces Alternative Lengthening of Telomeres in Telomerase Positive Colon Cancer Cells.Genes (Basel). 2019 Sep 10;10(9):697. doi: 10.3390/genes10090697.
|
| 288 |
miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1.Oncol Lett. 2019 Sep;18(3):2825-2834. doi: 10.3892/ol.2019.10629. Epub 2019 Jul 18.
|
| 289 |
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.J Pathol. 2020 Feb;250(2):134-147. doi: 10.1002/path.5347. Epub 2019 Dec 2.
|
| 290 |
C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I.Exp Ther Med. 2017 May;13(5):2493-2500. doi: 10.3892/etm.2017.4249. Epub 2017 Mar 21.
|
| 291 |
Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.Exp Cell Res. 2018 May 15;366(2):127-138. doi: 10.1016/j.yexcr.2018.03.009. Epub 2018 Mar 15.
|
| 292 |
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.Gut. 2015 Dec;64(12):1905-12. doi: 10.1136/gutjnl-2014-307663. Epub 2014 Nov 26.
|
| 293 |
Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis.Gut. 2016 Sep;65(9):1482-93. doi: 10.1136/gutjnl-2014-308614. Epub 2015 Jun 12.
|
| 294 |
Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.Carcinogenesis. 2004 Aug;25(8):1495-505. doi: 10.1093/carcin/bgh155. Epub 2004 Apr 1.
|
| 295 |
Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer.Genes Chromosomes Cancer. 2019 Jan;58(1):23-33. doi: 10.1002/gcc.22686. Epub 2018 Nov 18.
|
| 296 |
Suppressive effect of an analog of the antimicrobial peptide of LL?7 on colon cancer cells via exosomeencapsulated miRNAs.Int J Mol Med. 2018 Dec;42(6):3009-3016. doi: 10.3892/ijmm.2018.3875. Epub 2018 Sep 13.
|
| 297 |
Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas.Pathology. 2010 Jan;42(1):73-6. doi: 10.3109/00313020903434371.
|
| 298 |
microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer.Mol Cancer. 2014 May 26;13:124. doi: 10.1186/1476-4598-13-124.
|
| 299 |
Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population.Br J Cancer. 2017 Sep 5;117(6):898-906. doi: 10.1038/bjc.2017.242. Epub 2017 Aug 1.
|
| 300 |
miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.Sci Rep. 2019 Apr 1;9(1):5405. doi: 10.1038/s41598-019-41862-2.
|
| 301 |
Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation.Biochem Pharmacol. 2018 Mar;149:186-204. doi: 10.1016/j.bcp.2017.10.011. Epub 2017 Oct 23.
|
| 302 |
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients.Eur J Cancer. 2010 Aug;46(12):2304-13. doi: 10.1016/j.ejca.2010.05.011. Epub 2010 Jun 9.
|
| 303 |
Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.Chin J Integr Med. 2019 Jun;25(6):416-424. doi: 10.1007/s11655-018-2997-z. Epub 2018 Nov 27.
|
| 304 |
Dual-agonist occupancy of orexin receptor 1 and cholecystokinin A receptor heterodimers decreases G-protein-dependent signaling and migration in the human colon cancer cell line HT-29.Biochim Biophys Acta Mol Cell Res. 2017 Jul;1864(7):1153-1164. doi: 10.1016/j.bbamcr.2017.03.003. Epub 2017 Mar 10.
|
| 305 |
MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA.Oncotarget. 2017 Feb 28;8(9):14887-14896. doi: 10.18632/oncotarget.14841.
|
| 306 |
The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9.Dig Liver Dis. 2011 Jan;43(1):40-7. doi: 10.1016/j.dld.2010.05.013. Epub 2010 Jul 6.
|
| 307 |
Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1 and VEGF.Mol Carcinog. 2011 Sep;50(9):707-18. doi: 10.1002/mc.20736. Epub 2011 Jan 25.
|
| 308 |
NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expression.Cell Biol Int. 2018 May;42(5):589-597. doi: 10.1002/cbin.10935. Epub 2018 Feb 6.
|
| 309 |
Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo.Cell Biol Int. 2012 Aug 1;36(8):765-70. doi: 10.1042/CBI20110404.
|
| 310 |
Adiponectin and metformin additively attenuate IL1-induced malignant potential of colon cancer.Endocr Relat Cancer. 2013 Oct 24;20(6):849-59. doi: 10.1530/ERC-13-0240. Print 2013 Dec.
|
| 311 |
CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis.Clin Exp Metastasis. 2014 Dec;31(8):977-89. doi: 10.1007/s10585-014-9684-z. Epub 2014 Oct 18.
|
| 312 |
Overexpression of Evi-1 oncoprotein represses TGF- signaling in colorectal cancer.Mol Carcinog. 2013 Apr;52(4):255-264. doi: 10.1002/mc.21852. Epub 2011 Dec 7.
|
| 313 |
Modified TLR-mediated downregulation of miR-125b-5p enhances CD248 (endosialin)-induced metastasis and drug resistance in colorectal cancer cells.Mol Carcinog. 2020 Feb;59(2):154-167. doi: 10.1002/mc.23137. Epub 2019 Nov 19.
|
| 314 |
RETRACTED: KYA1797K down-regulates PD-L1 in colon cancer stem cells to block immune evasion by suppressing the -catenin/STT3 signaling pathway.Int Immunopharmacol. 2020 Jan;78:106003. doi: 10.1016/j.intimp.2019.106003. Epub 2019 Dec 5.
|
| 315 |
Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells.J Exp Clin Cancer Res. 2019 May 9;38(1):190. doi: 10.1186/s13046-019-1205-0.
|
| 316 |
CUB domain containing protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells.BMC Cancer. 2014 Oct 9;14:754. doi: 10.1186/1471-2407-14-754.
|
| 317 |
microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells.Cancer Res. 2009 Oct 15;69(20):8157-65. doi: 10.1158/0008-5472.CAN-09-1996. Epub 2009 Oct 13.
|
| 318 |
Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922.Oncotarget. 2016 Aug 2;7(31):49597-49610. doi: 10.18632/oncotarget.10414.
|
| 319 |
Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion.J Proteome Res. 2018 Jan 5;17(1):265-275. doi: 10.1021/acs.jproteome.7b00550. Epub 2017 Nov 7.
|
| 320 |
Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer.Clin Cancer Res. 2013 Nov 1;19(21):6006-19. doi: 10.1158/1078-0432.CCR-13-1130. Epub 2013 Sep 11.
|
| 321 |
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor.Mol Oncol. 2018 Mar;12(3):287-304. doi: 10.1002/1878-0261.12148. Epub 2018 Jan 28.
|
| 322 |
Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors.Bioorg Med Chem Lett. 2017 Sep 15;27(18):4399-4404. doi: 10.1016/j.bmcl.2017.08.018. Epub 2017 Aug 12.
|
| 323 |
NEAT1 promotes colon cancer progression through sponging miR-495-3p and activating CDK6 in vitro and in vivo.J Cell Physiol. 2019 Nov;234(11):19582-19591. doi: 10.1002/jcp.28557. Epub 2019 Jun 7.
|
| 324 |
Cyclin-dependent kinase 9 expression and its association with CD8(+) T cell infiltration in microsatellite-stable colorectal cancer.Oncol Lett. 2019 Dec;18(6):6046-6056. doi: 10.3892/ol.2019.10970. Epub 2019 Oct 8.
|
| 325 |
Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studies.Invest New Drugs. 2013 Apr;31(2):247-55. doi: 10.1007/s10637-012-9839-1. Epub 2012 Jun 2.
|
| 326 |
Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation.Am J Physiol Gastrointest Liver Physiol. 2008 Sep;295(3):G591-7. doi: 10.1152/ajpgi.00055.2008. Epub 2008 Jul 24.
|
| 327 |
Combined 5-FU and ChoK inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.PLoS One. 2013 Jun 10;8(6):e64961. doi: 10.1371/journal.pone.0064961. Print 2013.
|
| 328 |
REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival.Cell Death Dis. 2017 Jan 5;8(1):e2536. doi: 10.1038/cddis.2016.462.
|
| 329 |
The Role of M3 Muscarinic Receptor Ligand-Induced Kinase Signaling in Colon Cancer Progression.Cancers (Basel). 2019 Mar 5;11(3):308. doi: 10.3390/cancers11030308.
|
| 330 |
Up-regulation of CIT promotes the growth of colon cancer cells.Oncotarget. 2017 Jun 27;8(42):71954-71964. doi: 10.18632/oncotarget.18615. eCollection 2017 Sep 22.
|
| 331 |
Prognostic value of chloride channel accessory mRNA expression in colon cancer.Oncol Lett. 2019 Sep;18(3):2967-2976. doi: 10.3892/ol.2019.10615. Epub 2019 Jul 15.
|
| 332 |
CLIC1 overexpression is associated with poor prognosis in gallbladder cancer.Tumour Biol. 2015 Jan;36(1):193-8. doi: 10.1007/s13277-014-2606-5. Epub 2014 Sep 17.
|
| 333 |
The CLN3 gene is a novel molecular target for cancer drug discovery.Cancer Res. 2002 Feb 1;62(3):801-8.
|
| 334 |
Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.Oncogene. 2017 Feb 23;36(8):1069-1079. doi: 10.1038/onc.2016.271. Epub 2016 Aug 15.
|
| 335 |
Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissue.PLoS One. 2013 Sep 6;8(9):e73866. doi: 10.1371/journal.pone.0073866. eCollection 2013.
|
| 336 |
Integrated analysis of gene expression signatures associated with colon cancer from three datasets.Gene. 2018 May 15;654:95-102. doi: 10.1016/j.gene.2018.02.007. Epub 2018 Feb 3.
|
| 337 |
Cross talk between receptor guanylyl cyclase C and c-src tyrosine kinase regulates colon cancer cell cytostasis.Mol Cell Biol. 2009 Oct;29(19):5277-89. doi: 10.1128/MCB.00001-09. Epub 2009 Jul 20.
|
| 338 |
Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer.BMC Cancer. 2013 Jun 5;13:277. doi: 10.1186/1471-2407-13-277.
|
| 339 |
MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting subunit of protein kinase CKII in human colorectal cancer cells.Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):173-9. doi: 10.1016/j.bbrc.2012.10.117. Epub 2012 Nov 5.
|
| 340 |
Investigation of fusion gene expression in HCT116 cells.Oncol Lett. 2017 Dec;14(6):6962-6968. doi: 10.3892/ol.2017.7055. Epub 2017 Sep 25.
|
| 341 |
Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair.Clin Chem. 2017 Mar;63(3):700-713. doi: 10.1373/clinchem.2016.263582. Epub 2016 Dec 22.
|
| 342 |
High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.Ann Surg Oncol. 2015 Jul;22(7):2431-8. doi: 10.1245/s10434-014-4155-y. Epub 2014 Oct 28.
|
| 343 |
A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.Sci Rep. 2015 May 20;5:10442. doi: 10.1038/srep10442.
|
| 344 |
Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.Cell Commun Signal. 2019 Sep 10;17(1):119. doi: 10.1186/s12964-019-0432-5.
|
| 345 |
CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.Mol Cell Biochem. 2015 Feb;400(1-2):287-95. doi: 10.1007/s11010-014-2285-y. Epub 2014 Dec 5.
|
| 346 |
Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival.Cancer Sci. 2015 Mar;106(3):262-9. doi: 10.1111/cas.12603. Epub 2015 Mar 5.
|
| 347 |
CXCR4/TGF-1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.Cancer Biol Ther. 2020;21(3):258-268. doi: 10.1080/15384047.2019.1685157. Epub 2019 Dec 11.
|
| 348 |
Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.Gastroenterology. 2016 Jun;150(7):1633-1645. doi: 10.1053/j.gastro.2016.02.076. Epub 2016 Mar 8.
|
| 349 |
Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk.Mutat Res. 2002 Sep 30;506-507:175-85. doi: 10.1016/s0027-5107(02)00164-1.
|
| 350 |
Chemopreventive efficacy zingerone (4-[4-hydroxy-3-methylphenyl] butan-2-one) in experimental colon carcinogenesis in Wistar rats.Environ Toxicol. 2019 May;34(5):610-625. doi: 10.1002/tox.22727. Epub 2019 Feb 5.
|
| 351 |
Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer.Oncotarget. 2017 May 23;8(21):34773-34786. doi: 10.18632/oncotarget.16718.
|
| 352 |
A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.Oncotarget. 2017 May 23;8(21):35033-35047. doi: 10.18632/oncotarget.16591.
|
| 353 |
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.J Exp Clin Cancer Res. 2012 Sep 11;31(1):71. doi: 10.1186/1756-9966-31-71.
|
| 354 |
Fascin1 suppresses RIG-I-like receptor signaling and interferon- production by associating with IB kinase (IKK) in colon cancer.J Biol Chem. 2018 Apr 27;293(17):6326-6336. doi: 10.1074/jbc.M117.819201. Epub 2018 Mar 1.
|
| 355 |
Expression and new exon mutations of the human Beta defensins and their association on colon cancer development.PLoS One. 2015 Jun 3;10(6):e0126868. doi: 10.1371/journal.pone.0126868. eCollection 2015.
|
| 356 |
DEK Expression is controlled by E2F and deregulated in diverse tumor types.Cell Cycle. 2006 Jun;5(11):1202-7. doi: 10.4161/cc.5.11.2801. Epub 2006 Jun 1.
|
| 357 |
Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.Angiogenesis. 2017 Nov;20(4):547-555. doi: 10.1007/s10456-017-9566-5. Epub 2017 Jul 18.
|
| 358 |
Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells.J Biomol Struct Dyn. 2017 May;35(7):1474-1490. doi: 10.1080/07391102.2016.1186560. Epub 2016 Aug 5.
|
| 359 |
An apoptosis-independent role of SMAC in tumor suppression.Oncogene. 2013 May 9;32(19):2380-9. doi: 10.1038/onc.2012.265. Epub 2012 Jul 2.
|
| 360 |
Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines.Int J Cancer. 1999 Mar 15;80(6):919-29. doi: 10.1002/(sici)1097-0215(19990315)80:6<919::aid-ijc19>3.0.co;2-u.
|
| 361 |
Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations.Cancer Res. 2011 Mar 1;71(5):1520-5. doi: 10.1158/0008-5472.CAN-10-2817. Epub 2010 Dec 30.
|
| 362 |
Neutrophil extracellular traps promote peritoneal metastasis of colon cancer cells.Oncotarget. 2019 Feb 8;10(12):1238-1249. doi: 10.18632/oncotarget.26664. eCollection 2019 Feb 8.
|
| 363 |
Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.BMC Cancer. 2015 Nov 10;15:882. doi: 10.1186/s12885-015-1702-2.
|
| 364 |
Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.J Cancer Res Clin Oncol. 2011 Feb;137(2):201-10. doi: 10.1007/s00432-010-0872-1. Epub 2010 Apr 13.
|
| 365 |
Prognostic significance of miR-215 in colon cancer.Clin Colorectal Cancer. 2011 Dec;10(4):340-7. doi: 10.1016/j.clcc.2011.06.002. Epub 2011 Jul 12.
|
| 366 |
Novel function of MKP-5/DUSP10, a phosphatase of stress-activated kinases, on ERK-dependent gene expression, and upregulation of its gene expression in colon carcinomas.Oncol Rep. 2012 Sep;28(3):931-6. doi: 10.3892/or.2012.1862. Epub 2012 Jun 12.
|
| 367 |
E2F1 facilitates DNA break repair by localizing to break sites and enhancing the expression of homologous recombination factors.Exp Mol Med. 2019 Sep 18;51(9):1-12. doi: 10.1038/s12276-019-0307-2.
|
| 368 |
Systemic delivery of full-length C/EBP beta/liposome complex suppresses growth of human colon cancer in nude mice.Cell Res. 2005 Oct;15(10):770-6. doi: 10.1038/sj.cr.7290346.
|
| 369 |
Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer.Int J Cancer. 2013 Mar 1;132(5):1004-12. doi: 10.1002/ijc.27762. Epub 2012 Aug 24.
|
| 370 |
Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells.Autophagy. 2014 Sep;10(9):1495-508. doi: 10.4161/auto.29164. Epub 2014 Jun 19.
|
| 371 |
Bufalin-Loaded CaP/DPPE-PEG-EGF Nanospheres: Preparation, Cellular Uptake, Distribution, and Anti-Tumor Effects.J Biomed Nanotechnol. 2019 Feb 1;15(2):329-339. doi: 10.1166/jbn.2019.2681.
|
| 372 |
Vanillic Acid Suppresses HIF-1 Expression via Inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK Pathways in Human Colon Cancer HCT116 Cells.Int J Mol Sci. 2019 Jan 22;20(3):465. doi: 10.3390/ijms20030465.
|
| 373 |
Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling.Exp Cell Res. 2007 Feb 1;313(3):437-49. doi: 10.1016/j.yexcr.2006.09.030. Epub 2006 Oct 28.
|
| 374 |
Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-3 (E-NPP3/CD203c/PD-I beta/B10/gp130RB13-6) in human colon carcinoma.Int J Mol Med. 2003 Nov;12(5):763-6.
|
| 375 |
Construction of chimeric antigen receptormodified T cells targeting EpCAM and assessment of their antitumor effect on cancer cells.Mol Med Rep. 2019 Sep;20(3):2355-2364. doi: 10.3892/mmr.2019.10460. Epub 2019 Jul 3.
|
| 376 |
Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery.Int J Mol Sci. 2017 Feb 3;18(2):307. doi: 10.3390/ijms18020307.
|
| 377 |
EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer.Dig Dis Sci. 2019 Jun;64(6):1514-1522. doi: 10.1007/s10620-018-5421-9. Epub 2018 Dec 17.
|
| 378 |
Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab.PLoS One. 2018 Dec 17;13(12):e0208080. doi: 10.1371/journal.pone.0208080. eCollection 2018.
|
| 379 |
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers.Clin Chem. 2004 Mar;50(3):490-9. doi: 10.1373/clinchem.2003.026849. Epub 2004 Jan 15.
|
| 380 |
Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale.Adv Ther. 2019 Jun;36(6):1480-1484. doi: 10.1007/s12325-019-00949-y. Epub 2019 Apr 12.
|
| 381 |
EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer.Exp Mol Pathol. 2016 Jun;100(3):402-8. doi: 10.1016/j.yexmp.2016.03.011. Epub 2016 Apr 9.
|
| 382 |
Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.Mutat Res. 2012 Jun 1;734(1-2):30-40. doi: 10.1016/j.mrfmmm.2012.04.002. Epub 2012 Apr 15.
|
| 383 |
Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer.FEBS Lett. 2020 Mar;594(6):1021-1035. doi: 10.1002/1873-3468.13686. Epub 2019 Nov 29.
|
| 384 |
RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer.FEBS Lett. 2011 Aug 4;585(15):2537-44. doi: 10.1016/j.febslet.2011.07.005. Epub 2011 Jul 13.
|
| 385 |
Decreased expression of protease-activated receptor 4 in human gastric cancer.Int J Biochem Cell Biol. 2011 Sep;43(9):1277-83. doi: 10.1016/j.biocel.2011.05.008. Epub 2011 May 25.
|
| 386 |
A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.J Cancer Res Clin Oncol. 2013 Jun;139(6):1015-23. doi: 10.1007/s00432-013-1417-1. Epub 2013 Mar 15.
|
| 387 |
Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature.Am J Gastroenterol. 2002 Jul;97(7):1822-7. doi: 10.1111/j.1572-0241.2002.05850.x.
|
| 388 |
A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.Hum Mutat. 2013 Jan;34(1):200-9. doi: 10.1002/humu.22213. Epub 2012 Oct 11.
|
| 389 |
Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab.Cancer Immunol Res. 2015 May;3(5):567-74. doi: 10.1158/2326-6066.CIR-14-0188. Epub 2015 Mar 13.
|
| 390 |
Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis.Oncotarget. 2016 Aug 23;7(34):54415-54429. doi: 10.18632/oncotarget.10074.
|
| 391 |
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.Int J Nanomedicine. 2018 Nov 15;13:7533-7548. doi: 10.2147/IJN.S170692. eCollection 2018.
|
| 392 |
Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.Clin Genet. 2017 Nov;92(5):495-502. doi: 10.1111/cge.12968. Epub 2017 Aug 2.
|
| 393 |
Involvement of FFA1 and FFA4 in the regulation of cellular functions during tumor progression in colon cancer cells.Exp Cell Res. 2018 Aug 1;369(1):54-60. doi: 10.1016/j.yexcr.2018.05.005. Epub 2018 May 8.
|
| 394 |
Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.Int J Cancer. 2018 Aug 15;143(4):886-896. doi: 10.1002/ijc.31366. Epub 2018 Mar 30.
|
| 395 |
Upregulation of Fibroblast Growth Factor 19 Is Associated with the Initiation of Colorectal Adenoma.Dig Dis. 2019;37(3):214-225. doi: 10.1159/000494454. Epub 2018 Dec 5.
|
| 396 |
A transforming gene, hst, found in NIH 3T3 cells transformed with DNA from three stomach cancers and a colon cancer.Jpn J Cancer Res. 1987 Apr;78(4):325-8.
|
| 397 |
Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells.Dig Dis Sci. 2016 Feb;61(2):444-52. doi: 10.1007/s10620-015-3908-1. Epub 2015 Oct 29.
|
| 398 |
FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.Oncogene. 2013 Apr 25;32(17):2140-9. doi: 10.1038/onc.2012.228. Epub 2012 Jun 11.
|
| 399 |
Fos-like antigen 2 (FOSL2) promotes metastasis in colon cancer. Exp Cell Res. 2018 Dec 15;373(1-2):57-61.
|
| 400 |
Quxie Capsule Inhibits Colon Tumor Growth Partially Through Foxo1-Mediated Apoptosis and Immune Modulation.Integr Cancer Ther. 2019 Jan-Dec;18:1534735419846377. doi: 10.1177/1534735419846377.
|
| 401 |
Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.Anticancer Res. 2018 Aug;38(8):4417-4423. doi: 10.21873/anticanres.12743.
|
| 402 |
Formyl peptide receptor 2 mediated chemotherapeutics drug resistance in colon cancer cells.Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):95-100. doi: 10.26355/eurrev_201801_14105.
|
| 403 |
Studying human disease genes in Caenorhabditis elegans: a molecular genetics laboratory project.CBE Life Sci Educ. 2012 Summer;11(2):165-79. doi: 10.1187/cbe-11-06-0045.
|
| 404 |
Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - beta-catenin - TCF signaling pathway.Int J Mol Med. 2002 Feb;9(2):107-12.
|
| 405 |
Overexpression of FZD7 is associated with poor survival in patients with colon cancer.Pathol Res Pract. 2019 Aug;215(8):152478. doi: 10.1016/j.prp.2019.152478. Epub 2019 May 27.
|
| 406 |
The roles and mechanisms of G3BP1 in tumour promotion. J Drug Target. 2019 Mar;27(3):300-305.
|
| 407 |
Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.PLoS One. 2008 Apr 30;3(4):e2079. doi: 10.1371/journal.pone.0002079.
|
| 408 |
Genome-wide diet-gene interaction analyses for risk of colorectal cancer.PLoS Genet. 2014 Apr 17;10(4):e1004228. doi: 10.1371/journal.pgen.1004228. eCollection 2014 Apr.
|
| 409 |
Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.Oncotarget. 2018 Jan 31;9(12):10650-10664. doi: 10.18632/oncotarget.24367. eCollection 2018 Feb 13.
|
| 410 |
Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression.Biochem Biophys Res Commun. 2001 Aug 17;286(2):406-13. doi: 10.1006/bbrc.2001.5399.
|
| 411 |
siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.World J Gastroenterol. 2013 Nov 28;19(44):8108-13. doi: 10.3748/wjg.v19.i44.8108.
|
| 412 |
Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways.Eur J Pharmacol. 2016 Apr 5;776:124-31. doi: 10.1016/j.ejphar.2016.02.044. Epub 2016 Feb 12.
|
| 413 |
Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing.Oncotarget. 2016 Dec 6;7(49):80190-80207. doi: 10.18632/oncotarget.13376.
|
| 414 |
Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway.Oncotarget. 2017 Jun 22;8(33):54838-54857. doi: 10.18632/oncotarget.18601. eCollection 2017 Aug 15.
|
| 415 |
Geminin ablation in vivo enhances tumorigenesis through increased genomic instability.J Pathol. 2018 Oct;246(2):134-140. doi: 10.1002/path.5128. Epub 2018 Aug 21.
|
| 416 |
Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.Medicine (Baltimore). 2017 Nov;96(47):e8487. doi: 10.1097/MD.0000000000008487.
|
| 417 |
Phosphoglucose isomerase enhances colorectal cancer metastasis.Int J Oncol. 2009 Nov;35(5):1117-21. doi: 10.3892/ijo_00000427.
|
| 418 |
Down-regulation of GPR137 expression inhibits proliferation of colon cancer cells. RETRACTED ARTICLESee: Retraction NoticeActa Biochim Biophys Sin (Shanghai). 2014 Nov;46(11):935-41.
|
| 419 |
Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.Tumour Biol. 2019 Jun;41(6):1010428319858885. doi: 10.1177/1010428319858885.
|
| 420 |
Extravirgin olive oil up-regulates CB?tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms.J Nutr Biochem. 2015 Mar;26(3):250-8. doi: 10.1016/j.jnutbio.2014.10.013. Epub 2014 Dec 3.
|
| 421 |
Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.J Cell Biochem. 2019 Apr;120(4):5583-5596. doi: 10.1002/jcb.27842. Epub 2018 Nov 13.
|
| 422 |
The miR-487b-3p/GRM3/TGF signaling axis is an important regulator of colon cancer tumorigenesis.Oncogene. 2017 Jun 15;36(24):3477-3489. doi: 10.1038/onc.2016.499. Epub 2017 Jan 23.
|
| 423 |
Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients.J Cancer. 2019 Jan 30;10(5):1288-1296. doi: 10.7150/jca.28529. eCollection 2019.
|
| 424 |
Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.Mol Pharmacol. 1992 Jan;41(1):69-75.
|
| 425 |
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor. Nat Commun. 2016 Oct 5;7:13084.
|
| 426 |
Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent -Glucuronidase Inhibitors.Curr Cancer Drug Targets. 2019;19(11):906-918. doi: 10.2174/1568009619666190320102238.
|
| 427 |
Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment.Oncotarget. 2018 Jun 19;9(47):28364-28378. doi: 10.18632/oncotarget.25342. eCollection 2018 Jun 19.
|
| 428 |
Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression.Cancer Cell. 2017 Apr 10;31(4):563-575.e5. doi: 10.1016/j.ccell.2017.03.006.
|
| 429 |
Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A.Biochim Biophys Acta Mol Basis Dis. 2018 Nov;1864(11):3618-3628. doi: 10.1016/j.bbadis.2018.08.023. Epub 2018 Aug 18.
|
| 430 |
HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma.Oncol Lett. 2017 Oct;14(4):4923-4929. doi: 10.3892/ol.2017.6818. Epub 2017 Aug 24.
|
| 431 |
Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.Biochem J. 2009 Jan 1;417(1):379-89. doi: 10.1042/BJ20081132.
|
| 432 |
Histone deacetylase 6 is overexpressed and promotes tumor growth of colon cancer through regulation of the MAPK/ERK signal pathway.Onco Targets Ther. 2019 Apr 2;12:2409-2419. doi: 10.2147/OTT.S194986. eCollection 2019.
|
| 433 |
Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3(+) regulatory T cells in murine colon cancer.Oncoimmunology. 2017 Feb 10;6(3):e1290034. doi: 10.1080/2162402X.2017.1290034. eCollection 2017.
|
| 434 |
Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).Development. 2005 Jan;132(2):415-27. doi: 10.1242/dev.01579. Epub 2004 Dec 16.
|
| 435 |
A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition.Nat Biotechnol. 2001 May;19(5):434-9. doi: 10.1038/88099.
|
| 436 |
Correlation of ERK/MAPK signaling pathway with proliferation and apoptosis of colon cancer cells.Oncol Lett. 2019 Feb;17(2):2266-2270. doi: 10.3892/ol.2018.9857. Epub 2018 Dec 20.
|
| 437 |
Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function.Am J Pathol. 2011 May;178(5):1986-98. doi: 10.1016/j.ajpath.2011.01.021.
|
| 438 |
Predictive value of different proportion of lesion HLA-G expression in colorectal cancer.Oncotarget. 2017 Nov 18;8(64):107441-107451. doi: 10.18632/oncotarget.22487. eCollection 2017 Dec 8.
|
| 439 |
KLF4 sensitizes the colon cancer cell HCT-15 to cisplatin by altering the expression of HMGB1 and hTERT.Life Sci. 2019 Mar 1;220:169-176. doi: 10.1016/j.lfs.2019.02.005. Epub 2019 Feb 2.
|
| 440 |
Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study.Br J Cancer. 2017 Jun 6;116(12):1652-1659. doi: 10.1038/bjc.2017.139. Epub 2017 May 18.
|
| 441 |
Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer prevention.Sci Rep. 2019 Apr 17;9(1):6192. doi: 10.1038/s41598-019-42363-y.
|
| 442 |
microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1.Oncogene. 2014 Oct 2;33(40):4847-56. doi: 10.1038/onc.2013.429. Epub 2013 Oct 28.
|
| 443 |
A novel long non-coding RNA from the HOXA6-HOXA5 locus facilitates colon cancer cell growth.BMC Cancer. 2019 Jun 3;19(1):532. doi: 10.1186/s12885-019-5715-0.
|
| 444 |
Graphene OxidePEGProtocatechuic Acid Nanocomposite Formulation with Improved Anticancer Properties.Nanomaterials (Basel). 2018 Oct 11;8(10):820. doi: 10.3390/nano8100820.
|
| 445 |
Insulin, CCAAT/enhancer-binding proteins and lactate regulate the human 11-hydroxysteroid dehydrogenase type 2 gene expression in colon cancer cell lines.PLoS One. 2014 Aug 18;9(8):e105354. doi: 10.1371/journal.pone.0105354. eCollection 2014.
|
| 446 |
Developing antineoplastic agents that target peroxisomal enzymes: cytisine-linked isoflavonoids as inhibitors of hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4).Org Biomol Chem. 2017 Sep 20;15(36):7623-7629. doi: 10.1039/c7ob01584d.
|
| 447 |
Polymer mediated transport of the Hsp90 inhibitor LB76, a polar cyclic peptide, produces an Hsp90 cellular phenotype.Chem Commun (Camb). 2019 Apr 11;55(31):4515-4518. doi: 10.1039/c9cc00890j.
|
| 448 |
Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94.Curr Top Med Chem. 2016;16(25):2765-78. doi: 10.2174/1568026616666160413141613.
|
| 449 |
Antiproliferative effect of p-Coumaric acid targets UPR activation by downregulating Grp78 in colon cancer. Chem Biol Interact. 2018 Aug 1;291:16-28. doi: 10.1016/j.cbi.2018.06.001. Epub 2018 Jun 5.
|
| 450 |
Heat shock cognate protein 70 encodes antigenic epitopes recognised by HLA-B4601-restricted cytotoxic T lymphocytes from cancer patients.Br J Cancer. 2003 Sep 15;89(6):1079-85. doi: 10.1038/sj.bjc.6601203.
|
| 451 |
Associations of ICOS and PD.1 Gene Variants with Colon Cancer Risk in The Iranian Population.Asian Pac J Cancer Prev. 2018 Mar 27;19(3):693-698. doi: 10.22034/APJCP.2018.19.3.693.
|
| 452 |
Polymorphisms in the ICOS/CD28-ICOSL pathway are related to capecitabine-based chemotherapy response in advanced colon cancer patients.Mol Immunol. 2018 Apr;96:78-82. doi: 10.1016/j.molimm.2018.02.017. Epub 2018 Mar 5.
|
| 453 |
Insights into Resistance Mechanisms of Inhibitors to Mps1 C604Y Mutation via a Comprehensive Molecular Modeling Study.Molecules. 2018 Jun 20;23(6):1488. doi: 10.3390/molecules23061488.
|
| 454 |
Changes Due to Ageing in the Glycan Structure of Alpha-2-Macroglobulin and Its Reactivity with Ligands.Protein J. 2019 Feb;38(1):23-29. doi: 10.1007/s10930-018-9806-6.
|
| 455 |
Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.Cancer Causes Control. 2012 Jul;23(7):1127-38. doi: 10.1007/s10552-012-9981-2. Epub 2012 May 8.
|
| 456 |
The role of IGFBP-5 in mediating the anti-proliferation effect of tetrandrine in human colon cancer cells.Int J Oncol. 2015 Mar;46(3):1205-13. doi: 10.3892/ijo.2014.2800. Epub 2014 Dec 17.
|
| 457 |
Elevated expression of tumor necrosis factor-alpha signaling molecules in colonic tumors of Zucker obese (fa/fa) rats.Int J Cancer. 2010 Nov 1;127(9):2042-50. doi: 10.1002/ijc.25232.
|
| 458 |
Helminth-derived molecules inhibit colitis-associated colon cancer development through NF-B and STAT3 regulation.Int J Cancer. 2019 Dec 1;145(11):3126-3139. doi: 10.1002/ijc.32626. Epub 2019 Aug 30.
|
| 459 |
The immune microenvironment of the colorectal tumor: Involvement of immunity genes and microRNAs belonging to the TH17 pathway.Biochim Biophys Acta. 2015 Aug;1856(1):28-38. doi: 10.1016/j.bbcan.2015.04.001. Epub 2015 Apr 21.
|
| 460 |
Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma.Oncology. 2005;68(2-3):138-45. doi: 10.1159/000086768. Epub 2005 Jul 4.
|
| 461 |
Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis.J Biol Chem. 2015 Sep 4;290(36):22212-24. doi: 10.1074/jbc.M115.644823. Epub 2015 Jul 24.
|
| 462 |
IL-21 Enhances the Development of Colitis-Associated Colon Cancer: Possible Involvement of Activation-Induced Cytidine Deaminase Expression.J Immunol. 2019 Jun 1;202(11):3326-3333. doi: 10.4049/jimmunol.1800550. Epub 2019 Apr 24.
|
| 463 |
Interleukin (IL)-22 from IL-20 Subfamily of Cytokines Induces Colonic Epithelial Cell Proliferation Predominantly through ERK1/2 Pathway.Int J Mol Sci. 2019 Jul 15;20(14):3468. doi: 10.3390/ijms20143468.
|
| 464 |
IL-32 expression indicates unfavorable prognosis in patients with colon cancer.Oncol Lett. 2019 May;17(5):4655-4660. doi: 10.3892/ol.2019.10136. Epub 2019 Mar 12.
|
| 465 |
Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survival.Sci Signal. 2017 Oct 10;10(500):eaam5353. doi: 10.1126/scisignal.aam5353.
|
| 466 |
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis.Cell Rep. 2018 Dec 11;25(11):3036-3046.e6. doi: 10.1016/j.celrep.2018.11.050.
|
| 467 |
Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.J Cancer Res Clin Oncol. 2015 Dec;141(12):2097-107. doi: 10.1007/s00432-015-1972-8. Epub 2015 Apr 23.
|
| 468 |
Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.Int J Pharm. 2009 Jan 21;366(1-2):201-10. doi: 10.1016/j.ijpharm.2008.09.016. Epub 2008 Sep 19.
|
| 469 |
MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3.Cell Physiol Biochem. 2016;39(3):1165-76. doi: 10.1159/000447823. Epub 2016 Aug 31.
|
| 470 |
Tumor specific delivery and therapy mediate by integrin 6-target immunoliposomes for 6-siRNA in colon carcinoma.Oncotarget. 2016 Dec 20;7(51):85163-85175. doi: 10.18632/oncotarget.13209.
|
| 471 |
Long noncoding RNA ENST00000455974 plays an oncogenic role through up-regulating JAG2 in human DNA mismatch repair-proficient colon cancer.Biochem Biophys Res Commun. 2019 Jan 8;508(2):339-347. doi: 10.1016/j.bbrc.2018.11.088. Epub 2018 Nov 23.
|
| 472 |
Association analyses of the JAK/STAT signaling pathway with the progression and prognosis of colon cancer.Oncol Lett. 2019 Jan;17(1):159-164. doi: 10.3892/ol.2018.9569. Epub 2018 Oct 12.
|
| 473 |
Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2.Am J Cancer Res. 2018 May 1;8(5):852-865. eCollection 2018.
|
| 474 |
Downregulation of the hexokinase II gene sensitizes human colon cancer cells to 5-fluorouracil.Chemotherapy. 2008;54(5):357-63. doi: 10.1159/000153655. Epub 2008 Sep 5.
|
| 475 |
Activity of voltage-gated K+ channels is associated with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer.Life Sci. 1999;65(1):55-62. doi: 10.1016/s0024-3205(99)00218-0.
|
| 476 |
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.Cancer Res. 2016 Sep 1;76(17):5103-14. doi: 10.1158/0008-5472.CAN-15-2980. Epub 2016 Apr 20.
|
| 477 |
[Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin].Ai Zheng. 2005 Aug;24(8):924-9.
|
| 478 |
Silencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1.Cell Rep. 2014 Jul 24;8(2):501-13. doi: 10.1016/j.celrep.2014.06.035. Epub 2014 Jul 17.
|
| 479 |
Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.Mol Cell. 2019 Jun 20;74(6):1250-1263.e6. doi: 10.1016/j.molcel.2019.04.009. Epub 2019 May 1.
|
| 480 |
The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.J Cell Biochem. 2012 Apr;113(4):1368-76. doi: 10.1002/jcb.24009.
|
| 481 |
KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1.Biomed Pharmacother. 2018 Nov;107:1205-1209. doi: 10.1016/j.biopha.2018.08.041. Epub 2018 Aug 29.
|
| 482 |
Kisspeptin effect on endothelial monocyte activating polypeptide II (EMAP-II)-associated lymphocyte cell death and metastases in colorectal cancer patients.Mol Med. 2014 Mar 18;20(1):80-92. doi: 10.2119/molmed.2013.00151.
|
| 483 |
Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.Biol Chem. 2014 Sep;395(9):1075-86. doi: 10.1515/hsz-2014-0142.
|
| 484 |
Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein.Oncotarget. 2019 Oct 22;10(58):6062-6078. doi: 10.18632/oncotarget.27153. eCollection 2019 Oct 22.
|
| 485 |
Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice.Int J Nanomedicine. 2017 Apr 13;12:3095-3107. doi: 10.2147/IJN.S128032. eCollection 2017.
|
| 486 |
Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.PLoS One. 2016 Jul 8;11(7):e0158715. doi: 10.1371/journal.pone.0158715. eCollection 2016.
|
| 487 |
Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases.Eur J Immunol. 2001 Feb;31(2):323-32. doi: 10.1002/1521-4141(200102)31:2<323::aid-immu323>3.0.co;2-0.
|
| 488 |
Reduced Lipocalin 2 Expression Contributes to Vincristine Resistance in Human Colon Cancer Cells.Recent Pat Anticancer Drug Discov. 2018;13(2):248-254. doi: 10.2174/1574892813666171221120504.
|
| 489 |
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.BMC Cancer. 2019 Feb 15;19(1):155. doi: 10.1186/s12885-019-5327-8.
|
| 490 |
Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin.JCI Insight. 2018 Jul 26;3(14):e121221. doi: 10.1172/jci.insight.121221. eCollection 2018 Jul 26.
|
| 491 |
Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma.Int J Oncol. 2011 Aug;39(2):337-44. doi: 10.3892/ijo.2011.1050. Epub 2011 May 23.
|
| 492 |
Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer.Sci Rep. 2017 Mar 30;7:45624. doi: 10.1038/srep45624.
|
| 493 |
Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.Genes Chromosomes Cancer. 2017 Apr;56(4):285-295. doi: 10.1002/gcc.22434. Epub 2017 Jan 25.
|
| 494 |
Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate.Cancer Res. 1992 Jun 15;52(12):3378-83.
|
| 495 |
Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients.Oncotarget. 2016 May 26;8(36):60015-60024. doi: 10.18632/oncotarget.9623. eCollection 2017 Sep 1.
|
| 496 |
LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival.Clin Cancer Res. 2015 Nov 1;21(21):4892-902. doi: 10.1158/1078-0432.CCR-14-3096. Epub 2015 Jul 23.
|
| 497 |
MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.Gastroenterology. 2011 Mar;140(3):924-34. doi: 10.1053/j.gastro.2010.11.054. Epub 2010 Dec 4.
|
| 498 |
Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells.Tumour Biol. 2012 Dec;33(6):1899-905. doi: 10.1007/s13277-012-0450-z. Epub 2012 Jul 5.
|
| 499 |
Platelets subvert T cell immunity against cancer via GARP-TGF axis.Sci Immunol. 2017 May 5;2(11):eaai7911. doi: 10.1126/sciimmunol.aai7911.
|
| 500 |
Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.Oncogene. 2015 Aug 20;34(34):4519-30. doi: 10.1038/onc.2014.386. Epub 2014 Dec 8.
|
| 501 |
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene.Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7859-64. doi: 10.1073/pnas.1332465100. Epub 2003 Jun 16.
|
| 502 |
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer.Cancer Discov. 2019 Sep;9(9):1182-1191. doi: 10.1158/2159-8290.CD-19-0356. Epub 2019 Jun 21.
|
| 503 |
Gamma-secretase inhibition attenuates oxaliplatin-induced apoptosis through increased Mcl-1 and/or Bcl-xL in human colon cancer cells.Apoptosis. 2013 Oct;18(10):1163-74. doi: 10.1007/s10495-013-0883-x.
|
| 504 |
Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis.Cancer Res. 2016 Feb 1;76(3):724-35. doi: 10.1158/0008-5472.CAN-15-0701-T. Epub 2015 Dec 4.
|
| 505 |
ASK1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis.JCI Insight. 2017 Sep 21;2(18):e91828. doi: 10.1172/jci.insight.91828. eCollection 2017 Sep 21.
|
| 506 |
The Level of TWIST1 expression determines the response of colon cancer cells to mitogen-activated protein kinases inhibitors.Saudi J Gastroenterol. 2018 Jan-Feb;24(1):37-45. doi: 10.4103/sjg.SJG_270_17.
|
| 507 |
Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines.Br J Cancer. 2009 May 5;100(9):1415-24. doi: 10.1038/sj.bjc.6605021. Epub 2009 Apr 7.
|
| 508 |
Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival.Oncogene. 2015 Feb 26;34(9):1150-9. doi: 10.1038/onc.2014.40. Epub 2014 Mar 24.
|
| 509 |
Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.Am J Pathol. 2003 May;162(5):1503-13. doi: 10.1016/S0002-9440(10)64283-6.
|
| 510 |
Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis.BMC Cancer. 2014 Mar 17;14:196. doi: 10.1186/1471-2407-14-196.
|
| 511 |
Myc-Associated Zinc Finger Protein Regulates the Proinflammatory Response in Colitis and Colon Cancer via STAT3 Signaling.Mol Cell Biol. 2018 Oct 29;38(22):e00386-18. doi: 10.1128/MCB.00386-18. Print 2018 Nov 15.
|
| 512 |
Evidence Suggests Sphingosine 1-Phosphate Might Be Actively Generated, Degraded, and Transported to Extracellular Spaces With Increased S1P(2) and S1P(3) Expression in ColonCancer.Clin Colorectal Cancer. 2018 Jun;17(2):e171-e182. doi: 10.1016/j.clcc.2017.11.004. Epub 2017 Nov 21.
|
| 513 |
Correlations of MC4R and MSH2 expression with obesity in colon cancer patients.Eur Rev Med Pharmacol Sci. 2017 May;21(9):2108-2113.
|
| 514 |
Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate Cancer Cells In-Vitro.Asian Pac J Cancer Prev. 2019 Nov 1;20(11):3341-3351. doi: 10.31557/APJCP.2019.20.11.3341.
|
| 515 |
Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression.Nat Commun. 2018 Jul 3;9(1):2574. doi: 10.1038/s41467-018-04999-8.
|
| 516 |
Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats.Chem Biol Interact. 2009 Jan 27;177(2):128-36. doi: 10.1016/j.cbi.2008.10.047. Epub 2008 Nov 5.
|
| 517 |
CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases.Cancer Res. 2018 Dec 1;78(23):6594-6606. doi: 10.1158/0008-5472.CAN-18-1583. Epub 2018 Sep 5.
|
| 518 |
DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.Int J Cancer. 2020 Jan 15;146(2):363-372. doi: 10.1002/ijc.32516. Epub 2019 Jul 4.
|
| 519 |
USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer.FEBS Lett. 2019 Feb;593(4):406-413. doi: 10.1002/1873-3468.13323. Epub 2019 Jan 16.
|
| 520 |
Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential.Oncogene. 2003 Jan 16;22(2):186-97. doi: 10.1038/sj.onc.1206075.
|
| 521 |
Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk.J Nutrigenet Nutrigenomics. 2008;1(4):196-204. doi: 10.1159/000136651. Epub 2008 Jun 2.
|
| 522 |
Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.Carcinogenesis. 2009 Aug;30(8):1452-8. doi: 10.1093/carcin/bgp137. Epub 2009 Jun 11.
|
| 523 |
Abrogation of MUC5AC Expression Contributes to the Apoptosis and Cell Cycle Arrest of Colon Cancer Cells.Cancer Biother Radiopharm. 2016 Sep;31(7):261-7. doi: 10.1089/cbr.2016.2054.
|
| 524 |
A human MUTYH variant linking colonic polyposis to redox degradation of the [4Fe4S](2+) cluster.Nat Chem. 2018 Aug;10(8):873-880. doi: 10.1038/s41557-018-0068-x. Epub 2018 Jun 18.
|
| 525 |
Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers.Genes Chromosomes Cancer. 2006 Dec;45(12):1143-54. doi: 10.1002/gcc.20378.
|
| 526 |
Overexpression of MYC binding protein promotes invasion and migration in gastric cancer.Oncol Lett. 2018 Apr;15(4):5243-5249. doi: 10.3892/ol.2018.7944. Epub 2018 Feb 2.
|
| 527 |
Single nucleotide polymorphisms in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans.PLoS One. 2018 Aug 30;13(8):e0200916. doi: 10.1371/journal.pone.0200916. eCollection 2018.
|
| 528 |
Defective IL-23/IL-17 Axis Protects p47phox-/- Mice from Colon Cancer.Front Immunol. 2017 Jan 27;8:44. doi: 10.3389/fimmu.2017.00044. eCollection 2017.
|
| 529 |
Nucleolin facilitates nuclear retention of an ultraconserved region containing TRA24 and accelerates colon cancer cell growth.Oncotarget. 2018 Jun 1;9(42):26817-26833. doi: 10.18632/oncotarget.25510. eCollection 2018 Jun 1.
|
| 530 |
NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines.J Cancer. 2018 Jul 30;9(17):3032-3037. doi: 10.7150/jca.26256. eCollection 2018.
|
| 531 |
Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway.J Virol. 2017 Apr 28;91(10):e02191-16. doi: 10.1128/JVI.02191-16. Print 2017 May 15.
|
| 532 |
The Nedd8-activating enzyme inhibitor MLN4924 suppresses colon cancer cell growth via triggering autophagy.Korean J Physiol Pharmacol. 2018 Nov;22(6):617-625. doi: 10.4196/kjpp.2018.22.6.617. Epub 2018 Oct 25.
|
| 533 |
Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine.Mol Oncol. 2017 Aug;11(8):1065-1077. doi: 10.1002/1878-0261.12074. Epub 2017 May 30.
|
| 534 |
IBK and NFB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry.Carcinogenesis. 2013 Jan;34(1):79-85. doi: 10.1093/carcin/bgs296. Epub 2012 Sep 22.
|
| 535 |
SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.Cancer Res. 2007 Oct 1;67(19):9568-76. doi: 10.1158/0008-5472.CAN-06-2707.
|
| 536 |
The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis.J Immunol. 2015 Apr 1;194(7):3369-80. doi: 10.4049/jimmunol.1402098. Epub 2015 Feb 27.
|
| 537 |
The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.Cell Rep. 2016 Mar 22;14(11):2562-75. doi: 10.1016/j.celrep.2016.02.064. Epub 2016 Mar 10.
|
| 538 |
Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran.Antioxid Redox Signal. 2013 Sep 20;19(9):899-911. doi: 10.1089/ars.2012.4736. Epub 2013 Mar 4.
|
| 539 |
NOTCH1 activates the Wnt/-catenin signaling pathway in colon cancer.Oncotarget. 2017 Jul 25;8(36):60378-60389. doi: 10.18632/oncotarget.19534. eCollection 2017 Sep 1.
|
| 540 |
Proteomic and functional investigation of the colon cancer relapse-associated genes NOX4 and ITGA3.J Proteome Res. 2014 Nov 7;13(11):4910-8. doi: 10.1021/pr500557n. Epub 2014 Aug 18.
|
| 541 |
Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids.Oncotarget. 2018 Jun 19;9(47):28717-28730. doi: 10.18632/oncotarget.25617. eCollection 2018 Jun 19.
|
| 542 |
Anthocyanin Encapsulated by Ferulic Acid-Grafted-Maltodextrin (FA-g-MD) Microcapsules Potentially Improved its Free Radical Scavenging Capabilities Against H(2)O(2)-Induced Oxidative Stress.Molecules. 2019 Apr 23;24(8):1596. doi: 10.3390/molecules24081596.
|
| 543 |
Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells.J Nutr. 2016 Feb;146(2):236-42. doi: 10.3945/jn.115.216580. Epub 2015 Nov 25.
|
| 544 |
Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.BMC Cancer. 2010 May 14;10:207. doi: 10.1186/1471-2407-10-207.
|
| 545 |
Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.Eur J Cancer. 2013 Nov;49(16):3420-30. doi: 10.1016/j.ejca.2013.06.001. Epub 2013 Jun 25.
|
| 546 |
MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.Gene. 2018 Feb 5;642:354-361. doi: 10.1016/j.gene.2017.11.019. Epub 2017 Nov 8.
|
| 547 |
Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.Ann Surg. 2017 Nov;266(5):765-771. doi: 10.1097/SLA.0000000000002430.
|
| 548 |
Analysis of risk factors for colon cancer progression.Onco Targets Ther. 2019 May 22;12:3991-4000. doi: 10.2147/OTT.S207390. eCollection 2019.
|
| 549 |
Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer.World J Surg. 2009 May;33(5):1053-7. doi: 10.1007/s00268-008-9909-x.
|
| 550 |
ypoxia-inducible factor 1- promotes colon cell proliferation and migration by upregulating AMPK-related protein kinase 5 under hypoxic conditions.Oncol Lett. 2018 Mar;15(3):3639-3645. doi: 10.3892/ol.2018.7748. Epub 2018 Jan 8.
|
| 551 |
Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells.Biochem Biophys Res Commun. 2015 Mar 27;459(1):29-35. doi: 10.1016/j.bbrc.2015.02.043. Epub 2015 Feb 19.
|
| 552 |
Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses.Cancer Res. 2018 Aug 1;78(15):4303-4315. doi: 10.1158/0008-5472.CAN-18-0116. Epub 2018 May 31.
|
| 553 |
Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model.Front Oncol. 2019 Sep 19;9:927. doi: 10.3389/fonc.2019.00927. eCollection 2019.
|
| 554 |
TRPC1 and ORAI1 channels in colon cancer.Cell Calcium. 2019 Jul;81:59-66. doi: 10.1016/j.ceca.2019.06.003. Epub 2019 Jun 7.
|
| 555 |
Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.PLoS One. 2009 Aug 7;4(8):e6555. doi: 10.1371/journal.pone.0006555.
|
| 556 |
PADI3 plays an antitumor role via the Hsp90/CKS1 pathway in colon cancer.Cancer Cell Int. 2019 Nov 5;19:277. doi: 10.1186/s12935-019-0999-3. eCollection 2019.
|
| 557 |
PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth.Cell Death Dis. 2017 May 25;8(5):e2820. doi: 10.1038/cddis.2017.85.
|
| 558 |
Biophysical characterization and structural determination of the potent cytotoxic Psathyrella asperospora lectin.Proteins. 2017 May;85(5):969-975. doi: 10.1002/prot.25265. Epub 2017 Mar 7.
|
| 559 |
The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.Apoptosis. 2011 Dec;16(12):1285-94. doi: 10.1007/s10495-011-0648-3.
|
| 560 |
The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.J Pathol. 2018 Jan;244(1):36-48. doi: 10.1002/path.4986. Epub 2017 Nov 27.
|
| 561 |
Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer.Arch Med Sci. 2019 May;15(3):559-569. doi: 10.5114/aoms.2019.84732. Epub 2019 Apr 30.
|
| 562 |
Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer.Int J Oncol. 2018 Oct;53(4):1442-1454. doi: 10.3892/ijo.2018.4489. Epub 2018 Jul 19.
|
| 563 |
Combination of attenuated Salmonella carrying PD-1 siRNA with nifuroxazide for colon cancer therapy.J Cell Biochem. 2020 Feb;121(2):1973-1985. doi: 10.1002/jcb.29432. Epub 2019 Nov 6.
|
| 564 |
The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer.PLoS Genet. 2018 Sep 6;14(9):e1007611. doi: 10.1371/journal.pgen.1007611. eCollection 2018 Sep.
|
| 565 |
Phosphodiesterase-5 inhibition suppresses colonic inflammation-induced tumorigenesis via blocking the recruitment of MDSC.Am J Cancer Res. 2017 Jan 1;7(1):41-52. eCollection 2017.
|
| 566 |
Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.Nutr Cancer. 2011 Nov;63(8):1226-34. doi: 10.1080/01635581.2011.607545. Epub 2011 Oct 14.
|
| 567 |
Evidence for various 20q status using allelotyping, CGH arrays, and quantitative PCR in distal CIN colon cancers.Cancer Lett. 2009 Sep 18;282(2):195-204. doi: 10.1016/j.canlet.2009.03.012. Epub 2009 Apr 25.
|
| 568 |
PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.Int J Mol Sci. 2019 Oct 30;20(21):5415. doi: 10.3390/ijms20215415.
|
| 569 |
CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling.Int J Colorectal Dis. 2013 Nov;28(11):1479-87. doi: 10.1007/s00384-013-1712-y. Epub 2013 May 7.
|
| 570 |
Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53. Nat Commun. 2016 Dec 23;7:13755.
|
| 571 |
The effect of omentin-1 on the proliferation and apoptosis of colon cancer stem cells and the potential mechanism.J BUON. 2019 Jan-Feb;24(1):91-98.
|
| 572 |
NF-B potentiates tumor growth by suppressing a novel target LPTS.Cell Commun Signal. 2017 Oct 10;15(1):39. doi: 10.1186/s12964-017-0196-8.
|
| 573 |
Circular RNA PIP5K1A promotes colon cancer development through inhibiting miR-1273a.World J Gastroenterol. 2019 Sep 21;25(35):5300-5309. doi: 10.3748/wjg.v25.i35.5300.
|
| 574 |
PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway.Mol Cancer. 2018 Jan 24;17(1):13. doi: 10.1186/s12943-017-0747-z.
|
| 575 |
HT-29 human colon cancer cell proliferation is regulated by cytosolic phospholipase A(2) dependent PGE(2)via both PKA and PKB pathways.Biochim Biophys Acta. 2012 Sep;1821(9):1224-34. doi: 10.1016/j.bbalip.2012.06.005. Epub 2012 Jun 19.
|
| 576 |
Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter.BioDrugs. 2010 Apr 1;24(2):131-46. doi: 10.2165/11530840-000000000-00000.
|
| 577 |
Phosphoinositide-specific phospholipase C1 inhibition induces autophagy in human colon cancer and hepatocellular carcinoma cells.Sci Rep. 2017 Oct 24;7(1):13912. doi: 10.1038/s41598-017-13334-y.
|
| 578 |
PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells.Nat Commun. 2018 Mar 16;9(1):1106. doi: 10.1038/s41467-018-03494-4.
|
| 579 |
Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability.Cell Death Dis. 2019 Jul 29;10(8):570. doi: 10.1038/s41419-019-1778-8.
|
| 580 |
Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells.Biochem Biophys Res Commun. 2003 Feb 14;301(3):675-9. doi: 10.1016/s0006-291x(03)00022-6.
|
| 581 |
Hypoxia provokes base excision repair changes and a repair-deficient, mutator phenotype in colorectal cancer cells.Mol Cancer Res. 2014 Oct;12(10):1407-15. doi: 10.1158/1541-7786.MCR-14-0246. Epub 2014 Jul 16.
|
| 582 |
Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-/ overexpression.J Natl Cancer Inst. 2014 Apr;106(4):dju052. doi: 10.1093/jnci/dju052. Epub 2014 Mar 28.
|
| 583 |
Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPAR partial agonists.Sci Rep. 2019 Apr 1;9(1):5434. doi: 10.1038/s41598-019-41765-2.
|
| 584 |
Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARgamma-coactivator 1 (PGC-1).Cancer Lett. 2004 Jan 8;203(1):25-33. doi: 10.1016/j.canlet.2003.08.024.
|
| 585 |
Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans.Hepatology. 2011 Nov;54(5):1661-78. doi: 10.1002/hep.24539.
|
| 586 |
Effect of ganoderic acid D on colon cancer Warburg effect: Role of SIRT3/cyclophilin D.Eur J Pharmacol. 2018 Apr 5;824:72-77. doi: 10.1016/j.ejphar.2018.01.026. Epub 2018 Jan 31.
|
| 587 |
Silencing of PPMD1 inhibits proliferation of human colon cancer cells via induction of apoptosis and cell cycle arrest.J BUON. 2019 Jul-Aug;24(4):1464-1469.
|
| 588 |
Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.Clin Cancer Res. 2015 Aug 15;21(16):3695-704. doi: 10.1158/1078-0432.CCR-14-2457. Epub 2015 May 5.
|
| 589 |
In vitro and in vivo inhibitory effects of a Pleurotus eryngii protein on colon cancer cells.Food Funct. 2017 Oct 18;8(10):3553-3562. doi: 10.1039/c7fo00895c.
|
| 590 |
SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk.PLoS One. 2015 Dec 2;10(12):e0143894. doi: 10.1371/journal.pone.0143894. eCollection 2015.
|
| 591 |
Beta-catenin represses protein kinase D1 gene expression by non-canonical pathway through MYC/MAX transcription complex in prostate cancer.Oncotarget. 2017 Aug 12;8(45):78811-78824. doi: 10.18632/oncotarget.20229. eCollection 2017 Oct 3.
|
| 592 |
Loss of MLH1 sensitizes colon cancer cells to DNA-PKcs inhibitor KU60648.Mol Carcinog. 2017 Jul;56(7):1816-1824. doi: 10.1002/mc.22640. Epub 2017 Mar 10.
|
| 593 |
Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.Clin Cancer Res. 2004 Sep 1;10(17):5828-36. doi: 10.1158/1078-0432.CCR-04-0350.
|
| 594 |
New dimeric cGMP analogues reduce proliferation in three colon cancer cell lines.Eur J Med Chem. 2017 Dec 1;141:61-72. doi: 10.1016/j.ejmech.2017.09.053. Epub 2017 Sep 27.
|
| 595 |
Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cells.Oncol Rep. 2018 Jul;40(1):536-544. doi: 10.3892/or.2018.6402. Epub 2018 Apr 25.
|
| 596 |
Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines.Oncol Rep. 2013 Feb;29(2):459-63. doi: 10.3892/or.2012.2124. Epub 2012 Nov 6.
|
| 597 |
Expression of a thioredoxin-related protein-1 is induced by prostaglandin E(2).Int J Cancer. 2006 Apr 1;118(7):1670-9. doi: 10.1002/ijc.21572.
|
| 598 |
The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer.Cancer Res. 2011 Dec 1;71(23):7145-54. doi: 10.1158/0008-5472.CAN-10-1883. Epub 2011 Oct 28.
|
| 599 |
MicroRNA-1254 inhibits the migration of colon adenocarcinoma cells by targeting PSMD10.J Dig Dis. 2017 Mar;18(3):169-178. doi: 10.1111/1751-2980.12463.
|
| 600 |
Prostaglandin E?regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells.Biochem Pharmacol. 2011 Feb 1;81(3):379-87. doi: 10.1016/j.bcp.2010.11.001. Epub 2010 Nov 9.
|
| 601 |
Upregulation of C-C chemokine receptor type 7 expression by membrane-associated prostaglandin E synthase-1/prostaglandin E2 requires glycogen synthase kinase 3-mediated signal transduction in colon cancer cells.Mol Med Rep. 2015 Nov;12(5):7169-75. doi: 10.3892/mmr.2015.4290. Epub 2015 Sep 3.
|
| 602 |
Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):502-8. doi: 10.1158/1055-9965.EPI-05-0804.
|
| 603 |
WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.Ann Surg Oncol. 2019 Dec;26(13):4826-4834. doi: 10.1245/s10434-019-07780-3. Epub 2019 Sep 23.
|
| 604 |
pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1).PLoS One. 2014 Jan 22;9(1):e85796. doi: 10.1371/journal.pone.0085796. eCollection 2014.
|
| 605 |
Cytokine associated sensitivity of colon carcinoma cells to FasR-mediated cytotoxicity of CTL.Asian J Surg. 2002 Jan;25(1):89-97.
|
| 606 |
B-cell leukemia protein-2 and peptide YY chemotherapy resistance in colon cancer.Am J Surg. 1999 Nov;178(5):411-4. doi: 10.1016/s0002-9610(99)00209-3.
|
| 607 |
MicroRNA-193b acts as a tumor suppressor in colon cancer progression via targeting RAB22A.Exp Ther Med. 2019 May;17(5):3921-3928. doi: 10.3892/etm.2019.7435. Epub 2019 Mar 26.
|
| 608 |
RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition.Cancer Cell Int. 2017 Nov 28;17:111. doi: 10.1186/s12935-017-0483-x. eCollection 2017.
|
| 609 |
Loss of caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis.Cell Death Dis. 2015 Apr 23;6(4):e1729. doi: 10.1038/cddis.2015.104.
|
| 610 |
miR-223 promotes colon cancer by directly targeting p120 catenin.Oncotarget. 2017 Jul 25;8(38):63764-63779. doi: 10.18632/oncotarget.19541. eCollection 2017 Sep 8.
|
| 611 |
Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.Oncol Rep. 2015 Jan;33(1):320-8. doi: 10.3892/or.2014.3559. Epub 2014 Oct 22.
|
| 612 |
Expression of RNA-binding Motif Protein 3 (RBM3) and Cold-inducible RNA-binding protein (CIRP) Is Associated with Improved Clinical Outcome in Patients with Colon Cancer.Anticancer Res. 2017 Apr;37(4):1779-1785. doi: 10.21873/anticanres.11511.
|
| 613 |
Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.Cell Death Dis. 2015 Feb 12;6(2):e1636. doi: 10.1038/cddis.2015.16.
|
| 614 |
RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients.Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):474-9. doi: 10.1158/1055-9965.EPI-05-0606.
|
| 615 |
High hRFI expression correlates with resistance to fluoropyrimidines in human colon cancer cell lines and in xenografts.J Exp Clin Cancer Res. 2005 Sep;24(3):397-403.
|
| 616 |
Comparative genomics on ROR1 and ROR2 orthologs.Oncol Rep. 2005 Nov;14(5):1381-4. doi: 10.3892/or.14.5.1381.
|
| 617 |
Inositol Hexaphosphate Inhibits Proliferation and Induces Apoptosis of Colon Cancer Cells by Suppressing the AKT/mTOR Signaling Pathway.Molecules. 2017 Oct 3;22(10):1657. doi: 10.3390/molecules22101657.
|
| 618 |
Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase.Cancer Res. 2006 Jul 1;66(13):6497-502. doi: 10.1158/0008-5472.CAN-05-4462.
|
| 619 |
Rsf-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer.Tumour Biol. 2012 Oct;33(5):1485-91. doi: 10.1007/s13277-012-0399-y. Epub 2012 Apr 20.
|
| 620 |
R-Spondin1/LGR5 Activates TGF Signaling and Suppresses Colon Cancer Metastasis.Cancer Res. 2017 Dec 1;77(23):6589-6602. doi: 10.1158/0008-5472.CAN-17-0219. Epub 2017 Sep 22.
|
| 621 |
Dentatin exerts anticancer effects on human colon cancer cell lines via cell cycle arrest, autophagy, inhibition of cell migration and JAK/STAT signalling pathway.J BUON. 2019 Jul-Aug;24(4):1488-1493.
|
| 622 |
Oncogenic potential of truncated RXR during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling.Nat Commun. 2019 Apr 1;10(1):1463. doi: 10.1038/s41467-019-09375-8.
|
| 623 |
Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXR activation.J Exp Med. 2013 Nov 18;210(12):2675-92. doi: 10.1084/jem.20122292. Epub 2013 Nov 4.
|
| 624 |
S100A4 May Be a Good Prognostic Marker and a Therapeutic Target for Colon Cancer.J Oncol. 2018 Jul 9;2018:1828791. doi: 10.1155/2018/1828791. eCollection 2018.
|
| 625 |
The effect of S100A6 on nuclear translocation of CacyBP/SIP in colon cancer cells.PLoS One. 2018 Mar 13;13(3):e0192208. doi: 10.1371/journal.pone.0192208. eCollection 2018.
|
| 626 |
Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.Biochem Biophys Res Commun. 2019 Oct 29;519(1):100-105. doi: 10.1016/j.bbrc.2019.08.137. Epub 2019 Aug 31.
|
| 627 |
Voltage-gated Na+ Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling.Sci Rep. 2015 Jun 22;5:11541. doi: 10.1038/srep11541.
|
| 628 |
Proteoglycans as potential microenvironmental biomarkers for colon cancer.Cell Tissue Res. 2015 Sep;361(3):833-44. doi: 10.1007/s00441-015-2141-8. Epub 2015 Feb 26.
|
| 629 |
Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues.PLoS One. 2017 Mar 10;12(3):e0173747. doi: 10.1371/journal.pone.0173747. eCollection 2017.
|
| 630 |
Semaphoring 4D is required for the induction of antioxidant stress and anti-inflammatory effects of dihydromyricetin in colon cancer.Int Immunopharmacol. 2019 Feb;67:220-230. doi: 10.1016/j.intimp.2018.12.025. Epub 2018 Dec 15.
|
| 631 |
SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors.Cancer Lett. 2011 Oct 1;309(1):78-84. doi: 10.1016/j.canlet.2011.05.019. Epub 2011 Jun 12.
|
| 632 |
Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer.Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1082-6. doi: 10.1073/pnas.93.3.1082.
|
| 633 |
Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1 via the mTOR/p70S6K/4E-BP1 and MAPK pathways.J Ethnopharmacol. 2017 May 5;203:27-38. doi: 10.1016/j.jep.2017.03.033. Epub 2017 Mar 21.
|
| 634 |
SFRP4 expression correlates with epithelial mesenchymal transition-linked genes and poor overall survival in colon cancer patients.World J Gastrointest Oncol. 2019 Aug 15;11(8):589-598. doi: 10.4251/wjgo.v11.i8.589.
|
| 635 |
Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model.Mol Carcinog. 2016 May;55(5):600-10. doi: 10.1002/mc.22306. Epub 2015 Mar 14.
|
| 636 |
Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase.Oncogene. 2019 Jun;38(24):4788-4803. doi: 10.1038/s41388-019-0758-x. Epub 2019 Feb 28.
|
| 637 |
Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.Lancet Oncol. 2018 Jun;19(6):758-767. doi: 10.1016/S1470-2045(18)30188-8. Epub 2018 Apr 26.
|
| 638 |
Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis.Onco Targets Ther. 2018 Apr 13;11:2157-2167. doi: 10.2147/OTT.S157836. eCollection 2018.
|
| 639 |
Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids.Carcinogenesis. 2015 Oct;36(10):1193-200. doi: 10.1093/carcin/bgv107. Epub 2015 Jul 25.
|
| 640 |
Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcbeta1-->6GalNAcalpha core structure as a tumor-associated antigen.Biochem Biophys Res Commun. 1998 Jun 18;247(2):514-7. doi: 10.1006/bbrc.1998.8824.
|
| 641 |
Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing.Cell Res. 2014 Jun;24(6):701-12. doi: 10.1038/cr.2014.43. Epub 2014 Apr 4.
|
| 642 |
Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy.Br J Cancer. 2002 Apr 22;86(8):1262-9. doi: 10.1038/sj.bjc.6600264.
|
| 643 |
Astragalus saponins modulates colon cancer development by regulating calpain-mediated glucose-regulated protein expression.BMC Complement Altern Med. 2014 Oct 15;14:401. doi: 10.1186/1472-6882-14-401.
|
| 644 |
Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis.Cancer Res. 2005 Feb 1;65(3):887-97.
|
| 645 |
Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines. Biol Pharm Bull. 2012;35(3):301-7.
|
| 646 |
CD44-SLC1A2 fusion transcripts in primary colorectal cancer.Pathol Oncol Res. 2015 Jul;21(3):759-64. doi: 10.1007/s12253-014-9887-2. Epub 2015 Jan 10.
|
| 647 |
Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAF(V600E) In Vivo.Mol Imaging Biol. 2017 Jun;19(3):421-428. doi: 10.1007/s11307-016-1008-z.
|
| 648 |
Associations of single nucleotide polymorphisms with mucinous colorectal cancer: genome-wide common variant and gene-based rare variant analyses.Biomark Res. 2018 Jun 13;6:17. doi: 10.1186/s40364-018-0133-z. eCollection 2018.
|
| 649 |
L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.Free Radic Biol Med. 2016 Jun;95:200-8. doi: 10.1016/j.freeradbiomed.2016.03.009. Epub 2016 Mar 22.
|
| 650 |
Differential expression of hENT1 and hENT2 in colon cancer cell lines.Genet Mol Res. 2017 Feb 16;16(1). doi: 10.4238/gmr16019549.
|
| 651 |
Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer.ACS Nano. 2018 Jun 26;12(6):5253-5265. doi: 10.1021/acsnano.7b08499. Epub 2018 Jun 8.
|
| 652 |
EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.Oncotarget. 2017 Sep 16;8(54):92195-92208. doi: 10.18632/oncotarget.21028. eCollection 2017 Nov 3.
|
| 653 |
Expression of OATP family members in hormone-related cancers: potential markers of progression.PLoS One. 2011;6(5):e20372. doi: 10.1371/journal.pone.0020372. Epub 2011 May 19.
|
| 654 |
Possible role of nuclear -catenin in resistance to preoperative chemoradiotherapy in locally advanced rectal cancer.Histopathology. 2017 Aug;71(2):227-237. doi: 10.1111/his.13227. Epub 2017 May 22.
|
| 655 |
Liver acid sphingomyelinase inhibits growth of metastatic colon cancer.J Clin Invest. 2013 Feb;123(2):834-43. doi: 10.1172/JCI65188. Epub 2013 Jan 9.
|
| 656 |
SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway.Onco Targets Ther. 2019 Apr 8;12:2585-2594. doi: 10.2147/OTT.S186806. eCollection 2019.
|
| 657 |
Effects of -synuclein on the tumorigenicity and metastasis of colon cancer SW1116 cells in vitro and in vivo.Oncol Rep. 2013 Nov;30(5):2161-70. doi: 10.3892/or.2013.2688. Epub 2013 Aug 22.
|
| 658 |
B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP).PLoS One. 2011;6(6):e21102. doi: 10.1371/journal.pone.0021102. Epub 2011 Jun 27.
|
| 659 |
Baicalin induces apoptosis in SW480 cells through downregulation of the SP1 transcription factor.Anticancer Drugs. 2019 Feb;30(2):153-158. doi: 10.1097/CAD.0000000000000708.
|
| 660 |
PDEF is a negative regulator of colon cancer cell growth and migration.J Cell Biochem. 2009 Dec 15;108(6):1389-98. doi: 10.1002/jcb.22371.
|
| 661 |
Overexpression of SphK2 contributes to ATRA resistance in colon cancer through rapid degradation of cytoplasmic RXR by K48/K63-linked polyubiquitination.Oncotarget. 2017 Jun 13;8(24):39605-39617. doi: 10.18632/oncotarget.17174.
|
| 662 |
Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.Cancer Res. 2005 May 15;65(10):4228-37. doi: 10.1158/0008-5472.CAN-04-4585.
|
| 663 |
Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines.Biomed Res Int. 2015;2015:690721. doi: 10.1155/2015/690721. Epub 2015 Oct 25.
|
| 664 |
The many faces of SRPK1.J Pathol. 2017 Mar;241(4):437-440. doi: 10.1002/path.4846. Epub 2017 Feb 1.
|
| 665 |
SRPK2 promotes the growth and migration of the colon cancer cells.Gene. 2016 Jul 15;586(1):41-7. doi: 10.1016/j.gene.2016.03.051. Epub 2016 Apr 12.
|
| 666 |
Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer.PLoS One. 2015 Feb 27;10(2):e0118332. doi: 10.1371/journal.pone.0118332. eCollection 2015.
|
| 667 |
Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells.BMC Cancer. 2016 Dec 7;16(1):941. doi: 10.1186/s12885-016-2969-7.
|
| 668 |
Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide.Mol Ther. 2004 Sep;10(3):553-61. doi: 10.1016/j.ymthe.2004.06.158.
|
| 669 |
Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells.Biol Chem. 2003 Feb;384(2):257-66. doi: 10.1515/BC.2003.029.
|
| 670 |
Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer. Cancer Immunol Res. 2017 May;5(5):385-396.
|
| 671 |
SYK-CARD9 Signaling Axis Promotes Gut Fungi-Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer.Immunity. 2018 Sep 18;49(3):515-530.e5. doi: 10.1016/j.immuni.2018.08.024.
|
| 672 |
Upregulation of HRD1 promotes cell migration and invasion in colon cancer.Mol Cell Biochem. 2019 Apr;454(1-2):1-9. doi: 10.1007/s11010-018-3447-0. Epub 2018 Oct 10.
|
| 673 |
TNF- promotes colon cancer cell migration and invasion by upregulating TROP-2.Oncol Lett. 2018 Mar;15(3):3820-3827. doi: 10.3892/ol.2018.7735. Epub 2018 Jan 5.
|
| 674 |
Thymine DNA glycosylase promotes transactivation of -catenin/TCFs by cooperating with CBP.J Mol Cell Biol. 2014 Jun;6(3):231-9. doi: 10.1093/jmcb/mju014. Epub 2014 Apr 18.
|
| 675 |
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.Sci Rep. 2015 Dec 1;5:17369. doi: 10.1038/srep17369.
|
| 676 |
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.Nat Cell Biol. 2013 Jul;15(7):818-28. doi: 10.1038/ncb2774. Epub 2013 Jun 23.
|
| 677 |
Screening Method for Anti-Colon Cancer Drugs Using Two Sensor Cell Lines with Human 4-Galactosyltransferase 4 Gene Promoters.Sensors (Basel). 2018 Aug 6;18(8):2573. doi: 10.3390/s18082573.
|
| 678 |
TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process.Int J Oncol. 2019 Oct;55(4):789-804. doi: 10.3892/ijo.2019.4854. Epub 2019 Aug 5.
|
| 679 |
Tissue Factor Pathway Inhibitor Gene Polymorphism -33TC Predicts Improved Disease-Free Survival in Colorectal Cancer.Ann Surg Oncol. 2016 Jul;23(7):2274-80. doi: 10.1245/s10434-016-5169-4. Epub 2016 Mar 11.
|
| 680 |
Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.Cancer Res. 1999 Jul 15;59(14):3379-86.
|
| 681 |
Allele-specific expression of TGFBR1 in colon cancer patients.Carcinogenesis. 2010 Oct;31(10):1800-4. doi: 10.1093/carcin/bgq165. Epub 2010 Aug 12.
|
| 682 |
Loss of TGF signaling promotes colon cancer progression and tumor-associated inflammation.Oncotarget. 2017 Jan 17;8(3):3826-3839. doi: 10.18632/oncotarget.9830.
|
| 683 |
The CircRNA-ACAP2/Hsa-miR-21-5p/ Tiam1 Regulatory Feedback Circuit Affects the Proliferation, Migration, and Invasion of Colon Cancer SW480 Cells.Cell Physiol Biochem. 2018;49(4):1539-1550. doi: 10.1159/000493457. Epub 2018 Sep 13.
|
| 684 |
The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells.Anticancer Drugs. 2007 Apr;18(4):427-33. doi: 10.1097/CAD.0b013e328013d99e.
|
| 685 |
Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer.Gastroenterology. 2008 Aug;135(2):518-28. doi: 10.1053/j.gastro.2008.04.022. Epub 2008 Apr 23.
|
| 686 |
Toll-like receptor 6 expression, sequence variants, and their association with colorectal cancer risk.J Cancer. 2019 Jun 2;10(13):2969-2981. doi: 10.7150/jca.31011. eCollection 2019.
|
| 687 |
Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract.Histol Histopathol. 2004 Oct;19(4):1021-31. doi: 10.14670/HH-19.1021.
|
| 688 |
Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration.Oncotarget. 2017 Jun 13;8(24):38351-38366. doi: 10.18632/oncotarget.16323.
|
| 689 |
Glucocorticoids indirectly decrease colon cancer cell proliferation and invasion via effects on cancer-associated fibroblasts.Exp Cell Res. 2018 Jan 15;362(2):332-342. doi: 10.1016/j.yexcr.2017.11.034. Epub 2017 Nov 28.
|
| 690 |
Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.J Cell Biochem. 2019 Jan;120(1):928-939. doi: 10.1002/jcb.27456. Epub 2018 Aug 30.
|
| 691 |
Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon Cancer.Dig Dis Sci. 2019 Jul;64(7):1857-1867. doi: 10.1007/s10620-019-05507-8. Epub 2019 Feb 20.
|
| 692 |
Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30(-) Tumors.Mol Ther. 2019 Oct 2;27(10):1825-1835. doi: 10.1016/j.ymthe.2019.06.007. Epub 2019 Jun 19.
|
| 693 |
Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects.Oncoimmunology. 2019 Sep 6;8(12):e1651622. doi: 10.1080/2162402X.2019.1651622. eCollection 2019.
|
| 694 |
3-Bromopyruvate potentiates TRAIL-induced apoptosis in human colon cancer cells through a reactive oxygen species- and caspase-dependent mitochondrial pathway.Can J Physiol Pharmacol. 2019 Dec;97(12):1176-1184. doi: 10.1139/cjpp-2019-0131. Epub 2019 Sep 6.
|
| 695 |
Enormous influence of TNIK knockdown on intracellular signals and cell survival.Hum Cell. 2011 Sep;24(3):121-6. doi: 10.1007/s13577-011-0023-2. Epub 2011 Jun 28.
|
| 696 |
Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.Int J Oncol. 2016 Apr;48(4):1333-40. doi: 10.3892/ijo.2016.3360. Epub 2016 Jan 26.
|
| 697 |
Up-regulation of C-terminal tensin-like molecule promotes the tumorigenicity of colon cancer through beta-catenin.Cancer Res. 2009 Jun 1;69(11):4563-6. doi: 10.1158/0008-5472.CAN-09-0117.
|
| 698 |
Proliferation and invasion of colon cancer cells are suppressed by knockdown of TOP2A.J Cell Biochem. 2018 Sep;119(9):7256-7263. doi: 10.1002/jcb.26916. Epub 2018 May 15.
|
| 699 |
Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen.PLoS One. 2014 Apr 15;9(4):e95200. doi: 10.1371/journal.pone.0095200. eCollection 2014.
|
| 700 |
TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.J Transl Med. 2013 Dec 17;11:313. doi: 10.1186/1479-5876-11-313.
|
| 701 |
Identification of key tumorigenesisrelated genes and their microRNAs in colon cancer.Oncol Rep. 2018 Dec;40(6):3551-3560. doi: 10.3892/or.2018.6726. Epub 2018 Sep 21.
|
| 702 |
Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.J Cell Physiol. 2019 Aug;234(10):17612-17621. doi: 10.1002/jcp.28385. Epub 2019 Feb 22.
|
| 703 |
The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage.Biochem Pharmacol. 2018 Oct;156:291-301. doi: 10.1016/j.bcp.2018.08.039. Epub 2018 Aug 25.
|
| 704 |
MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2.PLoS One. 2015 Jun 24;10(6):e0129843. doi: 10.1371/journal.pone.0129843. eCollection 2015.
|
| 705 |
Isoflavones as Ah Receptor Agonists in Colon-Derived Cell Lines: Structure-Activity Relationships. Chem Res Toxicol. 2019 Nov 18;32(11):2353-2364. doi: 10.1021/acs.chemrestox.9b00352. Epub 2019 Oct 29.
|
| 706 |
Downregulation of Drp1, a fission regulator, is associated with human lung and colon cancers.Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):209-215. doi: 10.1093/abbs/gmx137.
|
| 707 |
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans.Eur J Clin Invest. 2014;44(3):285-94. doi: 10.1111/eci.12231. Epub 2014 Jan 22.
|
| 708 |
KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model.FEBS Lett. 2009 Feb 18;583(4):711-7. doi: 10.1016/j.febslet.2009.01.014. Epub 2009 Jan 21.
|
| 709 |
Sulindac sulfone inhibits the mTORC1 pathway in colon cancer cells by directly targeting voltage-dependent anion channel 1 and 2.Biochem Biophys Res Commun. 2018 Nov 10;505(4):1203-1210. doi: 10.1016/j.bbrc.2018.10.050. Epub 2018 Oct 14.
|
| 710 |
A molecular sub-cluster of colon cancer cells with low VDR expression is sensitive to chemotherapy, BRAF inhibitors and PI3K-mTOR inhibitors treatment.Aging (Albany NY). 2019 Oct 9;11(19):8587-8603. doi: 10.18632/aging.102349. Epub 2019 Oct 9.
|
| 711 |
Long Noncoding RNA ASLNC07322 Functions in VEGF-C Expression Regulated by Smad4 during Colon Cancer Metastasis.Mol Ther Nucleic Acids. 2019 Dec 6;18:851-862. doi: 10.1016/j.omtn.2019.10.012. Epub 2019 Oct 18.
|
| 712 |
VPAC1 overexpression is associated with poor differentiation in colon cancer.Tumour Biol. 2014 Jul;35(7):6397-404. doi: 10.1007/s13277-014-1852-x. Epub 2014 Mar 28.
|
| 713 |
Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.Cancer Immunol Res. 2019 Jul;7(7):1079-1090. doi: 10.1158/2326-6066.CIR-18-0507. Epub 2019 May 14.
|
| 714 |
Colitis and colon cancer in WASP-deficient mice require helicobacter species.Inflamm Bowel Dis. 2013 Sep;19(10):2041-50. doi: 10.1097/MIB.0b013e318295fd8f.
|
| 715 |
WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.BMC Cancer. 2018 Jun 20;18(1):673. doi: 10.1186/s12885-018-4580-6.
|
| 716 |
Wee1 inhibition can suppress tumor proliferation and sensitize p53 mutant colonic cancer cells to the anticancer effect of irinotecan.Mol Med Rep. 2018 Feb;17(2):3344-3349. doi: 10.3892/mmr.2017.8230. Epub 2017 Dec 8.
|
| 717 |
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.Anticancer Res. 2019 Apr;39(4):1719-1728. doi: 10.21873/anticanres.13278.
|
| 718 |
Investigation of Insulin-Like Growth Factor-1 (IGF-1), P53, and Wilms' Tumor 1 (WT1) Expression Levels in the Colon Polyp Subtypes in Colon Cancer.Med Sci Monit. 2019 Jul 25;25:5510-5517. doi: 10.12659/MSM.915335.
|
| 719 |
Suppression of YAP by DDP disrupts colon tumor progression.Oncol Rep. 2018 May;39(5):2114-2126. doi: 10.3892/or.2018.6297. Epub 2018 Mar 6.
|
| 720 |
Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.Clin Cancer Res. 2014 Feb 15;20(4):837-46. doi: 10.1158/1078-0432.CCR-13-1854. Epub 2013 Dec 9.
|
| 721 |
MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.Pathol Res Pract. 2019 Oct;215(10):152577. doi: 10.1016/j.prp.2019.152577. Epub 2019 Aug 2.
|
| 722 |
The candidate oncogene ZNF217 is frequently amplified in colon cancer.J Pathol. 2004 Nov;204(3):282-8. doi: 10.1002/path.1632.
|
| 723 |
Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.Cancer Res. 2018 Sep 15;78(18):5340-5348. doi: 10.1158/0008-5472.CAN-18-1119. Epub 2018 Jul 19.
|
| 724 |
Cationic liposome coupled endostatin gene for treatment of peritoneal colon cancer.Clin Exp Metastasis. 2010 May;27(5):307-18. doi: 10.1007/s10585-010-9328-x. Epub 2010 Apr 7.
|
| 725 |
Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors.Med Oncol. 2019 May 29;36(7):61. doi: 10.1007/s12032-019-1281-1.
|
| 726 |
Increased diacylglycerol kinase expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion.BMC Cancer. 2014 Mar 19;14:208. doi: 10.1186/1471-2407-14-208.
|
| 727 |
Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.Int J Oncol. 2012 Mar;40(3):889-98. doi: 10.3892/ijo.2011.1245. Epub 2011 Oct 25.
|
| 728 |
Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer.Dis Markers. 2017;2017:1202710. doi: 10.1155/2017/1202710. Epub 2017 Dec 28.
|
| 729 |
Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer.Signal Transduct Target Ther. 2019 Nov 29;4:51. doi: 10.1038/s41392-019-0086-1. eCollection 2019.
|
| 730 |
Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon--Dependent Manner.Cancer Immunol Res. 2018 Apr;6(4):409-421. doi: 10.1158/2326-6066.CIR-17-0218. Epub 2018 Feb 20.
|
| 731 |
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.Drug Resist Updat. 2017 Nov;33-35:36-42. doi: 10.1016/j.drup.2017.10.004. Epub 2017 Nov 3.
|
| 732 |
Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action.Oncol Rep. 2016 Apr;35(4):2097-106. doi: 10.3892/or.2016.4588. Epub 2016 Jan 22.
|
| 733 |
Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.PLoS One. 2012;7(5):e37312. doi: 10.1371/journal.pone.0037312. Epub 2012 May 17.
|
| 734 |
MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxiainducible factor-2 pathway in vitro and in vivo.Mol Med Rep. 2014 Nov;10(5):2401-8. doi: 10.3892/mmr.2014.2562. Epub 2014 Sep 12.
|
| 735 |
High Expression of PLOD1 Drives Tumorigenesis and Affects Clinical Outcome in Gastrointestinal Carcinoma.Genet Test Mol Biomarkers. 2018 Jun;22(6):366-373. doi: 10.1089/gtmb.2018.0009. Epub 2018 May 3.
|
| 736 |
Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.J Cancer Res Clin Oncol. 2010 Feb;136(2):249-59. doi: 10.1007/s00432-009-0656-7. Epub 2009 Aug 12.
|
| 737 |
Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers.Clin Transl Med. 2014 Nov 18;3:37. doi: 10.1186/s40169-014-0037-y. eCollection 2014.
|
| 738 |
Thymosin 4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition.Cancer Biol Ther. 2012 Feb 15;13(4):191-7. doi: 10.4161/cbt.13.4.18691. Epub 2012 Feb 15.
|
| 739 |
The haplotypes of TNFRSF17 polymorphisms are associated with colon cancer in a Korean population.Int J Colorectal Dis. 2012 Jun;27(6):701-7. doi: 10.1007/s00384-011-1364-8. Epub 2011 Nov 24.
|
| 740 |
Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.Theranostics. 2019 Apr 13;9(9):2526-2540. doi: 10.7150/thno.32915. eCollection 2019.
|
| 741 |
MicroRNA-522 reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5. Mol Med Rep. 2015 Sep;12(3):3930-3936.
|
| 742 |
Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer. Cancer Res. 2007 May 15;67(10):4860-8. doi: 10.1158/0008-5472.CAN-06-3096.
|
| 743 |
Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB(0,+) to deliver chemotherapeutic agents for colon cancer therapy.Drug Deliv. 2017 Nov;24(1):1338-1349. doi: 10.1080/10717544.2017.1377316.
|
| 744 |
Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi.Int J Cancer. 2008 May 1;122(9):1999-2007. doi: 10.1002/ijc.23321.
|
| 745 |
Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhibit liver metastasis in nude mice.Tumour Biol. 2015 Aug;36(8):6011-8. doi: 10.1007/s13277-015-3277-6. Epub 2015 Mar 5.
|
| 746 |
Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells. Cancer Res. 2010 May 15;70(10):4064-73.
|
| 747 |
The Constituents of the Stems of Cissus assamica and Their Bioactivities.Molecules. 2018 Oct 28;23(11):2799. doi: 10.3390/molecules23112799.
|
| 748 |
Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4 Is Mediated by a Novel Composite Regulatory Element.Mol Pharmacol. 2018 May;93(5):541-552. doi: 10.1124/mol.117.110619. Epub 2018 Mar 8.
|
| 749 |
Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK.J Mol Med (Berl). 2012 Jun;90(6):707-18. doi: 10.1007/s00109-011-0851-2. Epub 2012 Jan 7.
|
| 750 |
Glutathione, an Antioxidant Tripeptide: Dual Roles in Carcinogenesis and Chemoprevention.Curr Protein Pept Sci. 2019;20(9):907-917. doi: 10.2174/1389203720666190206130003.
|
| 751 |
Adenine Inhibits the Growth of Colon Cancer Cells via AMP-Activated Protein Kinase Mediated Autophagy.Evid Based Complement Alternat Med. 2019 Sep 12;2019:9151070. doi: 10.1155/2019/9151070. eCollection 2019.
|
| 752 |
Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women.Cancer Causes Control. 2014 Nov;25(11):1513-21. doi: 10.1007/s10552-014-0454-7. Epub 2014 Sep 16.
|
| 753 |
CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.Int J Oncol. 2018 Mar;52(3):721-732. doi: 10.3892/ijo.2018.4240. Epub 2018 Jan 8.
|
| 754 |
N-acetyl transferase 2/environmental factors and their association as a modulating risk factor for sporadic colon and rectal cancer.J Clin Lab Anal. 2017 Sep;31(5):e22098. doi: 10.1002/jcla.22098. Epub 2016 Nov 24.
|
| 755 |
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.JAMA Oncol. 2018 Jun 1;4(6):783-790. doi: 10.1001/jamaoncol.2018.0126.
|
| 756 |
Potential role of nucleoside diphosphate kinase in myricetin-induced selective apoptosis in colon cancer HCT-15?cells. Food Chem Toxicol. 2018 Jun;116(Pt B):315-322. doi: 10.1016/j.fct.2018.04.053. Epub 2018 Apr 24.
|
| 757 |
Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo--linolenic acid for colon cancer suppression.Redox Biol. 2019 Feb;21:101085. doi: 10.1016/j.redox.2018.101085. Epub 2018 Dec 18.
|
| 758 |
Alcohol intake, ADH1B and ADH1C genotypes, and the risk of colorectal cancer by sex and subsite in the Netherlands Cohort Study.Carcinogenesis. 2018 Mar 8;39(3):375-388. doi: 10.1093/carcin/bgy011.
|
| 759 |
AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.Mol Cancer Res. 2013 Dec;11(12):1554-63. doi: 10.1158/1541-7786.MCR-13-0330-T. Epub 2013 Oct 18.
|
| 760 |
Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.Chem Biol Interact. 2015 Jun 5;234:38-44. doi: 10.1016/j.cbi.2014.12.038. Epub 2015 Jan 29.
|
| 761 |
Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.Genes Chromosomes Cancer. 2008 Feb;47(2):95-106. doi: 10.1002/gcc.20511.
|
| 762 |
Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11.Br J Cancer. 2005 Mar 14;92(5):882-7. doi: 10.1038/sj.bjc.6602362.
|
| 763 |
Genetic modification of the effect of alcohol consumption on CHD.Proc Nutr Soc. 2004 Feb;63(1):73-9. doi: 10.1079/PNS2003321.
|
| 764 |
Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2540-8. doi: 10.1158/1055-9965.EPI-09-0228. Epub 2009 Aug 25.
|
| 765 |
Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.J Cancer Res Clin Oncol. 2013 Sep;139(9):1457-64. doi: 10.1007/s00432-013-1461-x. Epub 2013 Jun 23.
|
| 766 |
Polymorphisms in drug-metabolizing enzymes as modifiers of cancer risk.Clin Chem. 1995 Dec;41(12 Pt 2):1864-9.
|
| 767 |
Genetic polymorphism of cholesterol 7alpha-hydroxylase (CYP7A1) and colorectal adenomas: Self Defense Forces Health Study.Cancer Sci. 2006 May;97(5):406-10. doi: 10.1111/j.1349-7006.2006.00182.x.
|
| 768 |
MicroRNA-17 induces epithelial-mesenchymal transition consistent with the cancer stem cell phenotype by regulating CYP7B1 expression in colon cancer. Int J Mol Med. 2016 Aug;38(2):499-506.
|
| 769 |
Synthetic lethality by lentiviral short hairpin RNA silencing of thymidylate kinase and doxorubicin in colon cancer cells regardless of the p53 status. Cancer Res. 2008 Apr 15;68(8):2831-40. doi: 10.1158/0008-5472.CAN-07-3069.
|
| 770 |
Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.J Biol Chem. 2019 Jun 21;294(25):9949-9958. doi: 10.1074/jbc.RA118.007181. Epub 2019 May 15.
|
| 771 |
Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer.Oncol Lett. 2018 Mar;15(3):3923-3927. doi: 10.3892/ol.2018.7724. Epub 2018 Jan 4.
|
| 772 |
Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients.Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6012-9.
|
| 773 |
Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.Cell Chem Biol. 2019 Sep 19;26(9):1214-1228.e25. doi: 10.1016/j.chembiol.2019.06.005. Epub 2019 Jul 11.
|
| 774 |
Mutation of GDP-mannose-4,6-dehydratase in colorectal cancer metastasis.PLoS One. 2013 Jul 29;8(7):e70298. doi: 10.1371/journal.pone.0070298. Print 2013.
|
| 775 |
The diagnostic potential of glutathione S-transferase (GST) polymorphisms in patients with colorectal cancer.Adv Clin Exp Med. 2018 Nov;27(11):1561-1566. doi: 10.17219/acem/74682.
|
| 776 |
15-Keto prostaglandin E(2) induces heme oxygenase-1 expression through activation of Nrf2 in human colon epithelial CCD 841 CoN cells.Arch Biochem Biophys. 2020 Jan 15;679:108162. doi: 10.1016/j.abb.2019.108162. Epub 2019 Dec 24.
|
| 777 |
Effect of exogenous MSH6 and POLD1 expression on the mutation rate of the HPRT locus in a human colon cancer cell line with mutator phenotype, DLD-1.Int J Oncol. 2004 Mar;24(3):697-702.
|
| 778 |
17Beta-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancer.J Steroid Biochem Mol Biol. 2003 Nov;87(2-3):133-40. doi: 10.1016/j.jsbmb.2003.08.008.
|
| 779 |
The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration.Nat Commun. 2016 Mar 7;7:10764. doi: 10.1038/ncomms10764.
|
| 780 |
Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue.Biochim Biophys Acta. 2012 Jun;1822(6):918-26. doi: 10.1016/j.bbadis.2012.02.021. Epub 2012 Mar 9.
|
| 781 |
Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors.Funct Integr Genomics. 2011 Jun;11(2):215-24. doi: 10.1007/s10142-010-0200-5. Epub 2010 Nov 9.
|
| 782 |
Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk.Mol Nutr Food Res. 2013 Apr;57(4):721-34. doi: 10.1002/mnfr.201200180. Epub 2012 Sep 7.
|
| 783 |
Quantitative analysis of thymidine kinase 1 and 5'(3')-deoxyribonucleotidase mRNA expression: the role of fluorothymidine uptake.Anticancer Res. 2011 Jun;31(6):2135-9.
|
| 784 |
DJ-1 promotes survival of human colon cancer cells under hypoxia by modulating HIF-1 expression through the PI3K-AKT pathway.Cancer Manag Res. 2018 Oct 16;10:4615-4629. doi: 10.2147/CMAR.S172008. eCollection 2018.
|
| 785 |
Three-dimensional computed tomographic angiography with computed tomographic colonography for laparoscopic colorectal surgery.Jpn J Radiol. 2018 Dec;36(12):698-705. doi: 10.1007/s11604-018-0775-7. Epub 2018 Sep 14.
|
| 786 |
Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer.Mol Carcinog. 2009 Jul;48(7):642-7. doi: 10.1002/mc.20510.
|
| 787 |
Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species.Cancer Res. 2001 Mar 1;61(5):1810-5.
|
| 788 |
A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells.Arch Biochem Biophys. 2014 Jan 1;541:21-9. doi: 10.1016/j.abb.2013.10.023. Epub 2013 Nov 12.
|
| 789 |
Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer.Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1626-32. doi: 10.1158/1055-9965.EPI-04-0682.
|
| 790 |
The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.Cancer. 2013 Jul 1;119(13):2477-85. doi: 10.1002/cncr.28009. Epub 2013 Apr 10.
|
| 791 |
Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.PLoS One. 2018 Mar 8;13(3):e0193560. doi: 10.1371/journal.pone.0193560. eCollection 2018.
|
| 792 |
ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.BMC Cancer. 2018 Oct 22;18(1):1020. doi: 10.1186/s12885-018-4931-3.
|
| 793 |
Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.Cancer Res Treat. 2016 Apr;48(2):676-86. doi: 10.4143/crt.2015.153. Epub 2015 Sep 22.
|
| 794 |
Increased expression of GEF-H1 promotes colon cancer progression by RhoA signaling.Pathol Res Pract. 2019 May;215(5):1012-1019. doi: 10.1016/j.prp.2019.02.008. Epub 2019 Feb 27.
|
| 795 |
Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex.Cancer Sci. 2019 Dec;110(12):3788-3801. doi: 10.1111/cas.14205. Epub 2019 Nov 15.
|
| 796 |
miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.Biochem Biophys Res Commun. 2018 Feb 5;496(2):302-308. doi: 10.1016/j.bbrc.2018.01.021. Epub 2018 Jan 4.
|
| 797 |
Unexpected distribution of CA19.9 and other type 1 chain Lewis antigens in normal and cancer tissues of colon and pancreas: Importance of the detection method and role of glycosyltransferase regulation.Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3210-3220. doi: 10.1016/j.bbagen.2016.08.005. Epub 2016 Aug 14.
|
| 798 |
Suppression of B3GNT7 gene expression in colon adenocarcinoma and its potential effect in the metastasis of colon cancer cells.Glycobiology. 2014 Apr;24(4):359-67. doi: 10.1093/glycob/cwu002. Epub 2014 Jan 12.
|
| 799 |
Clinical and molecular characterization of individuals with recurrent genomic disorder at 10q22.3q23.2.Clin Genet. 2010 Aug;78(2):162-8. doi: 10.1111/j.1399-0004.2010.01373.x. Epub 2010 Feb 9.
|
| 800 |
Carbonic anhydrase-related protein VIII promotes colon cancer cell growth.Mol Carcinog. 2007 Mar;46(3):208-14. doi: 10.1002/mc.20264.
|
| 801 |
Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.J Surg Oncol. 2017 Nov;116(6):706-715. doi: 10.1002/jso.24705. Epub 2017 Jun 1.
|
| 802 |
Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.Biochem Biophys Res Commun. 2013 May 17;434(4):898-903. doi: 10.1016/j.bbrc.2013.04.053. Epub 2013 Apr 23.
|
| 803 |
Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor.Oncogene. 2006 Jan 19;25(3):480-6. doi: 10.1038/sj.onc.1209051.
|
| 804 |
Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.Clin Cancer Res. 2011 Jul 1;17(13):4531-40. doi: 10.1158/1078-0432.CCR-10-0763. Epub 2011 May 6.
|
| 805 |
Ingested nitrate, disinfection by-products, and risk of colon and rectal cancers in the Iowa Women's Health Study cohort.Environ Int. 2019 May;126:242-251. doi: 10.1016/j.envint.2019.02.010. Epub 2019 Feb 26.
|
| 806 |
TERT's role in colorectal carcinogenesis.Mol Carcinog. 2013 Jul;52(7):507-13. doi: 10.1002/mc.21885. Epub 2012 Feb 21.
|
| 807 |
The protein secretion modulator TMED9 drives CNIH4/TGF/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.Oncogene. 2019 Jul;38(29):5817-5837. doi: 10.1038/s41388-019-0845-z. Epub 2019 Jun 28.
|
| 808 |
SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin.Nat Commun. 2016 Jun 29;7:11996. doi: 10.1038/ncomms11996.
|
| 809 |
Silencing of bidirectional promoters by DNA methylation in tumorigenesis.Cancer Res. 2006 May 15;66(10):5077-84. doi: 10.1158/0008-5472.CAN-05-2629.
|
| 810 |
Cortactin promotes colon cancer progression by regulating ERK pathway.Int J Oncol. 2015 Sep;47(3):1034-42. doi: 10.3892/ijo.2015.3072. Epub 2015 Jul 6.
|
| 811 |
Expression of CUEDC2 in colorectal cancer with different invasion and migration abilities.J Int Med Res. 2019 Feb;47(2):905-914. doi: 10.1177/0300060518813072. Epub 2019 Jan 17.
|
| 812 |
Mutational analysis of hypoxia-related genes HIF1alpha and CUL2 in common human cancers.APMIS. 2009 Dec;117(12):880-5. doi: 10.1111/j.1600-0463.2009.02550.x.
|
| 813 |
Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.Tumour Biol. 2018 Sep;40(9):1010428318799251. doi: 10.1177/1010428318799251.
|
| 814 |
Diagnostic and prognostic values of CXC motif chemokine ligand 3 in patients with colon cancer.Oncol Rep. 2019 Nov;42(5):1996-2008. doi: 10.3892/or.2019.7326. Epub 2019 Sep 19.
|
| 815 |
Expression of DDB2 Protein in the Initiation, Progression, and Prognosis of Colorectal Cancer.Dig Dis Sci. 2018 Nov;63(11):2959-2968. doi: 10.1007/s10620-018-5224-z. Epub 2018 Jul 27.
|
| 816 |
Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death.Biochem Pharmacol. 2019 Apr;162:41-54. doi: 10.1016/j.bcp.2018.12.006. Epub 2018 Dec 7.
|
| 817 |
Drosophila homologue of Diaphanous 1 (DIAPH1) controls the metastatic potential of colon cancer cells by regulating microtubule-dependent adhesion.Oncotarget. 2015 Jul 30;6(21):18577-89. doi: 10.18632/oncotarget.4094.
|
| 818 |
Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/-catenin signaling pathway.Oncol Rep. 2014 May;31(5):2270-8. doi: 10.3892/or.2014.3057. Epub 2014 Mar 5.
|
| 819 |
Eukaryotic translation initiation factor 3 subunit G promotes human colorectal cancer.Am J Transl Res. 2019 Feb 15;11(2):612-623. eCollection 2019.
|
| 820 |
GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5951-9. doi: 10.1158/1078-0432.CCR-06-0736.
|
| 821 |
A retinoid responsive cytokine gene, MK, is preferentially expressed in the proximal tubules of the kidney and human tumor cell lines.Am J Pathol. 1993 Feb;142(2):425-31.
|
| 822 |
Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.Int J Cancer. 2017 Jun 15;140(12):2734-2747. doi: 10.1002/ijc.30698. Epub 2017 Apr 3.
|
| 823 |
Significance of Polymorphisms and Expression of Enzyme-Encoding Genes Related to Glutathione in Hematopoietic Cancers and Solid Tumors.Biomed Res Int. 2015;2015:853573. doi: 10.1155/2015/853573. Epub 2015 Nov 23.
|
| 824 |
Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer.Cancer Res. 2006 Jan 15;66(2):763-9. doi: 10.1158/0008-5472.CAN-05-3771.
|
| 825 |
Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma.Front Med. 2020 Feb;14(1):91-100. doi: 10.1007/s11684-019-0696-6. Epub 2019 Aug 2.
|
| 826 |
Expression of IARS2 gene in colon cancer and effect of its knockdown on biological behavior of RKO cells.Int J Clin Exp Pathol. 2015 Oct 1;8(10):12151-9. eCollection 2015.
|
| 827 |
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.J Exp Clin Cancer Res. 2019 Feb 8;38(1):63. doi: 10.1186/s13046-019-1072-8.
|
| 828 |
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.Biosci Rep. 2017 Feb 10;37(1):BSR20160432. doi: 10.1042/BSR20160432. Print 2017 Feb 28.
|
| 829 |
Loss of KLF14 triggers centrosome amplification and tumorigenesis.Nat Commun. 2015 Oct 6;6:8450. doi: 10.1038/ncomms9450.
|
| 830 |
Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.Cell Commun Signal. 2019 Oct 17;17(1):129. doi: 10.1186/s12964-019-0444-1.
|
| 831 |
High expression of leucinerich repeatcontaining8A is indicative of a worse outcome of colon cancer patients by enhancing cancer cell growth and metastasis.Oncol Rep. 2018 Sep;40(3):1275-1286. doi: 10.3892/or.2018.6556. Epub 2018 Jul 10.
|
| 832 |
Overexpression of lumican affects the migration of human colon cancer cells through up-regulation of gelsolin and filamentous actin reorganization.Exp Cell Res. 2012 Nov 1;318(18):2312-23. doi: 10.1016/j.yexcr.2012.07.005. Epub 2012 Jul 16.
|
| 833 |
A potential common role of the Jumonji C domain-containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer.Oncol Lett. 2018 Nov;16(5):6652-6662. doi: 10.3892/ol.2018.9487. Epub 2018 Sep 24.
|
| 834 |
Effect of RTKN on progression and metastasis of colon cancer in vitro.Biomed Pharmacother. 2015 Aug;74:117-23. doi: 10.1016/j.biopha.2015.07.012. Epub 2015 Aug 8.
|
| 835 |
Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancer.Hum Mol Genet. 2002 Jun 1;11(12):1449-53. doi: 10.1093/hmg/11.12.1449.
|
| 836 |
FAM188B enhances cell survival via interaction with USP7.Cell Death Dis. 2018 May 24;9(6):633. doi: 10.1038/s41419-018-0650-6.
|
| 837 |
Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer.Int J Oncol. 2007 Aug;31(2):333-8.
|
| 838 |
Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.Curr Mol Med. 2016;16(9):829-839. doi: 10.2174/1566524016666161124103020.
|
| 839 |
MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2.J Exp Clin Cancer Res. 2010 Jun 22;29(1):81. doi: 10.1186/1756-9966-29-81.
|
| 840 |
NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression.Cell Death Dis. 2019 Mar 11;10(3):236. doi: 10.1038/s41419-019-1487-3.
|
| 841 |
Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas.Oncogene. 2002 Sep 12;21(41):6387-94. doi: 10.1038/sj.onc.1205751.
|
| 842 |
NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 Inhibitor.Cell Rep. 2019 Nov 5;29(6):1469-1481.e9. doi: 10.1016/j.celrep.2019.09.087.
|
| 843 |
The oncogenic role of NKAP in the growth and invasion of colon cancer cells.Oncol Rep. 2019 Nov;42(5):2130-2138. doi: 10.3892/or.2019.7322. Epub 2019 Sep 18.
|
| 844 |
The orphan nuclear receptor EAR2 is overexpressed in colorectal cancer and it regulates survivability of colon cancer cells.Cancer Lett. 2011 Oct 28;309(2):137-44. doi: 10.1016/j.canlet.2011.05.025. Epub 2011 Jun 22.
|
| 845 |
Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas.Int J Cancer. 1996 Jun 11;66(6):817-20. doi: 10.1002/(SICI)1097-0215(19960611)66:6<817::AID-IJC18>3.0.CO;2-#.
|
| 846 |
Expression of prostaglandin H synthase-2 in human brain tumors.Acta Neuropathol. 2001 Aug;102(2):181-7. doi: 10.1007/s004010100373.
|
| 847 |
RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis.Cancer Res. 2007 Mar 1;67(5):1997-2005. doi: 10.1158/0008-5472.CAN-06-3093.
|
| 848 |
PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d.Cell Death Dis. 2018 Feb 15;9(3):271. doi: 10.1038/s41419-018-0320-8.
|
| 849 |
PKB-mediated PHF20 phosphorylation on Ser291 is required for p53 function in DNA damage.Cell Signal. 2013 Jan;25(1):74-84. doi: 10.1016/j.cellsig.2012.09.009. Epub 2012 Sep 11.
|
| 850 |
Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L.Cancer Biol Ther. 2008 Feb;7(2):285-92. doi: 10.4161/cbt.7.2.5302. Epub 2007 Nov 14.
|
| 851 |
siPRDX2-elevated DNM3 inhibits the proliferation and metastasis of colon cancer cells via AKT signaling pathway.Cancer Manag Res. 2019 Jun 28;11:5799-5811. doi: 10.2147/CMAR.S193805. eCollection 2019.
|
| 852 |
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.Carcinogenesis. 2010 Sep;31(9):1604-11. doi: 10.1093/carcin/bgq142. Epub 2010 Jul 9.
|
| 853 |
A colon cancer-derived mutant of Krppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3 (GSK3) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7 (FBW7).J Biol Chem. 2014 Feb 28;289(9):5997-6005. doi: 10.1074/jbc.M113.508549. Epub 2014 Jan 7.
|
| 854 |
Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.J Appl Genet. 2015 May;56(2):185-92. doi: 10.1007/s13353-014-0253-6. Epub 2014 Nov 1.
|
| 855 |
G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response.Radiother Oncol. 2017 Sep;124(3):395-402. doi: 10.1016/j.radonc.2017.03.002. Epub 2017 Mar 25.
|
| 856 |
PTPH1 immunohistochemical expression and promoter methylation in breast cancer patients from India: A retrospective study.J Cell Physiol. 2019 Feb;234(2):1071-1079. doi: 10.1002/jcp.27211. Epub 2018 Sep 6.
|
| 857 |
A siRNA-based method for efficient silencing of PYROXD1 gene expression in the colon cancer cell line HCT116.J Cell Biochem. 2019 Dec;120(12):19310-19317. doi: 10.1002/jcb.26858. Epub 2019 Sep 10.
|
| 858 |
RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas.Int J Cancer. 2006 Aug 15;119(4):801-6. doi: 10.1002/ijc.21912.
|
| 859 |
A role for RAD54B in homologous recombination in human cells.EMBO J. 2002 Jan 15;21(1-2):175-80. doi: 10.1093/emboj/21.1.175.
|
| 860 |
Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients.Hepatobiliary Pancreat Dis Int. 2019 Oct;18(5):446-451. doi: 10.1016/j.hbpd.2019.08.006. Epub 2019 Aug 24.
|
| 861 |
High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer.J Breast Cancer. 2018 Sep;21(3):288-296. doi: 10.4048/jbc.2018.21.e34. Epub 2018 Aug 28.
|
| 862 |
Blood transcriptional and microRNA responses to short-term exposure to disinfection by-products in a swimming pool.Environ Int. 2018 Jan;110:42-50. doi: 10.1016/j.envint.2017.10.003. Epub 2017 Nov 6.
|
| 863 |
R-spondin 2 promotes proliferation and migration via the Wnt/-catenin pathway in human hepatocellular carcinoma.Oncol Lett. 2017 Aug;14(2):1757-1765. doi: 10.3892/ol.2017.6339. Epub 2017 Jun 7.
|
| 864 |
SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell.Mol Cell Biochem. 2013 Jan;373(1-2):201-10. doi: 10.1007/s11010-012-1491-8. Epub 2012 Oct 29.
|
| 865 |
SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression.Biol Chem. 2004 Sep;385(9):785-90. doi: 10.1515/BC.2004.102.
|
| 866 |
Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil domain kinase messenger RNA expression and promotes cell motility.Ann Surg Oncol. 2003 Jun;10(5):582-7. doi: 10.1245/aso.2003.08.020.
|
| 867 |
p34 (SEI-1) inhibits ROS-induced cell death through suppression of ASK1.Cancer Biol Ther. 2011 Sep 1;12(5):421-6. doi: 10.4161/cbt.12.5.15972. Epub 2011 Sep 1.
|
| 868 |
Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages: A preclinical model of surgery-associated inflammation and tumor recurrence.PLoS One. 2018 Feb 20;13(2):e0192958. doi: 10.1371/journal.pone.0192958. eCollection 2018.
|
| 869 |
Association and diagnostic value of serum SPINK4 in colorectal cancer.PeerJ. 2019 Apr 4;7:e6679. doi: 10.7717/peerj.6679. eCollection 2019.
|
| 870 |
Serum response factor is alternatively spliced in human colon cancer.J Surg Res. 2004 Sep;121(1):92-100. doi: 10.1016/j.jss.2004.02.031.
|
| 871 |
RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis.Stem Cell Reports. 2017 Aug 8;9(2):438-450. doi: 10.1016/j.stemcr.2017.06.002. Epub 2017 Jul 6.
|
| 872 |
Identification of new binding proteins of focal adhesion kinase using immunoprecipitation and mass spectrometry.Sci Rep. 2019 Sep 9;9(1):12908. doi: 10.1038/s41598-019-49145-6.
|
| 873 |
p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance.Oncogene. 2019 Mar;38(11):1905-1919. doi: 10.1038/s41388-018-0524-5. Epub 2018 Nov 2.
|
| 874 |
Association between interleukin-4R and TGF-1 gene polymorphisms and the risk of colorectal cancer in a Korean population.Colorectal Dis. 2010 Dec;12(12):1208-12. doi: 10.1111/j.1463-1318.2009.02080.x.
|
| 875 |
Down-regulation of tensin2 enhances tumorigenicity and is associated with a variety of cancers.Oncotarget. 2016 Jun 21;7(25):38143-38153. doi: 10.18632/oncotarget.9411.
|
| 876 |
NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.Oncotarget. 2016 Feb 16;7(7):8399-412. doi: 10.18632/oncotarget.6724.
|
| 877 |
Serum Levels of TRIM72 Are Lower among Patients with Colon Cancer: Identification of a Potential Diagnostic Marker.Tohoku J Exp Med. 2018 May;245(1):61-68. doi: 10.1620/tjem.245.61.
|
| 878 |
The Endosomal Protein CEMIP Links WNT Signaling to MEK1-ERK1/2 Activation in Selumetinib-Resistant Intestinal Organoids.Cancer Res. 2018 Aug 15;78(16):4533-4548. doi: 10.1158/0008-5472.CAN-17-3149. Epub 2018 Jun 18.
|
| 879 |
Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.PLoS Genet. 2013 Apr;9(4):e1003464. doi: 10.1371/journal.pgen.1003464. Epub 2013 Apr 25.
|
| 880 |
SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.Cell Rep. 2017 Dec 19;21(12):3406-3413. doi: 10.1016/j.celrep.2017.11.091.
|
| 881 |
A recombinant reporter system for monitoring reactivation of an endogenously DNA hypermethylated gene.Cancer Res. 2014 Jul 15;74(14):3834-43. doi: 10.1158/0008-5472.CAN-13-2287. Epub 2014 May 29.
|
| 882 |
Synergistic activation of the NEU4 promoter by p73 and AP2 in colon cancer cells.Sci Rep. 2019 Jan 30;9(1):950. doi: 10.1038/s41598-018-37521-7.
|
| 883 |
DAC can restore expression of NALP1 to suppress tumor growth in colon cancer.Cell Death Dis. 2015 Jan 22;6(1):e1602. doi: 10.1038/cddis.2014.532.
|
| 884 |
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.Gastroenterology. 2006 Nov;131(5):1418-30. doi: 10.1053/j.gastro.2006.08.034. Epub 2006 Aug 18.
|
| 885 |
Disruption of Core 1-mediated O-glycosylation oppositely regulates CD44 expression in human colon cancer cells and tumor-derived exosomes.Biochem Biophys Res Commun. 2020 Jan 8;521(2):514-520. doi: 10.1016/j.bbrc.2019.10.149. Epub 2019 Oct 31.
|
| 886 |
DBC1 regulates Wnt/-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.Cell Death Dis. 2018 Aug 6;9(8):831. doi: 10.1038/s41419-018-0899-9.
|
| 887 |
Basic transcription factor 3 expression silencing attenuates colon cancer cell proliferation and migration in vitro.Oncol Lett. 2019 Jan;17(1):113-118. doi: 10.3892/ol.2018.9613. Epub 2018 Oct 24.
|
| 888 |
Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression.J Cell Physiol. 2019 Apr;234(4):4608-4616. doi: 10.1002/jcp.27245. Epub 2018 Sep 14.
|
| 889 |
Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors.Bioorg Chem. 2019 Dec;93:103317. doi: 10.1016/j.bioorg.2019.103317. Epub 2019 Sep 26.
|
| 890 |
ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer.Mol Oncol. 2018 Oct;12(10):1706-1717. doi: 10.1002/1878-0261.12365. Epub 2018 Aug 20.
|
| 891 |
Downregulation of DBN1 is related to vincristine resistance in colon cancer cells.J Cancer Res Ther. 2019 Jan-Mar;15(1):38-41. doi: 10.4103/0973-1482.192766.
|
| 892 |
Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling.Sci Rep. 2019 Jul 31;9(1):11094. doi: 10.1038/s41598-019-47539-0.
|
| 893 |
Use of the tumor repressor DEDD as a prognostic marker of cancer metastasis.Methods Mol Biol. 2014;1165:197-222. doi: 10.1007/978-1-4939-0856-1_14.
|
| 894 |
Elevated expression of Derlin-1 associates with unfavorable survival time of squamous cell carcinoma of the head and neck and promotes its malignance.J Cancer. 2017 Jul 21;8(12):2336-2345. doi: 10.7150/jca.19411. eCollection 2017.
|
| 895 |
Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.Mol Genet Genomic Med. 2019 Mar;7(3):e554. doi: 10.1002/mgg3.554. Epub 2019 Jan 8.
|
| 896 |
Independent prognostic genes and mechanism investigation for colon cancer.Biol Res. 2018 Apr 13;51(1):10. doi: 10.1186/s40659-018-0158-7.
|
| 897 |
Plasma Histone H4 and H4K20 Trimethylation Levels Differ Between Colon Cancer and Precancerous Polyps.In Vivo. 2019 Sep-Oct;33(5):1653-1658. doi: 10.21873/invivo.11651.
|
| 898 |
HBP1 promoter methylation augments the oncogenic -catenin to correlate with prognosis in NSCLC.J Cell Mol Med. 2014 Sep;18(9):1752-61. doi: 10.1111/jcmm.12318. Epub 2014 Jun 4.
|
| 899 |
HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2786-2793. doi: 10.26355/eurrev_201904_17553.
|
| 900 |
LncRNA-UCA1 modulates progression of colon cancer through regulating the miR-28-5p/HOXB3 axis.J Cell Biochem. 2019 May;120(5):6926-6936. doi: 10.1002/jcb.27630. Epub 2019 Jan 16.
|
| 901 |
Candidate genes involved in metastasis of colon cancer identified by integrated analysis.Cancer Med. 2019 May;8(5):2338-2347. doi: 10.1002/cam4.2071. Epub 2019 Mar 18.
|
| 902 |
miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.Mol Cell Probes. 2019 Dec;48:101445. doi: 10.1016/j.mcp.2019.101445. Epub 2019 Sep 9.
|
| 903 |
ITGB4 is a novel prognostic factor in colon cancer.J Cancer. 2019 Aug 28;10(21):5223-5233. doi: 10.7150/jca.29269. eCollection 2019.
|
| 904 |
Livin promotes colon cancer progression by regulation of H2A.X(Y39ph) via JMJD6.Life Sci. 2019 Oct 1;234:116788. doi: 10.1016/j.lfs.2019.116788. Epub 2019 Aug 22.
|
| 905 |
MALAT1-miR663a negative feedback loop in colon cancer cell functions through direct miRNA-lncRNA binding.Cell Death Dis. 2018 Aug 28;9(9):857. doi: 10.1038/s41419-018-0925-y.
|
| 906 |
CBP-triggered KDM2B acetylation accelerates the carcinogenesis of colon cancer.J Cell Physiol. 2020 Mar;235(3):2901-2910. doi: 10.1002/jcp.29196. Epub 2019 Sep 17.
|
| 907 |
Lemur tyrosine kinase 2 acts as a positive regulator of NF-B activation and colon cancer cell proliferation.Cancer Lett. 2019 Jul 10;454:70-77. doi: 10.1016/j.canlet.2019.04.011. Epub 2019 Apr 10.
|
| 908 |
LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL? and TNF?"Xu J. Zhang W
|
| 909 |
MKK6 is upregulated in human esophageal, stomach, and colon cancers.Cancer Invest. 2014 Oct;32(8):416-22. doi: 10.3109/07357907.2014.933236. Epub 2014 Jul 14.
|
| 910 |
Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.J Gen Intern Med. 2019 Jun;34(6):978-985. doi: 10.1007/s11606-018-4820-0. Epub 2019 Jan 25.
|
| 911 |
Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells. Nutr Cancer. 2011;63(7):1133-42. doi: 10.1080/01635581.2011.605984. Epub 2011 Sep 15.
|
| 912 |
Promoter hypomethylation contributes to the expression of MUC3A in cancer cells.Biochem Biophys Res Commun. 2010 Jun 25;397(2):333-9. doi: 10.1016/j.bbrc.2010.05.124. Epub 2010 May 27.
|
| 913 |
Long non-coding RNA MBNL1-AS1 regulates proliferation, migration, and invasion of cancer stem cells in colon cancer by interacting with MYL9 via sponging microRNA-412-3p.Clin Res Hepatol Gastroenterol. 2020 Feb;44(1):101-114. doi: 10.1016/j.clinre.2019.05.001. Epub 2019 Jun 26.
|
| 914 |
Immune Effects of M51R Vesicular Stomatitis Virus Treatment of Carcinomatosis From Colon Cancer.J Surg Res. 2020 Jan;245:127-135. doi: 10.1016/j.jss.2019.07.032. Epub 2019 Aug 12.
|
| 915 |
Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.Oncol Res. 2019 Mar 29;27(4):399-406. doi: 10.3727/096504018X15179675206495. Epub 2018 Feb 9.
|
| 916 |
Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides.Cancer Sci. 2011 Dec;102(12):2139-49. doi: 10.1111/j.1349-7006.2011.02086.x. Epub 2011 Oct 17.
|
| 917 |
Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.J Cell Biochem. 2010 Jun 1;110(3):687-96. doi: 10.1002/jcb.22579.
|
| 918 |
Vitamin D and the nutritional environment in functions of intestinal stem cells: Implications for tumorigenesis and prevention.J Steroid Biochem Mol Biol. 2020 Apr;198:105556. doi: 10.1016/j.jsbmb.2019.105556. Epub 2019 Nov 26.
|
| 919 |
Sequestration of 9-Hydroxystearic Acid in FAHFA (Fatty Acid Esters of Hydroxy Fatty Acids) as a Protective Mechanism for Colon Carcinoma Cells to Avoid Apoptotic Cell Death.Cancers (Basel). 2019 Apr 12;11(4):524. doi: 10.3390/cancers11040524.
|
| 920 |
Liver receptor homologue 1, a novel prognostic marker in colon cancer patients.Oncol Lett. 2018 Sep;16(3):2833-2838. doi: 10.3892/ol.2018.8988. Epub 2018 Jun 18.
|
| 921 |
P4HB knockdown induces human HT29 colon cancer cell apoptosis through the generation of reactive oxygen species and inactivation of STAT3 signaling.Mol Med Rep. 2019 Jan;19(1):231-237. doi: 10.3892/mmr.2018.9660. Epub 2018 Nov 15.
|
| 922 |
Berberine regulates the microRNA-21-ITG4-PDCD4 axis and inhibits colon cancer viability.Oncol Lett. 2018 Apr;15(4):5971-5976. doi: 10.3892/ol.2018.7997. Epub 2018 Feb 8.
|
| 923 |
Oncogenic effect of PHLDB2 is associated with epithelial-mesenchymal transition and E-cadherin regulation in colorectal cancer.Cancer Cell Int. 2019 Jul 16;19:184. doi: 10.1186/s12935-019-0903-1. eCollection 2019.
|
| 924 |
FAPP2 promotes tumor cell growth in human colon cancer through activation of Wnt signaling.Exp Cell Res. 2019 Jan 1;374(1):12-18. doi: 10.1016/j.yexcr.2018.11.002. Epub 2018 Nov 5.
|
| 925 |
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth.Genes Dev. 2014 May 15;28(10):1068-84. doi: 10.1101/gad.237206.113. Epub 2014 May 1.
|
| 926 |
Avenanthramide A Induces Cellular Senescence via miR-129-3p/Pirh2/p53 Signaling Pathway To Suppress Colon Cancer Growth.J Agric Food Chem. 2019 May 1;67(17):4808-4816. doi: 10.1021/acs.jafc.9b00833. Epub 2019 Apr 17.
|
| 927 |
Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.Genes Chromosomes Cancer. 2018 May;57(5):240-251. doi: 10.1002/gcc.22525. Epub 2018 Jan 30.
|
| 928 |
Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.Cell Commun Signal. 2019 Jan 25;17(1):9. doi: 10.1186/s12964-018-0316-0.
|
| 929 |
Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients.Sci Rep. 2019 Sep 10;9(1):13008. doi: 10.1038/s41598-019-49477-3.
|
| 930 |
RETRACTED: Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN.Biomed Pharmacother. 2019 Jan;109:2035-2042. doi: 10.1016/j.biopha.2018.08.017. Epub 2018 Nov 26.
|
| 931 |
SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer.Mod Pathol. 2019 Jul;32(8):1217-1231. doi: 10.1038/s41379-019-0265-1. Epub 2019 Apr 8.
|
| 932 |
Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer.Cell Death Dis. 2019 Feb 12;10(2):137. doi: 10.1038/s41419-019-1352-4.
|
| 933 |
Epithelial-mesenchymal transition induced by MyoD inhibits growth of high metastatic colorectal cancer.Med Hypotheses. 2019 Sep;130:109285. doi: 10.1016/j.mehy.2019.109285. Epub 2019 Jun 24.
|
| 934 |
MicroRNA-125a inhibits tumorigenesis by targeting Smurf1 in colorectal carcinoma.FEBS Open Bio. 2019 Jul;9(7):1305-1314. doi: 10.1002/2211-5463.12680. Epub 2019 Jun 17.
|
| 935 |
Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.Gastroenterology. 2009 Oct;137(4):1346-57. doi: 10.1053/j.gastro.2009.06.041. Epub 2009 Jun 21.
|
| 936 |
Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles.Anticancer Res. 2019 Apr;39(4):1705-1710. doi: 10.21873/anticanres.13276.
|
| 937 |
Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer.Int J Oncol. 2018 Jul;53(1):275-285. doi: 10.3892/ijo.2018.4385. Epub 2018 Apr 26.
|
| 938 |
Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis.Front Genet. 2019 Apr 17;10:355. doi: 10.3389/fgene.2019.00355. eCollection 2019.
|
| 939 |
TIPE1 impairs stemness maintenance in colorectal cancer through directly targeting -catenin.Carcinogenesis. 2020 Mar 13;41(1):25-35. doi: 10.1093/carcin/bgz079.
|
| 940 |
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma.Oncotarget. 2017 Mar 28;8(13):21229-21240. doi: 10.18632/oncotarget.15070.
|
| 941 |
TRAPPC9: Novel insights into its trafficking and signaling pathways in health and disease (Review).Int J Mol Med. 2018 Dec;42(6):2991-2997. doi: 10.3892/ijmm.2018.3889. Epub 2018 Sep 21.
|
| 942 |
ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients.Oncol Rep. 2005 May;13(5):907-13.
|
| 943 |
ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2.Autophagy. 2016 Nov;12(11):2167-2182. doi: 10.1080/15548627.2016.1217380. Epub 2016 Aug 25.
|
| 944 |
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3282-7. doi: 10.1073/pnas.041625098.
|
| 945 |
3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.PLoS One. 2016 Dec 19;11(12):e0168423. doi: 10.1371/journal.pone.0168423. eCollection 2016.
|
| 946 |
Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma.Cancer Res. 2001 Dec 1;61(23):8429-34.
|
| 947 |
A study of three polymorphic sites of ADA gene in colon cancer.Cancer Invest. 2010 Dec;28(10):989-92. doi: 10.3109/07357907.2010.483501. Epub 2010 Jun 30.
|
| 948 |
The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer.J Cell Sci. 2009 Aug 15;122(Pt 16):2906-13. doi: 10.1242/jcs.050468. Epub 2009 Jul 28.
|
| 949 |
Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer.Cancer Res. 2009 Jun 1;69(11):4926-34. doi: 10.1158/0008-5472.CAN-08-4155. Epub 2009 May 19.
|
| 950 |
Adamts18 deficiency promotes colon carcinogenesis by enhancing -catenin and p38MAPK/ERK1/2 signaling in the mouse model of AOM/DSS-induced colitis-associated colorectal cancer.Oncotarget. 2017 Mar 21;8(12):18979-18990. doi: 10.18632/oncotarget.14866.
|
| 951 |
ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.Int J Cancer. 2007 Oct 15;121(8):1710-6. doi: 10.1002/ijc.22882.
|
| 952 |
Elevated Adenylyl Cyclase 9 Expression Is a Potential Prognostic Biomarker for Patients with Colon Cancer.Med Sci Monit. 2018 Jan 2;24:19-25. doi: 10.12659/msm.906002.
|
| 953 |
Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population.BMC Med Genet. 2011 Jul 12;12:94. doi: 10.1186/1471-2350-12-94.
|
| 954 |
Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue.Oncol Rep. 2008 Sep;20(3):479-83.
|
| 955 |
ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer.Clin Cancer Res. 2017 Jun 1;23(11):2769-2780. doi: 10.1158/1078-0432.CCR-16-1604. Epub 2016 Nov 30.
|
| 956 |
Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer.Biochim Biophys Acta. 2014 Mar;1843(3):618-28. doi: 10.1016/j.bbamcr.2013.12.013.
|
| 957 |
MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer.Genes Dev. 2019 Sep 1;33(17-18):1236-1251. doi: 10.1101/gad.327056.119. Epub 2019 Aug 15.
|
| 958 |
Transcriptome profiling analysis reveals biomarkers in colon cancer samples of various differentiation.Oncol Lett. 2018 Jul;16(1):48-54. doi: 10.3892/ol.2018.8668. Epub 2018 May 8.
|
| 959 |
Screening for possible miRNA-mRNA associations in a colon cancer cell line.Gene. 2014 Jan 10;533(2):520-31. doi: 10.1016/j.gene.2013.08.005. Epub 2013 Aug 9.
|
| 960 |
Long non-coding RNA CASC7 inhibits the proliferation and migration of colon cancer cells via inhibiting microRNA-21.Biomed Pharmacother. 2017 Nov;95:1644-1653. doi: 10.1016/j.biopha.2017.09.052. Epub 2017 Oct 6.
|
| 961 |
Regulation of CD40 signaling in colon cancer cells and its implications in clinical tissues.Cancer Immunol Immunother. 2016 Aug;65(8):919-29. doi: 10.1007/s00262-016-1847-0. Epub 2016 Jun 4.
|
| 962 |
Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile.Glycobiology. 2009 Jul;19(7):726-34. doi: 10.1093/glycob/cwp040. Epub 2009 Mar 17.
|
| 963 |
PKA RI/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.J Gastroenterol Hepatol. 2015 Mar;30(3):496-503. doi: 10.1111/jgh.12689.
|
| 964 |
A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer.Exp Mol Pathol. 2018 Dec;105(3):364-370. doi: 10.1016/j.yexmp.2018.10.010. Epub 2018 Oct 30.
|
| 965 |
Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma.Oncol Rep. 2012 Nov;28(5):1792-8. doi: 10.3892/or.2012.2002. Epub 2012 Aug 30.
|
| 966 |
A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.J Exp Clin Cancer Res. 2015 Nov 21;34:142. doi: 10.1186/s13046-015-0258-y.
|
| 967 |
ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status.Br J Cancer. 2018 Jan;118(2):224-232. doi: 10.1038/bjc.2017.363. Epub 2017 Dec 12.
|
| 968 |
Therapeutic opportunities in colon cancer: Focus on phosphodiesterase inhibitors.Life Sci. 2019 Aug 1;230:150-161. doi: 10.1016/j.lfs.2019.05.043. Epub 2019 May 21.
|
| 969 |
Molecular cloning of complementary DNAs encoding alkaline phosphatase in human colon cancer cells.Cancer Res. 1990 Feb 15;50(4):1085-91.
|
| 970 |
Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.PLoS One. 2019 Mar 15;14(3):e0209392. doi: 10.1371/journal.pone.0209392. eCollection 2019.
|
| 971 |
AmotL2 disrupts apical-basal cell polarity and promotes tumour invasion.Nat Commun. 2014 Aug 1;5:4557. doi: 10.1038/ncomms5557.
|
| 972 |
Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells.Mol Cancer. 2006 Nov 17;5:63. doi: 10.1186/1476-4598-5-63.
|
| 973 |
The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer.Anticancer Res. 2012 Feb;32(2):559-64.
|
| 974 |
Anosmin-1 involved in neuronal cell migration is hypoxia inducible and cancer regulated.Cell Cycle. 2009 Nov 15;8(22):3770-6. doi: 10.4161/cc.8.22.10066. Epub 2009 Nov 14.
|
| 975 |
TAZ expression as a prognostic indicator in colorectal cancer.PLoS One. 2013;8(1):e54211. doi: 10.1371/journal.pone.0054211. Epub 2013 Jan 23.
|
| 976 |
Piroxicam and C-phycocyanin mediated apoptosis in 1,2-dimethylhydrazine dihydrochloride induced colon carcinogenesis: exploring the mitochondrial pathway.Nutr Cancer. 2012 Apr;64(3):409-18. doi: 10.1080/01635581.2012.655402. Epub 2012 Feb 27.
|
| 977 |
Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.Cancer Res. 2002 Oct 15;62(20):5651-6.
|
| 978 |
Apobec-1 transcription in rat colon cancer: decreased apobec-1 protein production through alterations in polysome distribution and mRNA translation associated with upstream AUGs.Biochim Biophys Acta. 2002 May 3;1575(1-3):54-62. doi: 10.1016/s0167-4781(02)00250-6.
|
| 979 |
Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity.J Cell Physiol. 2010 Jul;224(1):33-40. doi: 10.1002/jcp.22085.
|
| 980 |
Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo.PLoS One. 2013 Dec 30;8(12):e83629. doi: 10.1371/journal.pone.0083629. eCollection 2013.
|
| 981 |
Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/-Catenin Signaling.Cell Physiol Biochem. 2018;46(5):2138-2148. doi: 10.1159/000489543. Epub 2018 Apr 28.
|
| 982 |
Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis.Int J Oncol. 2014 Jan;44(1):211-21. doi: 10.3892/ijo.2013.2150. Epub 2013 Oct 25.
|
| 983 |
Activation of TIM1 induces colon cancer cell apoptosis via modulating Fas ligand expression.Biochem Biophys Res Commun. 2016 Apr 29;473(2):377-81. doi: 10.1016/j.bbrc.2016.02.085. Epub 2016 Feb 26.
|
| 984 |
Inhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer Micelles.Sci Rep. 2016 Feb 11;6:20896. doi: 10.1038/srep20896.
|
| 985 |
ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.Anticancer Res. 2019 Jun;39(6):2845-2853. doi: 10.21873/anticanres.13413.
|
| 986 |
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis.Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9. doi: 10.1073/pnas.0911082107. Epub 2010 Mar 22.
|
| 987 |
Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and 1 integrin/FAK-mediated signalling.Biochem Biophys Res Commun. 2018 Sep 5;503(2):843-848. doi: 10.1016/j.bbrc.2018.06.085. Epub 2018 Jun 21.
|
| 988 |
Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-kappaB activity via direct interaction with p50.Mol Cancer Ther. 2009 Jun;8(6):1613-24. doi: 10.1158/1535-7163.MCT-08-0694. Epub 2009 Jun 9.
|
| 989 |
ASF1A regulates H4(Y72) phosphorylation and promotes autophagy in colon cancer cells via a kinase activity.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2754-2763. doi: 10.1080/21691401.2019.1617725.
|
| 990 |
Induction of Nitric-Oxide Metabolism in Enterocytes Alleviates Colitis and Inflammation-Associated Colon Cancer.Cell Rep. 2018 May 15;23(7):1962-1976. doi: 10.1016/j.celrep.2018.04.053.
|
| 991 |
ATG3, a Target of miR-431-5p, Promotes Proliferation and Invasion of Colon Cancer via Promoting Autophagy.Cancer Manag Res. 2019 Dec 9;11:10275-10285. doi: 10.2147/CMAR.S226828. eCollection 2019.
|
| 992 |
lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway.Onco Targets Ther. 2019 Apr 9;12:2649-2660. doi: 10.2147/OTT.S188054. eCollection 2019.
|
| 993 |
Colorectal cancer-derived extracellular vesicles induce transformation of fibroblasts into colon carcinoma cells.J Exp Clin Cancer Res. 2019 Jun 14;38(1):257. doi: 10.1186/s13046-019-1248-2.
|
| 994 |
MicroRNA-613 promotes colon cancer cell proliferation, invasion and migration by targeting ATOH1.Biochem Biophys Res Commun. 2018 Oct 12;504(4):827-833. doi: 10.1016/j.bbrc.2018.09.054. Epub 2018 Sep 13.
|
| 995 |
Epigenetic regulation of the human ATP2A3 gene promoter in gastric and colon cancer cell lines.Mol Carcinog. 2019 Jun;58(6):887-897. doi: 10.1002/mc.22978. Epub 2019 Jan 29.
|
| 996 |
Plasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells.Carcinogenesis. 2009 Nov;30(11):1962-9. doi: 10.1093/carcin/bgp223. Epub 2009 Sep 15.
|
| 997 |
ATP Synthase Subunit Epsilon Overexpression Promotes Metastasis by Modulating AMPK Signaling to Induce Epithelial-to-Mesenchymal Transition and Is a Poor Prognostic Marker in Colorectal Cancer Patients.J Clin Med. 2019 Jul 21;8(7):1070. doi: 10.3390/jcm8071070.
|
| 998 |
Identification and characterization of functional single nucleotide polymorphisms (SNPs) in Axin 1 gene: a molecular dynamics approach.Cell Biochem Biophys. 2018 Jun;76(1-2):173-185. doi: 10.1007/s12013-017-0818-1. Epub 2017 Aug 2.
|
| 999 |
A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer.FEBS Lett. 2005 Jan 3;579(1):71-8. doi: 10.1016/j.febslet.2004.11.037.
|
| 1000 |
1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells.Oncotarget. 2014 Jun 15;5(11):3673-84. doi: 10.18632/oncotarget.1981.
|
| 1001 |
Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.PLoS One. 2018 Apr 26;13(4):e0196245. doi: 10.1371/journal.pone.0196245. eCollection 2018.
|
| 1002 |
BAD-mediated apoptotic pathway is associated with human cancer development.Int J Mol Med. 2015 Apr;35(4):1081-7. doi: 10.3892/ijmm.2015.2091. Epub 2015 Feb 5.
|
| 1003 |
Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy.Oncol Rep. 2016 Feb;35(2):978-84. doi: 10.3892/or.2015.4453. Epub 2015 Nov 26.
|
| 1004 |
A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.
|
| 1005 |
Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.Sci Rep. 2016 May 20;6:26273. doi: 10.1038/srep26273.
|
| 1006 |
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells.Sci Immunol. 2017 May 19;2(11):eaal1713. doi: 10.1126/sciimmunol.aal1713.
|
| 1007 |
A unique gene encodes spliceoforms of the B-cell adhesion molecule cell surface glycoprotein of epithelial cancer and of the Lutheran blood group glycoprotein.Blood. 1996 Sep 1;88(5):1865-72.
|
| 1008 |
Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.Int J Cancer. 2002 Apr 1;98(4):498-504. doi: 10.1002/ijc.10146.
|
| 1009 |
Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after -irradiation through Wnt/-catenin pathway.Carcinogenesis. 2015 Jun;36(6):622-31. doi: 10.1093/carcin/bgv044. Epub 2015 Mar 31.
|
| 1010 |
HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.Cell Death Dis. 2018 Dec 5;9(12):1176. doi: 10.1038/s41419-018-1217-2.
|
| 1011 |
Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.Biol Chem. 2008 Dec;389(12):1467-75. doi: 10.1515/BC.2008.173.
|
| 1012 |
BCL9-2 promotes early stages of intestinal tumor progression.Gastroenterology. 2011 Oct;141(4):1359-70, 1370.e1-3. doi: 10.1053/j.gastro.2011.06.039. Epub 2011 Jun 23.
|
| 1013 |
Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection.Nucleic Acids Res. 2006 May 2;34(8):e59. doi: 10.1093/nar/gkl218.
|
| 1014 |
The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer.J Transl Med. 2009 Aug 20;7:71. doi: 10.1186/1479-5876-7-71.
|
| 1015 |
Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target.Mol Cell Proteomics. 2011 Dec;10(12):M111.011353. doi: 10.1074/mcp.M111.011353. Epub 2011 Jul 25.
|
| 1016 |
Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.Isr Med Assoc J. 2007 Dec;9(12):847-50.
|
| 1017 |
2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species.J Biol Chem. 2004 Feb 20;279(8):6911-20. doi: 10.1074/jbc.M309708200. Epub 2003 Dec 3.
|
| 1018 |
BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways.J Exp Clin Cancer Res. 2019 Oct 28;38(1):428. doi: 10.1186/s13046-019-1435-1.
|
| 1019 |
The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types.Radiother Oncol. 2015 Sep;116(3):346-51. doi: 10.1016/j.radonc.2015.06.028. Epub 2015 Jul 10.
|
| 1020 |
Antimicrobial susceptibilities of specific syndromes created with organ-specific weighted incidence antibiograms (OSWIA) in patients with intra-abdominal infections.BMC Infect Dis. 2018 Nov 19;18(1):584. doi: 10.1186/s12879-018-3494-x.
|
| 1021 |
A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients.Oncol Rep. 2007 May;17(5):1089-94.
|
| 1022 |
Bayesian and frequentist analysis of an Austrian genome-wide association study of colorectal cancer and advanced adenomas.Oncotarget. 2017 Oct 9;8(58):98623-98634. doi: 10.18632/oncotarget.21697. eCollection 2017 Nov 17.
|
| 1023 |
BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma.J Clin Invest. 2011 Oct;121(10):4056-69. doi: 10.1172/JCI44228. Epub 2011 Sep 12.
|
| 1024 |
Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cells.PLoS One. 2013;8(3):e59792. doi: 10.1371/journal.pone.0059792. Epub 2013 Mar 25.
|
| 1025 |
Anticancer activity of synthetic ()-kusunokinin and its derivative ()-bursehernin on human cancer cell lines.Biomed Pharmacother. 2019 Sep;117:109115. doi: 10.1016/j.biopha.2019.109115. Epub 2019 Jun 17.
|
| 1026 |
Cables1 is a tumor suppressor gene that regulates intestinal tumor progression in Apc(Min) mice.Cancer Biol Ther. 2013 Jul;14(7):672-8. doi: 10.4161/cbt.25089. Epub 2013 May 31.
|
| 1027 |
Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer.J Mol Histol. 2012 Dec;43(6):715-21. doi: 10.1007/s10735-012-9438-7. Epub 2012 Aug 1.
|
| 1028 |
A bipartite butyrate-responsive element in the human calretinin (CALB2) promoter acts as a repressor in colon carcinoma cells but not in mesothelioma cells.J Cell Biochem. 2010 Feb 15;109(3):519-31. doi: 10.1002/jcb.22429.
|
| 1029 |
Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.Cancer Res. 2007 Aug 15;67(16):7703-12. doi: 10.1158/0008-5472.CAN-07-0991.
|
| 1030 |
The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.Int J Oncol. 2007 Oct;31(4):915-22.
|
| 1031 |
The miR-28-5p-CAMTA2 axis regulates colon cancer progression via Wnt/-catenin signaling.J Cell Biochem. 2021 Sep;122(9):945-957. doi: 10.1002/jcb.29536. Epub 2019 Nov 10.
|
| 1032 |
CARMA3 is overexpressed in colon cancer and regulates NF-B activity and cyclin D1 expression.Biochem Biophys Res Commun. 2012 Sep 7;425(4):781-7. doi: 10.1016/j.bbrc.2012.07.152. Epub 2012 Aug 2.
|
| 1033 |
TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer.J Biol Chem. 2001 Aug 24;276(34):32220-9. doi: 10.1074/jbc.M100433200. Epub 2001 Jun 14.
|
| 1034 |
CARD9 prevents lung cancer development by suppressing the expansion of myeloid-derived suppressor cells and IDO production.Int J Cancer. 2019 Oct 15;145(8):2225-2237. doi: 10.1002/ijc.32355. Epub 2019 May 6.
|
| 1035 |
Curcumin -D-Glucuronide Plays an Important Role to Keep High Levels of Free-Form Curcumin in the Blood.Biol Pharm Bull. 2017;40(9):1515-1524. doi: 10.1248/bpb.b17-00339.
|
| 1036 |
Regional Bias of Intratumoral Genetic Heterogeneity of Apoptosis-Related Genes BAX, APAF1, and FLASH in Colon Cancers with High Microsatellite Instability.Dig Dis Sci. 2015 Jun;60(6):1674-9. doi: 10.1007/s10620-014-3499-2. Epub 2015 Jan 20.
|
| 1037 |
Integral analyses of survival-related long non-coding RNA MIR210HG and its prognostic role in colon cancer.Oncol Lett. 2019 Aug;18(2):1107-1116. doi: 10.3892/ol.2019.10435. Epub 2019 Jun 4.
|
| 1038 |
CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.Thorac Cancer. 2019 Jun;10(6):1479-1488. doi: 10.1111/1759-7714.13097. Epub 2019 May 23.
|
| 1039 |
HP1 suppresses metastasis of human cancer cells by decreasing the expression and activation of MMP2.Int J Oncol. 2014 Dec;45(6):2541-8. doi: 10.3892/ijo.2014.2646. Epub 2014 Sep 9.
|
| 1040 |
CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle.Oncotarget. 2017 Mar 21;8(12):19934-19946. doi: 10.18632/oncotarget.15253.
|
| 1041 |
Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth.Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10213-8. doi: 10.1073/pnas.1221243110. Epub 2013 Jun 3.
|
| 1042 |
m(6)A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.Mol Cancer. 2019 Dec 18;18(1):185. doi: 10.1186/s12943-019-1116-x.
|
| 1043 |
Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells.J Biol Chem. 2009 Jul 31;284(31):20629-37. doi: 10.1074/jbc.M109.014332. Epub 2009 Jun 11.
|
| 1044 |
Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis.Cancer Res. 2017 May 1;77(9):2339-2350. doi: 10.1158/0008-5472.CAN-16-1883. Epub 2017 Mar 1.
|
| 1045 |
Dro1/Ccdc80 inactivation promotes AOM/DSS-induced colorectal carcinogenesis and aggravates colitis by DSS in mice.Carcinogenesis. 2018 Sep 21;39(9):1176-1184. doi: 10.1093/carcin/bgy077.
|
| 1046 |
KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer.Int J Oncol. 2012 Nov;41(5):1820-6. doi: 10.3892/ijo.2012.1601. Epub 2012 Aug 22.
|
| 1047 |
Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer.FASEB J. 2011 Feb;25(2):590-9. doi: 10.1096/fj.10-167304. Epub 2010 Oct 25.
|
| 1048 |
Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer.Cytokine. 2018 Oct;110:435-441. doi: 10.1016/j.cyto.2018.05.015. Epub 2018 May 23.
|
| 1049 |
The Effect of Pyrroloquinoline Quinone on the Expression of WISP1 in Traumatic Brain Injury.Stem Cells Int. 2017;2017:4782820. doi: 10.1155/2017/4782820. Epub 2017 Aug 16.
|
| 1050 |
Retroviral cyclin enhances cyclin-dependent kinase-8 activity.J Virol. 2012 May;86(10):5742-51. doi: 10.1128/JVI.07006-11. Epub 2012 Feb 29.
|
| 1051 |
GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.J Cell Biochem. 2007 Apr 15;100(6):1376-86. doi: 10.1002/jcb.21140.
|
| 1052 |
Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.Oncotarget. 2018 Jan 1;9(26):18559-18569. doi: 10.18632/oncotarget.24963. eCollection 2018 Apr 6.
|
| 1053 |
Autumn Royal and Ribier Grape Juice Extracts Reduced Viability and Metastatic Potential of Colon Cancer Cells.Evid Based Complement Alternat Med. 2018 Jan 14;2018:2517080. doi: 10.1155/2018/2517080. eCollection 2018.
|
| 1054 |
Clinical significance of transmembrane 4 superfamily in colon cancer.Br J Cancer. 2003 Jul 7;89(1):158-67. doi: 10.1038/sj.bjc.6601015.
|
| 1055 |
Colon cancer cells secrete exosomes to promote self-proliferation by shortening mitosis duration and activation of STAT3 in a hypoxic environment.Cell Biosci. 2019 Aug 6;9:62. doi: 10.1186/s13578-019-0325-8. eCollection 2019.
|
| 1056 |
Correlation between T-cadherin gene expression and aberrant methylation of T-cadherin promoter in human colon carcinoma cells.Med Oncol. 2012 Jun;29(2):915-8. doi: 10.1007/s12032-011-9836-9. Epub 2011 Feb 5.
|
| 1057 |
Down-regulation of liver-intestine cadherin enhances noscapine-induced apoptosis in human colon cancer cells.Expert Rev Anticancer Ther. 2017 Sep;17(9):857-863. doi: 10.1080/14737140.2017.1344097. Epub 2017 Jun 27.
|
| 1058 |
Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation.Carcinogenesis. 2002 Jul;23(7):1139-48. doi: 10.1093/carcin/23.7.1139.
|
| 1059 |
Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression.Oncotarget. 2017 Aug 24;8(43):75076-75086. doi: 10.18632/oncotarget.20507. eCollection 2017 Sep 26.
|
| 1060 |
Knockdown of PFTAIRE Protein Kinase 1 (PFTK1) Inhibits Proliferation, Invasion, and EMT in Colon Cancer Cells.Oncol Res. 2016;24(3):137-44. doi: 10.3727/096504016X14611963142218.
|
| 1061 |
EVI1 targets Np63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.Int J Biochem Cell Biol. 2013 Aug;45(8):1568-76. doi: 10.1016/j.biocel.2013.04.032. Epub 2013 May 9.
|
| 1062 |
Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.Ann Surg Oncol. 2019 Feb;26(2):406-414. doi: 10.1245/s10434-018-6865-z. Epub 2018 Oct 11.
|
| 1063 |
Induction of nonspecific cross-reacting antigen mRNA by interferon-gamma and anti-fibronectin receptor antibody in colon cancer cells.J Gastroenterol. 1997 Apr;32(2):200-5. doi: 10.1007/BF02936368.
|
| 1064 |
Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer.Hum Pathol. 2017 Oct;68:193-202. doi: 10.1016/j.humpath.2017.08.028. Epub 2017 Sep 4.
|
| 1065 |
Linking the ceramide synthases (CerSs) 4 and 5 with apoptosis, endometrial and colon cancers.Exp Mol Pathol. 2015 Jun;98(3):585-92. doi: 10.1016/j.yexmp.2015.03.019. Epub 2015 Mar 13.
|
| 1066 |
S100A4-induced cell motility and metastasis is restricted by the Wnt/-catenin pathway inhibitor calcimycin in colon cancer cells.Mol Biol Cell. 2011 Sep;22(18):3344-54. doi: 10.1091/mbc.E10-09-0739. Epub 2011 Jul 27.
|
| 1067 |
Differential involvement of destrin and cofilin-1 in the control of invasive properties of Isreco1 human colon cancer cells.Int J Cancer. 2007 Nov 15;121(10):2162-71. doi: 10.1002/ijc.22911.
|
| 1068 |
Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.Biochem Biophys Res Commun. 2014 Jun 27;449(2):208-15. doi: 10.1016/j.bbrc.2014.05.006. Epub 2014 May 15.
|
| 1069 |
CHTM1 regulates cancer cell sensitivity to metabolic stress via p38-AIF1 pathway.J Exp Clin Cancer Res. 2019 Jun 20;38(1):271. doi: 10.1186/s13046-019-1253-5.
|
| 1070 |
CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53.J Clin Lab Anal. 2020 Jan;34(1):e23026. doi: 10.1002/jcla.23026. Epub 2019 Sep 19.
|
| 1071 |
MicroRNA 429 regulates the expression of CHMP5 in the inflammatory colitis and colorectal cancer cells.Inflamm Res. 2018 Dec;67(11-12):985-996. doi: 10.1007/s00011-018-1194-z. Epub 2018 Oct 17.
|
| 1072 |
Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models.Food Funct. 2019 Apr 17;10(4):2040-2049. doi: 10.1039/c8fo01756e.
|
| 1073 |
Distinct substrate specificities of human GlcNAc-6-sulfotransferases revealed by mass spectrometry-based sulfoglycomic analysis.J Biol Chem. 2018 Sep 28;293(39):15163-15177. doi: 10.1074/jbc.RA118.001937. Epub 2018 Aug 9.
|
| 1074 |
DNA Replication and Sister Chromatid Cohesion 1 (DSCC1) of the Replication Factor Complex CTF18-RFC is Critical for Colon Cancer Cell Growth.J Cancer. 2019 Oct 15;10(24):6142-6153. doi: 10.7150/jca.32339. eCollection 2019.
|
| 1075 |
A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion.FEBS Lett. 2007 Dec 22;581(30):5904-10. doi: 10.1016/j.febslet.2007.11.072. Epub 2007 Dec 3.
|
| 1076 |
CIZ1 regulates the proliferation, cycle distribution and colony formation of RKO human colorectal cancer cells.Mol Med Rep. 2013 Dec;8(6):1630-4. doi: 10.3892/mmr.2013.1716. Epub 2013 Oct 8.
|
| 1077 |
Creatine kinase brain overexpression protects colorectal cells from various metabolic and non-metabolic stresses.J Cell Biochem. 2011 Apr;112(4):1066-75. doi: 10.1002/jcb.23020.
|
| 1078 |
Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases.Br J Cancer. 2010 Feb 16;102(4):774-82. doi: 10.1038/sj.bjc.6605536. Epub 2010 Jan 19.
|
| 1079 |
Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis.Cancer Sci. 2020 Feb;111(2):700-712. doi: 10.1111/cas.14249. Epub 2019 Dec 20.
|
| 1080 |
HDAC-4 regulates claudin-2 expression in EGFR-ERK1/2 dependent manner to regulate colonic epithelial cell differentiation.Oncotarget. 2017 Sep 23;8(50):87718-87736. doi: 10.18632/oncotarget.21190. eCollection 2017 Oct 20.
|
| 1081 |
Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.BMC Cancer. 2017 Feb 13;17(1):129. doi: 10.1186/s12885-017-3123-x.
|
| 1082 |
Tetranectin, a plasminogen kringle 4-binding protein. Cloning and gene expression pattern in human colon cancer.Lab Invest. 1992 Aug;67(2):253-62.
|
| 1083 |
DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.Biomed Pharmacother. 2020 Jan;121:109644. doi: 10.1016/j.biopha.2019.109644. Epub 2019 Nov 19.
|
| 1084 |
Isolation and characterization of a novel gene CLUAP1 whose expression is frequently upregulated in colon cancer.Oncogene. 2004 Dec 9;23(57):9289-94. doi: 10.1038/sj.onc.1208100.
|
| 1085 |
Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation.Mol Endocrinol. 2010 Jul;24(7):1441-52. doi: 10.1210/me.2009-0498. Epub 2010 May 5.
|
| 1086 |
Up-regulation of CNDP2 facilitates the proliferation of colon cancer.BMC Gastroenterol. 2014 May 21;14:96. doi: 10.1186/1471-230X-14-96.
|
| 1087 |
Calponin 3 promotes invasion and drug resistance of colon cancer cells.World J Gastrointest Oncol. 2019 Nov 15;11(11):971-982. doi: 10.4251/wjgo.v11.i11.971.
|
| 1088 |
Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region.Am J Pathol. 2006 Mar;168(3):856-65. doi: 10.2353/ajpath.2006.050384.
|
| 1089 |
Increasing Incidence of Colon Cancer in the Young: Assessing the Tumor Biology.J Am Coll Surg. 2019 Jul;229(1):79-90. doi: 10.1016/j.jamcollsurg.2019.03.022. Epub 2019 Apr 14.
|
| 1090 |
ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development.Cancer Cell. 2015 Aug 10;28(2):183-97. doi: 10.1016/j.ccell.2015.07.004.
|
| 1091 |
Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.Mol Cancer. 2015 Oct 13;14:180. doi: 10.1186/s12943-015-0450-x.
|
| 1092 |
Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer.Cancer Res. 1990 Mar 1;50(5):1596-600.
|
| 1093 |
Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.Cancer Prev Res (Phila). 2011 Dec;4(12):2015-26. doi: 10.1158/1940-6207.CAPR-11-0233. Epub 2011 Sep 1.
|
| 1094 |
Synthesis, docking, cytotoxicity, and LTA(4)H inhibitory activity of new gingerol derivatives as potential colorectal cancer therapy.Bioorg Med Chem. 2017 Feb 1;25(3):1277-1285. doi: 10.1016/j.bmc.2016.12.048. Epub 2016 Dec 29.
|
| 1095 |
Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.Biochim Biophys Acta Mol Cell Res. 2019 Oct;1866(10):1533-1543. doi: 10.1016/j.bbamcr.2019.07.001. Epub 2019 Jul 10.
|
| 1096 |
Crumbs3 regulates the expression of glycosphingolipids on the plasma membrane to promote colon cancer cell migration.Biochem Biophys Res Commun. 2019 Nov 5;519(2):287-293. doi: 10.1016/j.bbrc.2019.08.161. Epub 2019 Sep 26.
|
| 1097 |
Comparative effectiveness of screening strategies for Lynch syndrome.J Natl Cancer Inst. 2015 Mar 20;107(4):djv005. doi: 10.1093/jnci/djv005. Print 2015 Apr.
|
| 1098 |
The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.Int J Cancer. 2008 Jul 1;123(1):14-21. doi: 10.1002/ijc.23608.
|
| 1099 |
Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop.Life Sci. 2002 Feb 8;70(12):1359-67. doi: 10.1016/s0024-3205(01)01519-3.
|
| 1100 |
The role of CT10 regulation of kinase-like in cancer.Future Oncol. 2014 Dec;10(16):2687-97. doi: 10.2217/fon.14.199.
|
| 1101 |
Investigation of apoptotic effect of juglone on CCL-228-SW 480 colon cancer cell line.J Cancer Res Ther. 2019 Jan-Mar;15(1):68-74. doi: 10.4103/jcrt.JCRT_880_17.
|
| 1102 |
Evaluation of SAT-1, SAT-2 and GalNAcT-1 mRNA in colon cancer by real-time PCR.Mol Cell Biochem. 2007 Apr;298(1-2):59-68. doi: 10.1007/s11010-006-9350-0. Epub 2006 Nov 21.
|
| 1103 |
DDA1 promotes stage IIB-IIC colon cancer progression by activating NFB/CSN2/GSK-3 signaling.Oncotarget. 2016 Apr 12;7(15):19794-812. doi: 10.18632/oncotarget.7847.
|
| 1104 |
Identification of AXUD1, a novel human gene induced by AXIN1 and its reduced expression in human carcinomas of the lung, liver, colon and kidney.Oncogene. 2001 Aug 16;20(36):5062-6. doi: 10.1038/sj.onc.1204603.
|
| 1105 |
Hybrid Method Based on Information Gain and Support Vector Machine for Gene Selection in Cancer Classification.Genomics Proteomics Bioinformatics. 2017 Dec;15(6):389-395. doi: 10.1016/j.gpb.2017.08.002. Epub 2017 Dec 12.
|
| 1106 |
Let?d inhibits colorectal cancer cell proliferation through the CST1/p65 pathway.Int J Oncol. 2018 Aug;53(2):781-790. doi: 10.3892/ijo.2018.4419. Epub 2018 May 23.
|
| 1107 |
Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression.J Biol Chem. 2015 Oct 30;290(44):26533-48. doi: 10.1074/jbc.M115.660175. Epub 2015 Sep 13.
|
| 1108 |
Expression and epigenetic regulation of cystatin B in lung cancer and colorectal cancer.Pathol Res Pract. 2017 Dec;213(12):1568-1574. doi: 10.1016/j.prp.2017.06.007. Epub 2017 Jun 6.
|
| 1109 |
CTHRC1 overexpression predicts poor survival and enhances epithelial-mesenchymal transition in colorectal cancer.Cancer Med. 2018 Nov;7(11):5643-5654. doi: 10.1002/cam4.1807. Epub 2018 Oct 9.
|
| 1110 |
The alphaE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells.Oncogene. 1999 Jan 28;18(4):905-15. doi: 10.1038/sj.onc.1202348.
|
| 1111 |
Divergent roles of p120-catenin isoforms linked to altered cell viability, proliferation, and invasiveness in carcinogen-induced rat skin tumors.Mol Carcinog. 2017 Jul;56(7):1733-1742. doi: 10.1002/mc.22630. Epub 2017 Mar 6.
|
| 1112 |
High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.Cell Physiol Biochem. 2018;51(6):2829-2842. doi: 10.1159/000496013. Epub 2018 Dec 18.
|
| 1113 |
Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.Med Oncol. 2013;30(2):534. doi: 10.1007/s12032-013-0534-7. Epub 2013 May 7.
|
| 1114 |
The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.Int J Mol Sci. 2019 Nov 18;20(22):5793. doi: 10.3390/ijms20225793.
|
| 1115 |
Fibroblast-derived CXCL12/SDF-1 promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer.World J Gastroenterol. 2017 Jul 28;23(28):5167-5178. doi: 10.3748/wjg.v23.i28.5167.
|
| 1116 |
CYB5D2 displays tumor suppression activities towards cervical cancer.Biochim Biophys Acta. 2016 Apr;1862(4):556-565. doi: 10.1016/j.bbadis.2015.12.013. Epub 2015 Dec 12.
|
| 1117 |
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.Oncotarget. 2016 May 24;7(21):31350-60. doi: 10.18632/oncotarget.8912.
|
| 1118 |
IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2.Cancer Res. 2011 Mar 15;71(6):2172-82. doi: 10.1158/0008-5472.CAN-10-3295. Epub 2011 Jan 20.
|
| 1119 |
Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1.FEBS Lett. 2016 Feb;590(3):330-9. doi: 10.1002/1873-3468.12063. Epub 2016 Feb 2.
|
| 1120 |
Elevated d-2-hydroxyglutarate during colitis drives progression to colorectal cancer.Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1057-1062. doi: 10.1073/pnas.1712625115. Epub 2018 Jan 16.
|
| 1121 |
Oncogenic function of DACT1 in colon cancer through the regulation of -catenin.PLoS One. 2012;7(3):e34004. doi: 10.1371/journal.pone.0034004. Epub 2012 Mar 21.
|
| 1122 |
DACT2 is a functional tumor suppressor through inhibiting Wnt/-catenin pathway and associated with poor survival in colon cancer.Oncogene. 2015 May 14;34(20):2575-85. doi: 10.1038/onc.2014.201. Epub 2014 Jul 14.
|
| 1123 |
Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A(DCAF1) to promote colon cancer development.Cancer Lett. 2016 Jun 1;375(2):209-220. doi: 10.1016/j.canlet.2016.02.055. Epub 2016 Mar 7.
|
| 1124 |
Genome-wide association study of colorectal cancer identifies six new susceptibility loci.Nat Commun. 2015 Jul 7;6:7138. doi: 10.1038/ncomms8138.
|
| 1125 |
Construction and characterization of regulated cycle inhibiting factors induced upon Tet-On system in human colon cancer cell lines.Anticancer Drugs. 2018 Oct;29(9):854-860. doi: 10.1097/CAD.0000000000000654.
|
| 1126 |
DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.Cancer Res. 2013 Jun 15;73(12):3771-82. doi: 10.1158/0008-5472.CAN-12-4069. Epub 2013 Apr 22.
|
| 1127 |
The phospholipase DDHD1 as a new target in colorectal cancer therapy.J Exp Clin Cancer Res. 2018 Apr 13;37(1):82. doi: 10.1186/s13046-018-0753-z.
|
| 1128 |
Involvement of RNA helicases p68 and p72 in colon cancer.Cancer Res. 2007 Aug 15;67(16):7572-8. doi: 10.1158/0008-5472.CAN-06-4652.
|
| 1129 |
DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.Oncotarget. 2015 Jul 30;6(21):18602-12. doi: 10.18632/oncotarget.4329.
|
| 1130 |
Differential labeling by monoclonal antibodies Adnab-9 and anti-alpha-defensin 5 based on the distribution and adenomatous tissue content of colonic polyps.Dig Dis Sci. 2005 Apr;50(4):708-13. doi: 10.1007/s10620-005-2561-5.
|
| 1131 |
Expression of the human antimicrobial peptide -defensin-1 is repressed by the EGFR-ERK-MYC axis in colonic epithelial cells.Sci Rep. 2018 Dec 21;8(1):18043. doi: 10.1038/s41598-018-36387-z.
|
| 1132 |
Apoptotic Activity of Lactobacillus plantarum DGK-17-Fermented Soybean Seed Extract in Human Colon Cancer Cells via ROS-JNK Signaling Pathway.J Food Sci. 2017 Jun;82(6):1475-1483. doi: 10.1111/1750-3841.13732. Epub 2017 May 10.
|
| 1133 |
The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration.Oncogene. 2017 Mar 2;36(9):1191-1199. doi: 10.1038/onc.2016.282. Epub 2016 Oct 31.
|
| 1134 |
DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.Cancer Sci. 2009 Oct;100(10):1801-8. doi: 10.1111/j.1349-7006.2009.01246.x. Epub 2009 Jun 17.
|
| 1135 |
Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells.Cancer Lett. 2009 Apr 18;276(2):152-9. doi: 10.1016/j.canlet.2008.11.003. Epub 2008 Dec 6.
|
| 1136 |
Regulation of the oncogenic function of distal-less 4 by microRNA-122 in hepatocellular carcinoma.Mol Med Rep. 2015 Jul;12(1):1375-80. doi: 10.3892/mmr.2015.3554. Epub 2015 Mar 27.
|
| 1137 |
Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.Int J Mol Med. 2008 Jan;21(1):19-31.
|
| 1138 |
Discovery, synthesis and molecular substantiation of N-(benzo[d]thiazol-2-yl)-2-hydroxyquinoline-4-carboxamides as anticancer agents.Bioorg Chem. 2019 Oct;91:103171. doi: 10.1016/j.bioorg.2019.103171. Epub 2019 Jul 30.
|
| 1139 |
Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.Cell Growth Differ. 1997 Mar;8(3):269-74.
|
| 1140 |
Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.J Exp Clin Cancer Res. 2015 Jun 11;34(1):60. doi: 10.1186/s13046-015-0176-z.
|
| 1141 |
Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity.PLoS One. 2015 Apr 27;10(4):e0124818. doi: 10.1371/journal.pone.0124818. eCollection 2015.
|
| 1142 |
Cell growth inhibition by 3-deoxysappanchalcone is mediated by directly targeting the TOPK signaling pathway in colon cancer.Phytomedicine. 2019 Aug;61:152813. doi: 10.1016/j.phymed.2018.12.036. Epub 2018 Dec 31.
|
| 1143 |
Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling.Oncogene. 2014 Sep 4;33(36):4531-6. doi: 10.1038/onc.2013.442. Epub 2013 Oct 28.
|
| 1144 |
DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells.Redox Biol. 2018 Jul;17:224-235. doi: 10.1016/j.redox.2018.04.020. Epub 2018 Apr 23.
|
| 1145 |
Differential expression of DUSP2 in left- and right-sided colon cancer is associated with poor prognosis in colorectal cancer.Oncol Lett. 2018 Apr;15(4):4207-4214. doi: 10.3892/ol.2018.7881. Epub 2018 Jan 26.
|
| 1146 |
Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development.Nat Commun. 2015 Mar 16;6:6380. doi: 10.1038/ncomms7380.
|
| 1147 |
E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.J Cell Physiol. 2009 Nov;221(2):350-8. doi: 10.1002/jcp.21859.
|
| 1148 |
Proteomic Analysis of Liquid Biopsy from Tumor-Draining Vein Indicates that High Expression of Exosomal ECM1 Is Associated with Relapse in Stage I-III Colon Cancer.Transl Oncol. 2018 Jun;11(3):715-721. doi: 10.1016/j.tranon.2018.03.010. Epub 2018 Apr 13.
|
| 1149 |
Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer.J Biomed Sci. 2009;16(1):33. doi: 10.1186/1423-0127-16-33. Epub 2008 Dec 25.
|
| 1150 |
Expression of EEF1A1 Is Associated with Prognosis of Patients with Colon Adenocarcinoma.J Clin Med. 2019 Nov 7;8(11):1903. doi: 10.3390/jcm8111903.
|
| 1151 |
Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer.Br J Cancer. 2004 Apr 19;90(8):1620-6. doi: 10.1038/sj.bjc.6601723.
|
| 1152 |
RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells.World J Surg Oncol. 2012 Jun 26;10:119. doi: 10.1186/1477-7819-10-119.
|
| 1153 |
Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells.J Zhejiang Univ Sci B. 2013 Jun;14(6):451-9. doi: 10.1631/jzus.B1200230.
|
| 1154 |
hmiR-34c-3p upregulation inhibits the proliferation of colon cancer cells by targeting EIF3D.Anticancer Drugs. 2018 Nov;29(10):975-982. doi: 10.1097/CAD.0000000000000674.
|
| 1155 |
Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.Int J Clin Exp Pathol. 2014 Sep 15;7(10):6462-74. eCollection 2014.
|
| 1156 |
EIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and -catenin activation.Oncogene. 2014 Aug 7;33(32):4156-63. doi: 10.1038/onc.2013.397. Epub 2013 Sep 23.
|
| 1157 |
eIF3m expression influences the regulation of tumorigenesis-related genes in human colon cancer.Oncogene. 2011 Jan 27;30(4):398-409. doi: 10.1038/onc.2010.422. Epub 2010 Sep 13.
|
| 1158 |
A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1.Genome Res. 2016 Apr;26(4):541-53. doi: 10.1101/gr.193169.115. Epub 2016 Feb 9.
|
| 1159 |
Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis.Carcinogenesis. 2016 Jan;37(1):87-95. doi: 10.1093/carcin/bgv161. Epub 2015 Nov 19.
|
| 1160 |
Functional evidence for Eme1 as a marker of cisplatin resistance.Int J Cancer. 2009 Jun 15;124(12):2997-3001. doi: 10.1002/ijc.24268.
|
| 1161 |
Abrogation of EMILIN1-1 integrin interaction promotes experimental colitis and colon carcinogenesis.Matrix Biol. 2019 Oct;83:97-115. doi: 10.1016/j.matbio.2019.08.006. Epub 2019 Aug 31.
|
| 1162 |
Alkaline sphingomyelinase: an old enzyme with novel implications.Biochim Biophys Acta. 2006 Mar;1761(3):281-91. doi: 10.1016/j.bbalip.2006.03.007. Epub 2006 Mar 30.
|
| 1163 |
The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesis.Oncogene. 2013 Sep 26;32(39):4602-13. doi: 10.1038/onc.2012.485. Epub 2012 Oct 29.
|
| 1164 |
Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer.Cancer Lett. 2016 Oct 28;381(2):341-8. doi: 10.1016/j.canlet.2016.08.008. Epub 2016 Aug 15.
|
| 1165 |
Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells.Pharmacology. 2018;102(3-4):161-168. doi: 10.1159/000491587. Epub 2018 Jul 26.
|
| 1166 |
Elevated Expression of ERCC6 Confers Resistance to 5-Fluorouracil and Is Associated with Poor Patient Survival in Colorectal Cancer.DNA Cell Biol. 2017 Sep;36(9):781-786. doi: 10.1089/dna.2017.3768. Epub 2017 Jun 30.
|
| 1167 |
ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion.Biochem Biophys Res Commun. 2006 Jun 23;345(1):216-21. doi: 10.1016/j.bbrc.2006.04.094. Epub 2006 Apr 27.
|
| 1168 |
Common genetic variation in ETV6 is associated with colorectal cancer susceptibility.Nat Commun. 2016 May 5;7:11478. doi: 10.1038/ncomms11478.
|
| 1169 |
DNA Methylation Analysis Using Droplet Digital PCR.Methods Mol Biol. 2018;1768:363-383. doi: 10.1007/978-1-4939-7778-9_21.
|
| 1170 |
Exo70 is an independent prognostic factor in colon cancer.Sci Rep. 2017 Jul 11;7(1):5039. doi: 10.1038/s41598-017-05308-x.
|
| 1171 |
FABP7 promotes cell proliferation and survival in colon cancer through MEK/ERK signaling pathway.Biomed Pharmacother. 2018 Dec;108:119-129. doi: 10.1016/j.biopha.2018.08.038. Epub 2018 Sep 13.
|
| 1172 |
Mutation of FADD gene is rare in human colon and stomach cancers.APMIS. 2004 Sep;112(9):595-7. doi: 10.1111/j.1600-0463.2004.apm1120906.x.
|
| 1173 |
A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression.Cancer Lett. 2013 Jan 28;328(2):278-84. doi: 10.1016/j.canlet.2012.09.026. Epub 2012 Oct 8.
|
| 1174 |
Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PLoS One. 2011;6(10):e25564. doi: 10.1371/journal.pone.0025564. Epub 2011 Oct 19.
|
| 1175 |
F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.Biomed Pharmacother. 2018 Nov;107:1712-1719. doi: 10.1016/j.biopha.2018.08.119. Epub 2018 Sep 8.
|
| 1176 |
Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.Biochem Biophys Res Commun. 2011 May 6;408(2):195-201. doi: 10.1016/j.bbrc.2011.02.077. Epub 2011 Feb 19.
|
| 1177 |
Gene expression analysis in colorectal cancer using practical DNA array filter.Dis Colon Rectum. 2001 Feb;44(2):295-9. doi: 10.1007/BF02234309.
|
| 1178 |
RACK1 downregulates levels of the pro-apoptotic protein Fem1b in apoptosis-resistant colon cancer cells.Cancer Biol Ther. 2009 Dec;8(23):2297-305. doi: 10.4161/cbt.8.23.10262. Epub 2009 Dec 7.
|
| 1179 |
FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of -catenin transcriptional activity.Oncogene. 2017 Mar 30;36(13):1779-1792. doi: 10.1038/onc.2016.339. Epub 2016 Sep 19.
|
| 1180 |
Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22.Biochem Biophys Res Commun. 2000 Aug 2;274(2):337-43. doi: 10.1006/bbrc.2000.3142.
|
| 1181 |
Overexpression of FGF9 in colon cancer cells is mediated by hypoxia-induced translational activation.Nucleic Acids Res. 2014 Mar;42(5):2932-44. doi: 10.1093/nar/gkt1286. Epub 2013 Dec 10.
|
| 1182 |
ADAM-17/FHL2 colocalisation suggests interaction and role of these proteins in colorectal cancer.Tumour Biol. 2017 Mar;39(3):1010428317695024. doi: 10.1177/1010428317695024.
|
| 1183 |
Clinical significance and comparison of flotillin 1 expression in left and right colon cancer.Oncol Lett. 2019 Aug;18(2):997-1004. doi: 10.3892/ol.2019.10401. Epub 2019 May 27.
|
| 1184 |
Enhancement of anti-tumor effect of plasmid DNA-carrying MUC1 by the adjuvanticity of FLT3L in mouse model.Immunopharmacol Immunotoxicol. 2018 Aug;40(4):353-357. doi: 10.1080/08923973.2018.1498099. Epub 2018 Aug 15.
|
| 1185 |
Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK/AP-1/MMP-2 modulation in vitro.J Agric Food Chem. 2012 Dec 26;60(51):12451-7. doi: 10.1021/jf300964f. Epub 2012 Dec 13.
|
| 1186 |
2-Amino-4-(1-piperidine) pyridine exhibits inhibitory effect on colon cancer through suppression of FOXA2 expression.3 Biotech. 2019 Nov;9(11):384. doi: 10.1007/s13205-019-1915-1. Epub 2019 Oct 4.
|
| 1187 |
Forkhead Box Protein J1 (FOXJ1) is Overexpressed in Colorectal Cancer and Promotes Nuclear Translocation of -Catenin in SW620 Cells.Med Sci Monit. 2017 Feb 17;23:856-866. doi: 10.12659/msm.902906.
|
| 1188 |
Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.Oncol Rep. 2016 Oct;36(4):2151-9. doi: 10.3892/or.2016.5041. Epub 2016 Aug 25.
|
| 1189 |
Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells.Oncotarget. 2017 Feb 7;8(6):9783-9793. doi: 10.18632/oncotarget.14189.
|
| 1190 |
Follistatin-like protein 1 sustains colon cancer cell growth and survival.Oncotarget. 2018 Jul 27;9(58):31278-31290. doi: 10.18632/oncotarget.25811. eCollection 2018 Jul 27.
|
| 1191 |
The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach.Int J Biochem Cell Biol. 2011 Jan;43(1):130-9. doi: 10.1016/j.biocel.2010.10.004. Epub 2010 Oct 19.
|
| 1192 |
Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.J Biol Chem. 2014 Nov 7;289(45):31534-49. doi: 10.1074/jbc.M114.602680. Epub 2014 Oct 1.
|
| 1193 |
Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res. 2009 Apr 3;1:25-37.
|
| 1194 |
LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer.Br J Cancer. 2013 Aug 20;109(4):994-1003. doi: 10.1038/bjc.2013.364. Epub 2013 Jul 30.
|
| 1195 |
Ethanol-Mediated Stress Promotes Autophagic Survival and Aggressiveness of Colon Cancer Cells via Activation of Nrf2/HO-1 Pathway.Cancers (Basel). 2019 Apr 10;11(4):505. doi: 10.3390/cancers11040505.
|
| 1196 |
Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?.BMC Cancer. 2010 May 5;10:180. doi: 10.1186/1471-2407-10-180.
|
| 1197 |
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12921-5. doi: 10.1073/pnas.0901454106. Epub 2009 Jul 17.
|
| 1198 |
MiR-4262 promotes cell apoptosis and inhibits proliferation of colon cancer cells: involvement of GALNT4.Am J Transl Res. 2018 Dec 15;10(12):3969-3977. eCollection 2018.
|
| 1199 |
De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.J Biol Chem. 2018 Jan 26;293(4):1298-1314. doi: 10.1074/jbc.M117.812826. Epub 2017 Nov 29.
|
| 1200 |
The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients.Oncotarget. 2017 Jan 17;8(3):4747-4759. doi: 10.18632/oncotarget.13580.
|
| 1201 |
Associations between vitamin D-binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells.Cancer Prev Res (Phila). 2014 Apr;7(4):426-34. doi: 10.1158/1940-6207.CAPR-13-0269. Epub 2014 Jan 28.
|
| 1202 |
Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer.FEBS Lett. 2017 Jul;591(13):1902-1917. doi: 10.1002/1873-3468.12685. Epub 2017 Jun 10.
|
| 1203 |
Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer.Eur J Cancer. 2015 Jan;51(1):1-8. doi: 10.1016/j.ejca.2014.10.021. Epub 2014 Nov 11.
|
| 1204 |
Neoexpression of N-cadherin in E-cadherin positive colon cancers.Int J Cancer. 2004 Sep 20;111(5):711-9. doi: 10.1002/ijc.20317.
|
| 1205 |
Augmenter of liver regeneration gene expression in human colon cancer cell lines and clinical tissue samples.J BUON. 2015 Jan-Feb;20(1):84-91.
|
| 1206 |
PSF3 marks malignant colon cancer and has a role in cancer cell proliferation.Biochem Biophys Res Commun. 2010 Feb 5;392(2):150-4. doi: 10.1016/j.bbrc.2009.12.174. Epub 2010 Jan 6.
|
| 1207 |
Epigenetic silencing of glutaminase 2 in human liver and colon cancers.BMC Cancer. 2013 Dec 14;13:601. doi: 10.1186/1471-2407-13-601.
|
| 1208 |
Absence of GNAI2 codon 179 oncogene mutations in inflammatory bowel disease.Inflamm Bowel Dis. 2000 May;6(2):103-6. doi: 10.1097/00054725-200005000-00006.
|
| 1209 |
GOLPH3 expression promotes the resistance of HT29 cells to 5fluorouracil by activating multiple signaling pathways.Mol Med Rep. 2018 Jan;17(1):542-548. doi: 10.3892/mmr.2017.7877. Epub 2017 Oct 25.
|
| 1210 |
Tissue and cell-specific patterns of expression of rat liver and intestinal fatty acid binding protein during development and in experimental colonic and small intestinal adenocarcinomas.Lab Invest. 1993 Jun;68(6):663-75.
|
| 1211 |
Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.Int J Cancer. 2017 Jun 15;140(12):2728-2733. doi: 10.1002/ijc.30687. Epub 2017 Mar 28.
|
| 1212 |
The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients.Oncotarget. 2017 Aug 24;8(60):101189-101202. doi: 10.18632/oncotarget.20516. eCollection 2017 Nov 24.
|
| 1213 |
Phospholipase D activation mediates growth and migration of colon cancer cells interacting with cancer-associated fibroblasts.Cell Mol Biol (Noisy-le-grand). 2018 Nov 30;64(14):84-88.
|
| 1214 |
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.Nat Genet. 2012 May 27;44(7):770-6. doi: 10.1038/ng.2293.
|
| 1215 |
Anti-sense RNA of 32-kDa laminin-binding protein inhibits attachment and invasion of a human colon carcinoma cell line.J Surg Res. 1992 Apr;52(4):340-6. doi: 10.1016/0022-4804(92)90113-e.
|
| 1216 |
Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.Oncogene. 2008 Jun 5;27(25):3624-34. doi: 10.1038/sj.onc.1211021. Epub 2008 Jan 28.
|
| 1217 |
In vitro-fermented raw and roasted walnuts induce expression of CAT and GSTT2 genes, growth inhibition, and apoptosis in LT97 colon adenoma cells.Nutr Res. 2017 Nov;47:72-80. doi: 10.1016/j.nutres.2017.09.004. Epub 2017 Sep 18.
|
| 1218 |
Can colorectal cancer be prevented or treated by oral hormone replacement therapy?.Curr Mol Pharmacol. 2009 Nov;2(3):285-92. doi: 10.2174/1874467210902030285.
|
| 1219 |
Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer.Cell Death Dis. 2014 Jul 17;5(7):e1324. doi: 10.1038/cddis.2014.283.
|
| 1220 |
FAK and HAS inhibition synergistically decrease colon cancer cell viability and affect expression of critical genes.Anticancer Agents Med Chem. 2013 May;13(4):584-94. doi: 10.2174/1871520611313040008.
|
| 1221 |
Tim-3 suppresses the killing effect of V9V2T cells on colon cancer cells by reducing perforin and granzyme B expression.Exp Cell Res. 2020 Jan 1;386(1):111719. doi: 10.1016/j.yexcr.2019.111719. Epub 2019 Nov 11.
|
| 1222 |
A transcriptional regulatory role of the THAP11-HCF-1 complex in colon cancer cell function.Mol Cell Biol. 2012 May;32(9):1654-70. doi: 10.1128/MCB.06033-11. Epub 2012 Feb 27.
|
| 1223 |
Fucosylation Deficiency in Mice Leads to Colitis andAdenocarcinoma.Gastroenterology. 2017 Jan;152(1):193-205.e10. doi: 10.1053/j.gastro.2016.09.004. Epub 2016 Sep 14.
|
| 1224 |
Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family.Int J Mol Med. 2016 Sep;38(3):776-84. doi: 10.3892/ijmm.2016.2689. Epub 2016 Jul 22.
|
| 1225 |
Chromosome 5 allele loss at the glucocorticoid receptor locus in human colorectal carcinomas.Biochem Biophys Res Commun. 1988 Jan 29;150(2):591-8. doi: 10.1016/0006-291x(88)90434-2.
|
| 1226 |
Methylation of the Tumor Suppressor Genes HIC1 and RassF1A Clusters Independently From the Methylation of Polycomb Target Genes in Colon Cancer.Ann Surg Oncol. 2017 Feb;24(2):578-585. doi: 10.1245/s10434-015-5024-z. Epub 2015 Dec 15.
|
| 1227 |
Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.J Clin Invest. 2002 Aug;110(3):351-60. doi: 10.1172/JCI15529.
|
| 1228 |
Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.Int J Oncol. 2006 Jul;29(1):83-94.
|
| 1229 |
Loss of HLTF function promotes intestinal carcinogenesis.Mol Cancer. 2012 Mar 27;11:18. doi: 10.1186/1476-4598-11-18.
|
| 1230 |
Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction.Jpn J Cancer Res. 1999 Sep;90(9):987-92. doi: 10.1111/j.1349-7006.1999.tb00846.x.
|
| 1231 |
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.Med Sci Monit. 2019 Dec 11;25:9435-9445. doi: 10.12659/MSM.920381.
|
| 1232 |
Oncogenic heterogeneous nuclear ribonucleoprotein D-like promotes the growth of human colon cancer SW620 cells via its regulation of cell-cycle.Acta Biochim Biophys Sin (Shanghai). 2018 Sep 1;50(9):880-887. doi: 10.1093/abbs/gmy085.
|
| 1233 |
Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.J Biol Chem. 2018 Jun 15;293(24):9277-9291. doi: 10.1074/jbc.RA117.001507. Epub 2018 May 2.
|
| 1234 |
HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition.Gut. 2018 Jun;67(6):1103-1111. doi: 10.1136/gutjnl-2016-312927. Epub 2017 Mar 30.
|
| 1235 |
hnRNPM induces translation switch under hypoxia to promote colon cancer development.EBioMedicine. 2019 Mar;41:299-309. doi: 10.1016/j.ebiom.2019.02.059. Epub 2019 Mar 7.
|
| 1236 |
HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.J Cell Biochem. 2018 Mar;119(3):2864-2874. doi: 10.1002/jcb.26461. Epub 2017 Dec 12.
|
| 1237 |
Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation.J Cell Physiol. 2018 Feb;233(2):727-735. doi: 10.1002/jcp.25981. Epub 2017 Jul 11.
|
| 1238 |
The Significant Pathways and Genes Underlying the Colon Cancer Treatment by the Traditional Chinese Medicine PHY906.Evid Based Complement Alternat Med. 2017;2017:8753815. doi: 10.1155/2017/8753815. Epub 2017 May 15.
|
| 1239 |
Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.Nat Genet. 2013 Feb;45(2):191-6. doi: 10.1038/ng.2505. Epub 2012 Dec 23.
|
| 1240 |
HSP110 promotes colorectal cancer growth through STAT3 activation.Oncogene. 2017 Apr 20;36(16):2328-2336. doi: 10.1038/onc.2016.403. Epub 2016 Nov 7.
|
| 1241 |
Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy.Genomics. 2015 Dec;106(6):348-54. doi: 10.1016/j.ygeno.2015.10.002. Epub 2015 Oct 21.
|
| 1242 |
KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis.Clin Cancer Res. 2011 Jun 1;17(11):3558-68. doi: 10.1158/1078-0432.CCR-10-2729. Epub 2011 Apr 29.
|
| 1243 |
Increased IFRD1 Expression in Human Colon Cancers Predicts Reduced Patient Survival.Dig Dis Sci. 2017 Dec;62(12):3460-3467. doi: 10.1007/s10620-017-4819-0. Epub 2017 Nov 1.
|
| 1244 |
Long noncoding RNA HOTAIR silencing inhibits invasion and proliferation of human colon cancer LoVo cells via regulating IGF2BP2.J Cell Biochem. 2019 Feb;120(2):1221-1231. doi: 10.1002/jcb.27079. Epub 2018 Oct 18.
|
| 1245 |
Insulin-like growth factor binding protein-4 gene therapy increases apoptosis by altering Bcl-2 and Bax proteins and decreases angiogenesis in colorectal cancer.Int J Oncol. 2007 Apr;30(4):883-8.
|
| 1246 |
Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through 51 Integrin.J Cell Biochem. 2015 Oct;116(10):2385-96. doi: 10.1002/jcb.25189.
|
| 1247 |
Screening of Differentiation-Specific Molecular Biomarkers for Colon Cancer.Cell Physiol Biochem. 2018;46(6):2543-2550. doi: 10.1159/000489660. Epub 2018 May 5.
|
| 1248 |
Delivery of a Modified mRNA Encoding IL-22 Binding Protein (IL-22BP) for Colon Cancer Gene Therapy.J Biomed Nanotechnol. 2018 Jul 1;14(7):1239-1251. doi: 10.1166/jbn.2018.2577.
|
| 1249 |
NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer.Dig Dis Sci. 2014 Jun;59(6):1169-79. doi: 10.1007/s10620-014-3168-5. Epub 2014 May 6.
|
| 1250 |
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.Oncotarget. 2017 Dec 15;9(3):3432-3445. doi: 10.18632/oncotarget.23289. eCollection 2018 Jan 9.
|
| 1251 |
Cytotoxic, Anti-Proliferative and Apoptosis Activity of l-Amino Acid Oxidase from Malaysian Cryptelytrops purpureomaculatus (CP-LAAO) Venom on Human Colon Cancer Cells.Molecules. 2018 Jun 8;23(6):1388. doi: 10.3390/molecules23061388.
|
| 1252 |
Humoral autoimmune response to IGF2 mRNA-binding protein (IMP2/p62) and its tissue-specific expression in colon cancer.Scand J Immunol. 2013 Apr;77(4):255-60. doi: 10.1111/sji.12032.
|
| 1253 |
Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor.Cytogenet Cell Genet. 1998;83(3-4):232-5. doi: 10.1159/000015188.
|
| 1254 |
ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression.Int J Cancer. 2009 Sep 15;125(6):1306-15. doi: 10.1002/ijc.24437.
|
| 1255 |
ING4 is negatively correlated with microvessel density in colon cancer.Tumour Biol. 2012 Dec;33(6):2357-64. doi: 10.1007/s13277-012-0498-9. Epub 2012 Sep 28.
|
| 1256 |
Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment.Ann Oncol. 2018 Sep 1;29(9):2010-2017. doi: 10.1093/annonc/mdy240.
|
| 1257 |
INO80 haploinsufficiency inhibits colon cancer tumorigenesis via replication stress-induced apoptosis.Oncotarget. 2017 Dec 6;8(70):115041-115053. doi: 10.18632/oncotarget.22984. eCollection 2017 Dec 29.
|
| 1258 |
Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.Biochem Pharmacol. 2009 Sep 15;78(6):561-72. doi: 10.1016/j.bcp.2009.05.001. Epub 2009 May 9.
|
| 1259 |
Insulin-induced gene 2 expression correlates with colorectal cancer metastasis and disease outcome.IUBMB Life. 2016 Jan;68(1):65-71. doi: 10.1002/iub.1461. Epub 2015 Dec 10.
|
| 1260 |
PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity.Int J Cancer. 2015 May 15;136(10):2273-83. doi: 10.1002/ijc.29273. Epub 2014 Oct 30.
|
| 1261 |
Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.Int J Cancer. 2010 Jun 1;126(11):2563-74. doi: 10.1002/ijc.24987.
|
| 1262 |
IRAK2 counterbalances oncogenic Smurf1 in colon cancer cells by dictating ER stress.Cell Signal. 2018 Aug;48:69-80. doi: 10.1016/j.cellsig.2018.05.001. Epub 2018 May 9.
|
| 1263 |
Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression.J Biol Chem. 2003 Nov 21;278(47):46278-87. doi: 10.1074/jbc.M304721200. Epub 2003 Sep 12.
|
| 1264 |
Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.J Gastroenterol. 2018 Aug;53(8):932-944. doi: 10.1007/s00535-018-1432-8. Epub 2018 Jan 20.
|
| 1265 |
The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.Clin Cancer Res. 2008 Jun 1;14(11):3562-70. doi: 10.1158/1078-0432.CCR-07-4649.
|
| 1266 |
Antitumor activity of HPA3P through RIPK3-dependent regulated necrotic cell death in colon cancer.Oncotarget. 2018 Jan 9;9(8):7902-7917. doi: 10.18632/oncotarget.24083. eCollection 2018 Jan 30.
|
| 1267 |
Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1.J Cell Physiol. 2015 Aug;230(8):1883-94. doi: 10.1002/jcp.24918.
|
| 1268 |
Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype.Epigenetics. 2014 Sep;9(9):1290-301. doi: 10.4161/epi.32089. Epub 2014 Aug 4.
|
| 1269 |
Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line.J Hum Genet. 2007;52(12):978-984. doi: 10.1007/s10038-007-0204-8. Epub 2007 Oct 13.
|
| 1270 |
Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.Cancer Lett. 2018 Aug 1;428:1-11. doi: 10.1016/j.canlet.2018.04.012. Epub 2018 Apr 13.
|
| 1271 |
Kaiso differentially regulates components of the Notch signaling pathway in intestinal cells.Cell Commun Signal. 2017 Jun 21;15(1):24. doi: 10.1186/s12964-017-0178-x.
|
| 1272 |
JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression.Int J Hematol. 2015 Jul;102(1):76-85. doi: 10.1007/s12185-015-1797-x. Epub 2015 May 5.
|
| 1273 |
Lysyl-tRNA synthetase-expressing colon spheroids induce M2 macrophage polarization to promote metastasis.J Clin Invest. 2018 Nov 1;128(11):5034-5055. doi: 10.1172/JCI99806. Epub 2018 Oct 8.
|
| 1274 |
Activation of cPLA2 is required for leukotriene D4-induced proliferation in colon cancer cells.Carcinogenesis. 2005 Nov;26(11):1988-98. doi: 10.1093/carcin/bgi159. Epub 2005 Jun 23.
|
| 1275 |
Interaction of 14-3-3 with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells.World J Gastroenterol. 2013 Jun 28;19(24):3770-80. doi: 10.3748/wjg.v19.i24.3770.
|
| 1276 |
Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms. Oncogene. 2018 Jan 18;37(3):389-402.
|
| 1277 |
Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.Mol Cancer Ther. 2017 Feb;16(2):397-407. doi: 10.1158/1535-7163.MCT-16-0588. Epub 2016 Dec 15.
|
| 1278 |
Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.Cancer Res. 2002 Jul 15;62(14):4041-7.
|
| 1279 |
Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.Biochem Biophys Res Commun. 2019 Apr 16;511(4):772-779. doi: 10.1016/j.bbrc.2019.02.127. Epub 2019 Mar 2.
|
| 1280 |
The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition.Theranostics. 2019 Apr 13;9(10):2754-2767. doi: 10.7150/thno.33395. eCollection 2019.
|
| 1281 |
Mucin 16 and kallikrein 13 as potential prognostic factors in colon cancer: Results of an oncological 92-multiplex immunoassay.Tumour Biol. 2019 Jul;41(7):1010428319860728. doi: 10.1177/1010428319860728.
|
| 1282 |
Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.J Exp Clin Cancer Res. 2015 Dec 1;34:145. doi: 10.1186/s13046-015-0261-3.
|
| 1283 |
Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1.Br J Biomed Sci. 2018 Jul;75(3):122-127. doi: 10.1080/09674845.2018.1456309. Epub 2018 May 8.
|
| 1284 |
Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model.Int Immunopharmacol. 2017 Jan;42:122-129. doi: 10.1016/j.intimp.2016.11.017. Epub 2016 Nov 29.
|
| 1285 |
REG Controls Hippo Signaling and Reciprocal NF-B-YAP Regulation to Promote Colon Cancer.Clin Cancer Res. 2018 Apr 15;24(8):2015-2025. doi: 10.1158/1078-0432.CCR-17-2986. Epub 2018 Feb 6.
|
| 1286 |
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.
|
| 1287 |
Phytohemagglutinin-L (PHA-L) lectin surface binding of N-linked beta 1-6 carbohydrate and its relationship to activated mutant ras in human pancreatic cancer cell lines.Cancer Lett. 1996 Oct 22;107(2):285-91. doi: 10.1016/0304-3835(96)04386-8.
|
| 1288 |
The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic cleavage.Biochim Biophys Acta. 2010 Mar;1800(3):336-43. doi: 10.1016/j.bbagen.2009.07.030. Epub 2009 Aug 7.
|
| 1289 |
Human galectin-8 isoforms and cancer.Glycoconj J. 2002;19(7-9):557-63. doi: 10.1023/B:GLYC.0000014086.38343.98.
|
| 1290 |
Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.Front Physiol. 2018 Apr 26;9:452. doi: 10.3389/fphys.2018.00452. eCollection 2018.
|
| 1291 |
Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.Hum Mol Genet. 2014 Sep 1;23(17):4729-37. doi: 10.1093/hmg/ddu177. Epub 2014 Apr 15.
|
| 1292 |
DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target.Cancer Res. 2010 Mar 1;70(5):1766-72. doi: 10.1158/0008-5472.CAN-09-3263. Epub 2010 Feb 9.
|
| 1293 |
LIN28B promotes the progression of colon cancer by increasing B-cell lymphoma 2 expression.Biomed Pharmacother. 2018 Jul;103:355-361. doi: 10.1016/j.biopha.2018.04.002. Epub 2018 Apr 24.
|
| 1294 |
Downregulation of hepatic lipase is associated with decreased CD133 expression and clone formation in HepG2 cells.Int J Mol Med. 2018 Oct;42(4):2137-2144. doi: 10.3892/ijmm.2018.3756. Epub 2018 Jul 4.
|
| 1295 |
Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer.Oncol Res. 2007;16(9):431-5. doi: 10.3727/000000007783980855.
|
| 1296 |
Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes.Int J Oncol. 2018 Jan;52(1):89-102. doi: 10.3892/ijo.2017.4182. Epub 2017 Nov 1.
|
| 1297 |
High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.PLoS One. 2017 Sep 28;12(9):e0185607. doi: 10.1371/journal.pone.0185607. eCollection 2017.
|
| 1298 |
A gene encoding a family with sequence similarity 84, member A (FAM84A) enhanced migration of human colon cancer cells.Int J Oncol. 2006 Aug;29(2):341-7.
|
| 1299 |
A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation.Mol Cancer Ther. 2019 Jan;18(1):51-61. doi: 10.1158/1535-7163.MCT-18-0104. Epub 2018 Oct 18.
|
| 1300 |
Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells.Exp Cell Res. 2017 Aug 1;357(1):1-8. doi: 10.1016/j.yexcr.2017.04.010. Epub 2017 Apr 11.
|
| 1301 |
Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients.Clin Cancer Res. 2007 Nov 1;13(21):6351-8. doi: 10.1158/1078-0432.CCR-07-0882.
|
| 1302 |
Anti-Cancerous Potential of Polysaccharide Fractions Extracted from Peony Seed Dreg on Various Human Cancer Cell Lines Via Cell Cycle Arrest and Apoptosis.Front Pharmacol. 2017 Mar 3;8:102. doi: 10.3389/fphar.2017.00102. eCollection 2017.
|
| 1303 |
Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer.Oncol Rep. 2011 Aug;26(2):343-8. doi: 10.3892/or.2011.1312. Epub 2011 May 20.
|
| 1304 |
Genome-wide association study of colorectal cancer in Hispanics.Carcinogenesis. 2016 Jun;37(6):547-556. doi: 10.1093/carcin/bgw046. Epub 2016 Apr 18.
|
| 1305 |
MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer.Oncotarget. 2018 Jun 29;9(50):29445-29452. doi: 10.18632/oncotarget.25655. eCollection 2018 Jun 29.
|
| 1306 |
Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer.Am J Pathol. 2012 Jun;180(6):2516-26. doi: 10.1016/j.ajpath.2012.02.027. Epub 2012 Apr 27.
|
| 1307 |
Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer.Int J Cancer. 2007 Jan 1;120(1):207-11. doi: 10.1002/ijc.22155.
|
| 1308 |
MAEL expression links epithelial-mesenchymal transition and stem cell properties in colorectal cancer.Int J Cancer. 2016 Dec 1;139(11):2502-11. doi: 10.1002/ijc.30388. Epub 2016 Aug 29.
|
| 1309 |
RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer.Gastroenterology. 2010 Jan;138(1):231-40.e1-5. doi: 10.1053/j.gastro.2009.08.001. Epub 2009 Aug 15.
|
| 1310 |
Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer.Oncotarget. 2017 May 2;8(33):54604-54615. doi: 10.18632/oncotarget.17554. eCollection 2017 Aug 15.
|
| 1311 |
Knockout of MARCH2 inhibits the growth of HCT116 colon cancer cells by inducing endoplasmic reticulum stress.Cell Death Dis. 2017 Jul 27;8(7):e2957. doi: 10.1038/cddis.2017.347.
|
| 1312 |
Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.Int J Oncol. 2002 Nov;21(5):1021-6.
|
| 1313 |
MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/-catenin signaling.Mol Cancer. 2018 Aug 1;17(1):111. doi: 10.1186/s12943-018-0848-3.
|
| 1314 |
c-Myc inactivation by mutant Max alters growth and morphology of NCI-H-630 colon cancer cells.J Cell Physiol. 1996 Oct;169(1):200-8. doi: 10.1002/(SICI)1097-4652(199610)169:1<200::AID-JCP20>3.0.CO;2-F.
|
| 1315 |
The Mbd4 DNA glycosylase protects mice from inflammation-driven colon cancer and tissue injury.Oncotarget. 2016 May 10;7(19):28624-36. doi: 10.18632/oncotarget.8721.
|
| 1316 |
Frameshift mutations in the MBD4/MED1 gene in primary gastric cancer with high-frequency microsatellite instability.Cancer Lett. 2002 Jul 8;181(1):115-20. doi: 10.1016/s0304-3835(02)00043-5.
|
| 1317 |
Depletion of Mediator Kinase Module Subunits Represses Superenhancer-Associated Genes in Colon Cancer Cells.Mol Cell Biol. 2018 May 15;38(11):e00573-17. doi: 10.1128/MCB.00573-17. Print 2018 Jun 1.
|
| 1318 |
G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells.BMC Cancer. 2011 May 17;11:175. doi: 10.1186/1471-2407-11-175.
|
| 1319 |
MAP1D, a novel methionine aminopeptidase family member is overexpressed in colon cancer.Oncogene. 2006 Jun 8;25(24):3471-8. doi: 10.1038/sj.onc.1209383. Epub 2006 Mar 27.
|
| 1320 |
Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers.Pathol Oncol Res. 2018 Jul;24(3):617-622. doi: 10.1007/s12253-017-0287-2. Epub 2017 Aug 12.
|
| 1321 |
Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma.Virchows Arch. 2020 Mar;476(3):383-390. doi: 10.1007/s00428-019-02649-y. Epub 2019 Aug 18.
|
| 1322 |
miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition.Onco Targets Ther. 2017 Dec 22;11:67-74. doi: 10.2147/OTT.S113359. eCollection 2018.
|
| 1323 |
Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells.Clin Exp Metastasis. 2002;19(6):541-50. doi: 10.1023/a:1020325327461.
|
| 1324 |
Lycopene, sulforaphane, quercetin, and curcumin applied together show improved antiproliferative potential in colon cancer cells in vitro.J Food Biochem. 2019 Apr;43(4):e12802. doi: 10.1111/jfbc.12802. Epub 2019 Feb 11.
|
| 1325 |
Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer.Technol Cancer Res Treat. 2017 Aug;16(4):428-434. doi: 10.1177/1533034616655909. Epub 2016 Jul 18.
|
| 1326 |
MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties.J Biol Chem. 2007 Jul 27;282(30):21998-2010. doi: 10.1074/jbc.M701737200. Epub 2007 May 18.
|
| 1327 |
Knockdown of MON1B Exerts Anti-Tumor Effects in Colon Cancer In Vitro.Med Sci Monit. 2018 Oct 28;24:7710-7718. doi: 10.12659/MSM.911002.
|
| 1328 |
MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.Cancer Sci. 2019 Jan;110(1):135-146. doi: 10.1111/cas.13863. Epub 2018 Dec 21.
|
| 1329 |
N-Acetylcysteine Serves as Substrate of 3-Mercaptopyruvate Sulfurtransferase and Stimulates Sulfide Metabolism in Colon Cancer Cells.Cells. 2019 Aug 4;8(8):828. doi: 10.3390/cells8080828.
|
| 1330 |
A mutant allele of MRE11 found in mismatch repair-deficient tumor cells suppresses the cellular response to DNA replication fork stress in a dominant negative manner.Mol Biol Cell. 2008 Apr;19(4):1693-705. doi: 10.1091/mbc.e07-09-0975. Epub 2008 Feb 6.
|
| 1331 |
The oncogenic effects of p53-inducible gene 3 (PIG3) in colon cancer cells.Korean J Physiol Pharmacol. 2017 Mar;21(2):267-273. doi: 10.4196/kjpp.2017.21.2.267. Epub 2017 Feb 21.
|
| 1332 |
Myocardin-related transcription factor A (MRTF-A) mediates doxorubicin-induced PERP transcription in colon cancer cells.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1732-1739. doi: 10.1016/j.bbrc.2018.07.106. Epub 2018 Aug 2.
|
| 1333 |
Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer.Neoplasma. 2017;64(1):65-73. doi: 10.4149/neo_2017_108.
|
| 1334 |
Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p.Br J Cancer. 2018 Sep;119(6):744-755. doi: 10.1038/s41416-018-0254-z. Epub 2018 Sep 17.
|
| 1335 |
ZINC4085554 inhibits cancer cell adhesion by interfering with the interaction of Akt1 and FAK.Oncol Lett. 2019 Jun;17(6):5251-5260. doi: 10.3892/ol.2019.10192. Epub 2019 Mar 27.
|
| 1336 |
MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway.Oncotarget. 2017 Jul 22;8(35):58061-58071. doi: 10.18632/oncotarget.19487. eCollection 2017 Aug 29.
|
| 1337 |
Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis.Oncology. 2004;67(5-6):351-8. doi: 10.1159/000082918.
|
| 1338 |
One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.PLoS One. 2017 Oct 2;12(10):e0185792. doi: 10.1371/journal.pone.0185792. eCollection 2017.
|
| 1339 |
Functions and regulation of MUC13 mucin in colon cancer cells.J Gastroenterol. 2014 Oct;49(10):1378-91. doi: 10.1007/s00535-013-0885-z. Epub 2013 Oct 7.
|
| 1340 |
Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.J Transl Med. 2018 Sep 20;16(1):259. doi: 10.1186/s12967-018-1632-2.
|
| 1341 |
Mus81 knockdown sensitizes colon cancer cells to chemotherapeutic drugs by activating CHK1 pathway.Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):592-601. doi: 10.1016/j.clinre.2017.01.011. Epub 2017 Mar 11.
|
| 1342 |
MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression.Nat Commun. 2017 Feb 17;8:14448. doi: 10.1038/ncomms14448.
|
| 1343 |
Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca(2+) signalling.Cell Mol Life Sci. 2017 May;74(10):1907-1921. doi: 10.1007/s00018-016-2441-5. Epub 2016 Dec 24.
|
| 1344 |
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.Nat Genet. 2010 Nov;42(11):973-7. doi: 10.1038/ng.670. Epub 2010 Oct 24.
|
| 1345 |
Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis.Oncogenesis. 2019 Mar 8;8(3):21. doi: 10.1038/s41389-019-0130-6.
|
| 1346 |
Diverse roles of arrest defective 1 in cancer development.Arch Pharm Res. 2019 Dec;42(12):1040-1051. doi: 10.1007/s12272-019-01195-0. Epub 2019 Dec 7.
|
| 1347 |
Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer.Int J Mol Med. 2015 Dec;36(6):1630-8. doi: 10.3892/ijmm.2015.2364. Epub 2015 Oct 9.
|
| 1348 |
NCAPH plays important roles in human colon cancer.Cell Death Dis. 2017 Mar 16;8(3):e2680. doi: 10.1038/cddis.2017.88.
|
| 1349 |
NDC80 promotes proliferation and metastasis of colon cancer cells.Genet Mol Res. 2016 May 6;15(2). doi: 10.4238/gmr.15028312.
|
| 1350 |
Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme.Mol Med Rep. 2014 Aug;10(2):891-6. doi: 10.3892/mmr.2014.2237. Epub 2014 May 14.
|
| 1351 |
Characterization of human colon cancer antigens recognized by autologous antibodies.Int J Cancer. 1998 May 29;76(5):652-8. doi: 10.1002/(sici)1097-0215(19980529)76:5<652::aid-ijc7>3.0.co;2-p.
|
| 1352 |
Netrin-4 Mediates Corneal Hemangiogenesis but Not Lymphangiogenesis in the Mouse-Model of Suture-Induced Neovascularization.Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1387-1396. doi: 10.1167/iovs.16-19249.
|
| 1353 |
Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.Cancer Res. 2014 Dec 1;74(23):6947-57. doi: 10.1158/0008-5472.CAN-14-1592. Epub 2014 Oct 15.
|
| 1354 |
Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis.Cancer Res. 2012 Sep 1;72(17):4340-50. doi: 10.1158/0008-5472.CAN-11-4155. Epub 2012 Jun 27.
|
| 1355 |
ROS-induced cleavage of NHLRC2 by caspase-8 leads to apoptotic cell death in the HCT116 human colon cancer cell line.Cell Death Dis. 2017 Dec 14;8(12):3218. doi: 10.1038/s41419-017-0006-7.
|
| 1356 |
FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.EBioMedicine. 2019 Jul;45:25-38. doi: 10.1016/j.ebiom.2019.06.022. Epub 2019 Jun 28.
|
| 1357 |
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer.Mol Cancer. 2007 Feb 28;6:17. doi: 10.1186/1476-4598-6-17.
|
| 1358 |
Downregulation of NIT2 inhibits colon cancer cell proliferation and induces cell cycle arrest through the caspase-3 and PARP pathways.Int J Mol Med. 2015 May;35(5):1317-22. doi: 10.3892/ijmm.2015.2125. Epub 2015 Mar 4.
|
| 1359 |
The multifaceted nature of NLRP12.J Leukoc Biol. 2014 Dec;96(6):991-1000. doi: 10.1189/jlb.3RU0514-265RR. Epub 2014 Sep 23.
|
| 1360 |
Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer.PLoS One. 2018 Jun 21;13(6):e0199350. doi: 10.1371/journal.pone.0199350. eCollection 2018.
|
| 1361 |
NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury.Mucosal Immunol. 2017 Mar;10(2):434-445. doi: 10.1038/mi.2016.55. Epub 2016 Jun 29.
|
| 1362 |
Impact of Phytolacca americana extracts on gene expression of colon cancer cells.Phytother Res. 2014 Feb;28(2):219-23. doi: 10.1002/ptr.4979. Epub 2013 Apr 4.
|
| 1363 |
Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer.J Pathol. 2005 Apr;205(5):623-32. doi: 10.1002/path.1724.
|
| 1364 |
Lentivirus-mediated knockdown of NOB1 suppresses the proliferation of colon cancer cells.Z Gastroenterol. 2014 May;52(5):429-35. doi: 10.1055/s-0033-1356338. Epub 2014 May 13.
|
| 1365 |
Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor gene therapy combined with thermotherapy.J Cancer Res Clin Oncol. 2014 Apr;140(4):623-32. doi: 10.1007/s00432-014-1611-9. Epub 2014 Feb 15.
|
| 1366 |
NOX1-Dependent mTORC1 Activation via S100A9 Oxidation in Cancer Stem-like Cells Leads to Colon Cancer Progression.Cell Rep. 2019 Jul 30;28(5):1282-1295.e8. doi: 10.1016/j.celrep.2019.06.085.
|
| 1367 |
Clinical Significance of NADPH Oxidase 5 in Human Colon Cancer.Anticancer Res. 2019 Aug;39(8):4405-4410. doi: 10.21873/anticanres.13611.
|
| 1368 |
NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells.Cancer Res. 2016 Feb 15;76(4):855-65. doi: 10.1158/0008-5472.CAN-15-1512. Epub 2016 Jan 18.
|
| 1369 |
High efficiency reconstitution of a human-mouse chimeric Fab of CAb-1 antibody specific to human colon cancer.Scand J Immunol. 2008 Jul;68(1):12-21. doi: 10.1111/j.1365-3083.2008.02087.x. Epub 2008 May 13.
|
| 1370 |
Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway.Med Sci Monit. 2018 Mar 9;24:1424-1433. doi: 10.12659/msm.909186.
|
| 1371 |
Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.Genes Dev. 2002 Aug 15;16(16):2058-72. doi: 10.1101/gad.227502.
|
| 1372 |
Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation.JCI Insight. 2018 Apr 19;3(8):e91316. doi: 10.1172/jci.insight.91316. eCollection 2018 Apr 19.
|
| 1373 |
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer.Oncotarget. 2017 Oct 31;8(62):105356-105371. doi: 10.18632/oncotarget.22187. eCollection 2017 Dec 1.
|
| 1374 |
Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms.Gastroenterology. 2009 Jul;137(1):176-87. doi: 10.1053/j.gastro.2009.03.005. Epub 2009 Mar 18.
|
| 1375 |
In vitro and in vivo treatment of colon cancer by VIP antagonists.Regul Pept. 2002 Nov 15;109(1-3):127-33. doi: 10.1016/s0167-0115(02)00195-7.
|
| 1376 |
Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.Dis Markers. 2018 Sep 19;2018:4272064. doi: 10.1155/2018/4272064. eCollection 2018.
|
| 1377 |
Validation and development of MTH1 inhibitors for treatment of cancer.Ann Oncol. 2016 Dec;27(12):2275-2283. doi: 10.1093/annonc/mdw429. Epub 2016 Nov 8.
|
| 1378 |
High NUSAP1 expression predicts poor prognosis in colon cancer.Pathol Res Pract. 2018 Jul;214(7):968-973. doi: 10.1016/j.prp.2018.05.017. Epub 2018 May 22.
|
| 1379 |
miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells.J Immunol Res. 2018 Aug 2;2018:7498514. doi: 10.1155/2018/7498514. eCollection 2018.
|
| 1380 |
O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.Biochim Biophys Acta. 2011 Apr;1812(4):514-9. doi: 10.1016/j.bbadis.2011.01.009. Epub 2011 Jan 19.
|
| 1381 |
Interactions between XIAP associated factor 1 and a nuclear co-activator, CBP, in colon cancer cells.Digestion. 2008;77(2):79-86. doi: 10.1159/000121441. Epub 2008 Mar 21.
|
| 1382 |
Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.Clin Cancer Res. 2016 Jul 1;22(13):3298-309. doi: 10.1158/1078-0432.CCR-15-1709. Epub 2016 Feb 9.
|
| 1383 |
Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin.PLoS One. 2008;3(12):e4054. doi: 10.1371/journal.pone.0004054. Epub 2008 Dec 29.
|
| 1384 |
Colon cancer bears overexpression of OTUB1.Pathol Res Pract. 2014 Nov;210(11):770-3. doi: 10.1016/j.prp.2014.05.008. Epub 2014 May 22.
|
| 1385 |
MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.J Cell Biochem. 2019 Nov;120(11):18629-18639. doi: 10.1002/jcb.28874. Epub 2019 Jul 24.
|
| 1386 |
Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination.Cancer Sci. 2017 Apr;108(4):713-718. doi: 10.1111/cas.13179. Epub 2017 Apr 12.
|
| 1387 |
PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.Oncogene. 2016 Apr 14;35(15):1943-54. doi: 10.1038/onc.2015.259. Epub 2015 Jul 27.
|
| 1388 |
MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling.Oncol Rep. 2015 Aug;34(2):707-14. doi: 10.3892/or.2015.4039. Epub 2015 Jun 8.
|
| 1389 |
Palladin, an actin-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cells.Int J Oncol. 2010 Oct;37(4):909-26. doi: 10.3892/ijo_00000742.
|
| 1390 |
Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis.Cancer Res. 2005 Oct 1;65(19):8846-52. doi: 10.1158/0008-5472.CAN-05-0770.
|
| 1391 |
Zinc finger protein 278, a potential oncogene in human colorectal cancer.Acta Biochim Biophys Sin (Shanghai). 2008 Apr;40(4):289-96. doi: 10.1111/j.1745-7270.2008.00405.x.
|
| 1392 |
PAX2 protein induces expression of cyclin D1 through activating AP-1 protein and promotes proliferation of colon cancer cells.J Biol Chem. 2012 Dec 28;287(53):44164-72. doi: 10.1074/jbc.M112.401521. Epub 2012 Nov 7.
|
| 1393 |
PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis.Cancer Med. 2019 Jul;8(8):4001-4011. doi: 10.1002/cam4.2321. Epub 2019 May 29.
|
| 1394 |
PAF and EZH2 induce Wnt/-catenin signaling hyperactivation.Mol Cell. 2013 Oct 24;52(2):193-205. doi: 10.1016/j.molcel.2013.08.028. Epub 2013 Sep 19.
|
| 1395 |
The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability.Mol Oncol. 2008 Apr;1(4):431-9. doi: 10.1016/j.molonc.2007.08.002. Epub 2007 Aug 19.
|
| 1396 |
Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells.Anticancer Res. 2018 Nov;38(11):6195-6200. doi: 10.21873/anticanres.12973.
|
| 1397 |
PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress.Cancer Biol Ther. 2011 Mar 15;11(6):567-73. doi: 10.4161/cbt.11.6.14412. Epub 2011 Mar 15.
|
| 1398 |
The role of PEG3 in the occurrence and prognosis of colon cancer.Onco Targets Ther. 2019 Jul 25;12:6001-6012. doi: 10.2147/OTT.S208060. eCollection 2019.
|
| 1399 |
Reduced expression of PER3 is associated with incidence and development of colon cancer.Ann Surg Oncol. 2012 Sep;19(9):3081-8. doi: 10.1245/s10434-012-2279-5. Epub 2012 Feb 17.
|
| 1400 |
PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.Int J Biochem Cell Biol. 2018 Nov;104:1-8. doi: 10.1016/j.biocel.2018.08.014. Epub 2018 Aug 29.
|
| 1401 |
Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer.Int J Oncol. 2013 Aug;43(2):586-90. doi: 10.3892/ijo.2013.1971. Epub 2013 May 31.
|
| 1402 |
PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.Mol Oncol. 2015 Feb;9(2):450-62. doi: 10.1016/j.molonc.2014.09.009. Epub 2014 Oct 13.
|
| 1403 |
The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer.Transl Oncol. 2018 Apr;11(2):436-443. doi: 10.1016/j.tranon.2018.01.015. Epub 2018 Feb 21.
|
| 1404 |
MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1.Expert Opin Ther Targets. 2015;19(8):1017-26. doi: 10.1517/14728222.2015.1057569. Epub 2015 Jun 24.
|
| 1405 |
Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.J Cell Mol Med. 2019 Aug;23(8):5200-5210. doi: 10.1111/jcmm.14395. Epub 2019 May 29.
|
| 1406 |
PIASy stimulates HIF1 SUMOylation and negatively regulates HIF1 activity in response to hypoxia.Oncogene. 2010 Oct 14;29(41):5568-78. doi: 10.1038/onc.2010.297. Epub 2010 Jul 26.
|
| 1407 |
Characterization of the human polymeric immunoglobulin receptor (PIGR) 3'UTR and differential expression of PIGR mRNA during colon tumorigenesis.J Biomed Sci. 2003 Nov-Dec;10(6 Pt 2):792-804. doi: 10.1159/000073967.
|
| 1408 |
17-Hydroxy Wortmannin Restores TRAIL's Response by Ameliorating Increased Beclin 1 Level and Autophagy Function in TRAIL-Resistant Colon Cancer Cells.Mol Cancer Ther. 2019 Jul;18(7):1265-1277. doi: 10.1158/1535-7163.MCT-18-1241. Epub 2019 May 15.
|
| 1409 |
Interaction between physical activity, PITX1 rs647161 genetic polymorphism and colorectal cancer risk in a Korean population: a case-control study.Oncotarget. 2018 Jan 10;9(7):7590-7603. doi: 10.18632/oncotarget.24136. eCollection 2018 Jan 26.
|
| 1410 |
Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer.Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1019-1028. doi: 10.1158/1055-9965.EPI-18-0318. Epub 2018 Jul 5.
|
| 1411 |
Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity.Exp Biol Med (Maywood). 2012 Oct;237(10):1231-40. doi: 10.1258/ebm.2012.011380. Epub 2012 Oct 26.
|
| 1412 |
Multistage risk models and the age pattern in familial polyposis coli.Cancer Invest. 1984;2(6):443-8. doi: 10.3109/07357908409048517.
|
| 1413 |
The human PKP2/plakophilin-2 gene is induced by Wnt/-catenin in normal and colon cancer-associated fibroblasts.Int J Cancer. 2018 Feb 15;142(4):792-804. doi: 10.1002/ijc.31104. Epub 2017 Oct 31.
|
| 1414 |
Group III phospholipase A(2) promotes colitis and colorectal cancer.Sci Rep. 2017 Sep 25;7(1):12261. doi: 10.1038/s41598-017-12434-z.
|
| 1415 |
GWAS identifies two novel colorectal cancer loci at 16q24.1 and 20q13.12.Carcinogenesis. 2018 May 3;39(5):652-660. doi: 10.1093/carcin/bgy026.
|
| 1416 |
PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells.Oncol Rep. 2017 Jan;37(1):408-416. doi: 10.3892/or.2016.5216. Epub 2016 Nov 3.
|
| 1417 |
A common gene variant in PLS3 predicts colon cancer recurrence in women.Tumour Biol. 2013 Aug;34(4):2183-8. doi: 10.1007/s13277-013-0754-7. Epub 2013 Apr 3.
|
| 1418 |
A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.Gene. 2017 Mar 10;604:33-40. doi: 10.1016/j.gene.2016.12.016. Epub 2016 Dec 18.
|
| 1419 |
Enhanced Tumoral MLH1-Expression in MLH1-/PMS2-Deficient Colon Cancer Is Indicative of Sporadic Colon Cancer and Not HNPCC.Pathol Oncol Res. 2020 Jul;26(3):1435-1439. doi: 10.1007/s12253-018-00571-3. Epub 2019 Jan 6.
|
| 1420 |
Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer.Int J Mol Sci. 2017 Sep 23;18(10):2047. doi: 10.3390/ijms18102047.
|
| 1421 |
Human CAP10-Like Protein 46kDa Gene Promotes Malignancy in Colorectal Cancer.OMICS. 2017 May;21(5):266-274. doi: 10.1089/omi.2017.0037.
|
| 1422 |
Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient.J Hum Genet. 2019 Aug;64(8):729-740. doi: 10.1038/s10038-019-0611-7. Epub 2019 May 14.
|
| 1423 |
Identification of TMEM208 and PQLC2 as reference genes for normalizing mRNA expression in colorectal cancer treated with aspirin.Oncotarget. 2017 Apr 4;8(14):22759-22771. doi: 10.18632/oncotarget.15191.
|
| 1424 |
PPA1 regulates tumor malignant potential and clinical outcome of colon adenocarcinoma through JNK pathways.Oncotarget. 2017 Apr 24;8(35):58611-58624. doi: 10.18632/oncotarget.17381. eCollection 2017 Aug 29.
|
| 1425 |
Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer.Biochem Biophys Res Commun. 2019 May 21;513(1):207-212. doi: 10.1016/j.bbrc.2019.03.213. Epub 2019 Apr 4.
|
| 1426 |
Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.Biomed Pharmacother. 2017 Mar;87:366-374. doi: 10.1016/j.biopha.2016.12.103. Epub 2017 Jan 6.
|
| 1427 |
Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line.Cell Death Dis. 2017 Oct 12;8(10):e3096. doi: 10.1038/cddis.2017.477.
|
| 1428 |
PPP2R1B gene in chronic lymphocytic leukemias and mantle cell lymphomas.Leuk Lymphoma. 2001 Mar;41(1-2):177-83. doi: 10.3109/10428190109057968.
|
| 1429 |
Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.Clin Exp Metastasis. 1995 May;13(3):196-202. doi: 10.1007/BF00132208.
|
| 1430 |
DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer.Cancer Res. 2009 Sep 15;69(18):7412-21. doi: 10.1158/0008-5472.CAN-09-0116. Epub 2009 Sep 1.
|
| 1431 |
MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1.Am J Transl Res. 2019 Jul 15;11(7):4516-4523. eCollection 2019.
|
| 1432 |
Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma.Br J Cancer. 2001 Mar 23;84(6):743-7. doi: 10.1054/bjoc.2000.1667.
|
| 1433 |
Induction of radioprotective peroxiredoxin-I by ionizing irradiation.J Neurosci Res. 2002 Dec 15;70(6):794-8. doi: 10.1002/jnr.10435.
|
| 1434 |
Mitochondrial metabolism in cancer stem cells: a therapeutic target for colon cancer.BMB Rep. 2015 Oct;48(10):539-40. doi: 10.5483/bmbrep.2015.48.10.179.
|
| 1435 |
A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells.Sci Rep. 2018 Feb 28;8(1):3770. doi: 10.1038/s41598-018-22090-6.
|
| 1436 |
AMPK2 knockout enhances tumour inflammation through exacerbated liver injury and energy deprivation-associated AMPK1 activation.J Cell Mol Med. 2019 Mar;23(3):1687-1697. doi: 10.1111/jcmm.13978. Epub 2019 Jan 12.
|
| 1437 |
Impact of protamine I on colon cancer proliferation, invasion, migration, diagnosis and prognosis.Biol Chem. 2018 Feb 23;399(3):265-275. doi: 10.1515/hsz-2017-0222.
|
| 1438 |
Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor.J Cancer. 2018 Apr 6;9(8):1394-1402. doi: 10.7150/jca.23835. eCollection 2018.
|
| 1439 |
PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells.Cell Rep. 2014 Sep 25;8(6):1957-1973. doi: 10.1016/j.celrep.2014.08.041. Epub 2014 Sep 18.
|
| 1440 |
Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.Scand J Gastroenterol. 2018 Jan;53(1):38-45. doi: 10.1080/00365521.2017.1392597. Epub 2017 Oct 26.
|
| 1441 |
PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway.PLoS One. 2019 Oct 9;14(10):e0218839. doi: 10.1371/journal.pone.0218839. eCollection 2019.
|
| 1442 |
The identification of specific methylation patterns across different cancers.PLoS One. 2015 Mar 16;10(3):e0120361. doi: 10.1371/journal.pone.0120361. eCollection 2015.
|
| 1443 |
Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/-catenin signaling pathway.Pathol Res Pract. 2019 Oct;215(10):152593. doi: 10.1016/j.prp.2019.152593. Epub 2019 Aug 11.
|
| 1444 |
Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer.BMC Cancer. 2006 Oct 20;6:250. doi: 10.1186/1471-2407-6-250.
|
| 1445 |
Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies.J Immunol. 2002 Jul 15;169(2):1102-9. doi: 10.4049/jimmunol.169.2.1102.
|
| 1446 |
Downregulated miR-585-3p promotes cell growth and proliferation in colon cancer by upregulating PSME3.Onco Targets Ther. 2019 Aug 14;12:6525-6534. doi: 10.2147/OTT.S203175. eCollection 2019.
|
| 1447 |
Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH.Nat Cell Biol. 2014 Jul;16(7):685-94. doi: 10.1038/ncb2977. Epub 2014 Jun 1.
|
| 1448 |
PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR.Cancer Biother Radiopharm. 2018 Mar;33(2):60-64. doi: 10.1089/cbr.2017.2254.
|
| 1449 |
Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancer.Eur J Hum Genet. 2011 Mar;19(3):307-12. doi: 10.1038/ejhg.2010.187. Epub 2010 Dec 8.
|
| 1450 |
Loss of PTPRM associates with the pathogenic development of colorectal adenoma-carcinoma sequence.Sci Rep. 2015 Apr 24;5:9633. doi: 10.1038/srep09633.
|
| 1451 |
Tumour suppressor function of protein tyrosine phosphatase receptor-T.Biosci Rep. 2011 Oct;31(5):303-7. doi: 10.1042/BSR20100134.
|
| 1452 |
PTTG1 attenuates drug-induced cellular senescence.PLoS One. 2011;6(8):e23754. doi: 10.1371/journal.pone.0023754. Epub 2011 Aug 17.
|
| 1453 |
CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells.J Cell Mol Med. 2018 Jan;22(1):131-140. doi: 10.1111/jcmm.13301. Epub 2017 Aug 16.
|
| 1454 |
Down-regulated paxillin suppresses cell proliferation and invasion by inhibiting M2 macrophage polarization in colon cancer.Biol Chem. 2018 Oct 25;399(11):1285-1295. doi: 10.1515/hsz-2018-0002.
|
| 1455 |
Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes.Proc Natl Acad Sci U S A. 2007 May 8;104(19):8023-8. doi: 10.1073/pnas.0700720104. Epub 2007 Apr 26.
|
| 1456 |
Hypoxia-induced Rab11-family interacting protein4expression promotes migration and invasion of colon cancer and correlates with poor prognosis.Mol Med Rep. 2018 Mar;17(3):3797-3806. doi: 10.3892/mmr.2017.8283. Epub 2017 Dec 15.
|
| 1457 |
Epidermal growth factor-mediated Rab25 pathway regulates integrin 1 trafficking in colon cancer.Cancer Cell Int. 2018 Mar 5;18:32. doi: 10.1186/s12935-018-0526-y. eCollection 2018.
|
| 1458 |
A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.BMC Cancer. 2019 Jun 21;19(1):613. doi: 10.1186/s12885-019-5845-4.
|
| 1459 |
Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.Nat Commun. 2019 Dec 13;10(1):5349. doi: 10.1038/s41467-019-13082-9.
|
| 1460 |
Isolation of a novel member of small G protein superfamily and its expression in colon cancer.World J Gastroenterol. 2003 Aug;9(8):1719-24. doi: 10.3748/wjg.v9.i8.1719.
|
| 1461 |
Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas.Lab Invest. 2005 Sep;85(9):1130-8. doi: 10.1038/labinvest.3700315.
|
| 1462 |
3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.PLoS One. 2015 Jul 6;10(7):e0131125. doi: 10.1371/journal.pone.0131125. eCollection 2015.
|
| 1463 |
Frequent somatic demethylation of RAPGEF1/C3G intronic sequences in gastrointestinal and gynecological cancer.Int J Oncol. 2011 Jun;38(6):1575-7. doi: 10.3892/ijo.2011.972. Epub 2011 Mar 11.
|
| 1464 |
Association between chronic kidney disease and cancer mortality: A report from the ALLHAT.Clin Nephrol. 2017 Jan;87 (2017)(1):11-20. doi: 10.5414/CN108949.
|
| 1465 |
RASAL1 induces to downregulate the SCD1, leading to suppression of cell proliferation in colon cancer via LXR/SREBP1c pathway.Biol Res. 2019 Dec 17;52(1):60. doi: 10.1186/s40659-019-0268-x.
|
| 1466 |
RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-B pathway.Cancer Biol Ther. 2019;20(4):435-443. doi: 10.1080/15384047.2018.1529117. Epub 2018 Oct 25.
|
| 1467 |
Expression analysis and association of RBBP6 with apoptosis in colon cancers.J Mol Histol. 2016 Apr;47(2):169-82. doi: 10.1007/s10735-016-9663-6. Epub 2016 Feb 23.
|
| 1468 |
CtIP, a candidate tumor susceptibility gene is a team player with luminaries.Biochim Biophys Acta. 2006 Jan;1765(1):67-73. doi: 10.1016/j.bbcan.2005.09.002. Epub 2005 Oct 6.
|
| 1469 |
Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements.BMC Syst Biol. 2008 Aug 10;2:72. doi: 10.1186/1752-0509-2-72.
|
| 1470 |
RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer.J Cancer. 2019 Aug 27;10(20):4883-4891. doi: 10.7150/jca.35180. eCollection 2019.
|
| 1471 |
RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells.Biosci Rep. 2011 Oct;31(5):363-9. doi: 10.1042/BSR20100108.
|
| 1472 |
Anastomotic recurrence of colon cancer: Genetic analysis challenges the widely held theories of cancerous cells' intraluminal implantation and metachronous carcinogenesis.J Surg Oncol. 2016 Aug;114(2):228-36. doi: 10.1002/jso.24282. Epub 2016 May 9.
|
| 1473 |
Synthesis and Anticancer Activity Evaluation of Hydrolyzed Derivatives of Panaxnotoginseng Saponins.Molecules. 2018 Nov 19;23(11):3021. doi: 10.3390/molecules23113021.
|
| 1474 |
MicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3L.Oncotarget. 2017 Dec 26;9(4):5155-5168. doi: 10.18632/oncotarget.23703. eCollection 2018 Jan 12.
|
| 1475 |
Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer.J Nutr Biochem. 2009 Aug;20(8):649-55. doi: 10.1016/j.jnutbio.2008.07.001. Epub 2008 Oct 16.
|
| 1476 |
Pectin Oligosaccharides Ameliorate Colon Cancer by Regulating Oxidative Stress- and Inflammation-Activated Signaling Pathways.Front Immunol. 2018 Jun 27;9:1504. doi: 10.3389/fimmu.2018.01504. eCollection 2018.
|
| 1477 |
Response gene to complement 32 expression in macrophages augments paracrine stimulation-mediated colon cancer progression.Cell Death Dis. 2019 Oct 10;10(10):776. doi: 10.1038/s41419-019-2006-2.
|
| 1478 |
Senescence marker protein 30 protects intestinal epithelial cells against inflammation-induced cell death by enhancing Nrf2 activity.Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3668-3678. doi: 10.1016/j.bbadis.2018.09.031. Epub 2018 Sep 26.
|
| 1479 |
Subcellular localization of the Galphai3 protein and G alpha interacting protein, two proteins involved in the control of macroautophagy in human colon cancer HT-29 cells.Biochem J. 1999 Jan 15;337 ( Pt 2)(Pt 2):289-95.
|
| 1480 |
Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer.Gastroenterology. 2003 May;124(5):1337-47. doi: 10.1016/s0016-5085(03)00264-6.
|
| 1481 |
The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.Int J Oncol. 2013 Feb;42(2):676-82. doi: 10.3892/ijo.2012.1746. Epub 2012 Dec 20.
|
| 1482 |
RIN1-Ras-ERK pathway plays an important role in carcinogenesis in colon cancer cell line LoVo.Oncol Res. 2011;19(12):527-34. doi: 10.3727/096504012x13340632812514.
|
| 1483 |
Characterisation of tumour-associated antigens in colon cancer.Cancer Immunol Immunother. 2002 Nov;51(10):574-82. doi: 10.1007/s00262-002-0322-2. Epub 2002 Sep 19.
|
| 1484 |
Increased expression of a Myc target gene Mina53 in human colon cancer.Am J Pathol. 2004 Jan;164(1):205-16. doi: 10.1016/S0002-9440(10)63111-2.
|
| 1485 |
RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.Theranostics. 2019 Jun 2;9(12):3659-3673. doi: 10.7150/thno.32126. eCollection 2019.
|
| 1486 |
Macrophage inhibitory cytokine-1 (MIC-1) and subsequent urokinase-type plasminogen activator mediate cell death responses by ribotoxic anisomycin in HCT-116 colon cancer cells.Biochem Pharmacol. 2009 Nov 1;78(9):1205-13. doi: 10.1016/j.bcp.2009.06.012. Epub 2009 Jun 18.
|
| 1487 |
Ring Finger Protein 14 is a new regulator of TCF/-catenin-mediated transcription and colon cancer cell survival.EMBO Rep. 2013 Apr;14(4):347-55. doi: 10.1038/embor.2013.19. Epub 2013 Mar 1.
|
| 1488 |
Antiproliferative Effects of the Natural Oxadiazine Nocuolin A Are Associated With Impairment of Mitochondrial Oxidative Phosphorylation.Front Oncol. 2019 Apr 3;9:224. doi: 10.3389/fonc.2019.00224. eCollection 2019.
|
| 1489 |
Identification of a noncanonical function for ribose-5-phosphate isomerase A promotes colorectal cancer formation by stabilizing and activating -catenin via a novel C-terminal domain.PLoS Biol. 2018 Jan 16;16(1):e2003714. doi: 10.1371/journal.pbio.2003714. eCollection 2018 Jan.
|
| 1490 |
Repression of HIP/RPL29 expression induces differentiation in colon cancer cells.J Cell Physiol. 2006 May;207(2):287-92. doi: 10.1002/jcp.20589.
|
| 1491 |
Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles.Oncotarget. 2016 Nov 29;7(48):79670-79687. doi: 10.18632/oncotarget.13216.
|
| 1492 |
Calcitriol Supplementation Causes Decreases in Tumorigenic Proteins and Different Proteomic and Metabolomic Signatures in Right versus Left-Sided Colon Cancer.Metabolites. 2018 Jan 11;8(1):5. doi: 10.3390/metabo8010005.
|
| 1493 |
Rplp1 bypasses replicative senescence and contributes to transformation.Exp Cell Res. 2009 May 1;315(8):1372-83. doi: 10.1016/j.yexcr.2009.02.007. Epub 2009 Feb 20.
|
| 1494 |
MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.Mol Carcinog. 2018 Oct;57(10):1408-1420. doi: 10.1002/mc.22866. Epub 2018 Jul 3.
|
| 1495 |
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes.Sci Rep. 2016 Nov 28;6:37982. doi: 10.1038/srep37982.
|
| 1496 |
Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency. Gastroenterology. 2014 Sep;147(3):595-598.e5. doi: 10.1053/j.gastro.2014.06.009. Epub 2014 Jun 15.
|
| 1497 |
RPS24 knockdown inhibits colorectal cancer cell migration and proliferation in vitro.Gene. 2015 Oct 25;571(2):286-91. doi: 10.1016/j.gene.2015.06.084. Epub 2015 Jul 3.
|
| 1498 |
Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer.Biochim Biophys Acta. 1995 Dec 12;1272(3):147-53. doi: 10.1016/0925-4439(95)00079-8.
|
| 1499 |
RRS1 silencing suppresses colorectal cancer cell proliferation and tumorigenesis by inhibiting G2/M progression and angiogenesis.Oncotarget. 2017 Sep 15;8(47):82968-82980. doi: 10.18632/oncotarget.20897. eCollection 2017 Oct 10.
|
| 1500 |
Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells.Oncol Lett. 2017 Dec;14(6):8028-8034. doi: 10.3892/ol.2017.7182. Epub 2017 Oct 13.
|
| 1501 |
Cancer as an evolutionary process at the cell level: an epidemiological perspective.Carcinogenesis. 2003 Jan;24(1):1-6. doi: 10.1093/carcin/24.1.1.
|
| 1502 |
Regulation of COX-2 transcription in a colon cancer cell line by Pontin52/TIP49a.Mol Cancer. 2003 Dec 15;2:42. doi: 10.1186/1476-4598-2-42.
|
| 1503 |
Functional polymorphism in the MicroRNA-367 binding site as a prognostic factor for colonic cancer.Anticancer Res. 2013 Feb;33(2):513-9.
|
| 1504 |
miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4.Oncol Rep. 2015 Oct;34(4):1923-32. doi: 10.3892/or.2015.4168. Epub 2015 Aug 4.
|
| 1505 |
Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer.Biochem Biophys Res Commun. 2014 Nov 7;454(1):157-61. doi: 10.1016/j.bbrc.2014.10.054. Epub 2014 Oct 17.
|
| 1506 |
Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance.Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4723-8. doi: 10.1073/pnas.1519128113. Epub 2016 Apr 11.
|
| 1507 |
SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer.Oncol Rep. 2015 Aug;34(2):727-38. doi: 10.3892/or.2015.4014. Epub 2015 May 28.
|
| 1508 |
Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers.Cancer Lett. 2000 Mar 13;150(1):79-84. doi: 10.1016/s0304-3835(99)00378-x.
|
| 1509 |
Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis.Dis Markers. 2015;2015:230703. doi: 10.1155/2015/230703. Epub 2015 Feb 26.
|
| 1510 |
miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.Cell Mol Biol Lett. 2017 Jul 17;22:12. doi: 10.1186/s11658-017-0041-5. eCollection 2017.
|
| 1511 |
Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab.Invest New Drugs. 2013 Jun;31(3):516-24. doi: 10.1007/s10637-012-9875-x. Epub 2012 Sep 6.
|
| 1512 |
Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1.Biochem Biophys Res Commun. 2011 May 27;409(1):148-53. doi: 10.1016/j.bbrc.2011.04.135. Epub 2011 May 5.
|
| 1513 |
Banxia Xiexin decoction, a traditional Chinese medicine, alleviates colon cancer in nude mice.Ann Transl Med. 2019 Aug;7(16):375. doi: 10.21037/atm.2019.07.26.
|
| 1514 |
Proinflammatory cytokines down-regulate intestinal selenoprotein P biosynthesis via NOS2 induction.Free Radic Biol Med. 2010 Sep 1;49(5):777-85. doi: 10.1016/j.freeradbiomed.2010.05.035. Epub 2010 Jun 9.
|
| 1515 |
Endogenous axon guiding chemorepulsant semaphorin-3F inhibits the growth and metastasis of colorectal carcinoma.Clin Cancer Res. 2011 May 1;17(9):2702-11. doi: 10.1158/1078-0432.CCR-10-0839. Epub 2011 Feb 24.
|
| 1516 |
A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.J Cancer. 2017 Apr 9;8(7):1113-1122. doi: 10.7150/jca.17872. eCollection 2017.
|
| 1517 |
Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers.PLoS One. 2012;7(9):e46000. doi: 10.1371/journal.pone.0046000. Epub 2012 Sep 25.
|
| 1518 |
Heart Failure Stimulates Tumor Growth by Circulating Factors.Circulation. 2018 Aug 14;138(7):678-691. doi: 10.1161/CIRCULATIONAHA.117.030816.
|
| 1519 |
Localization of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, 2 and plasminogen in colon cancer.Jpn J Cancer Res. 1995 Jan;86(1):48-56. doi: 10.1111/j.1349-7006.1995.tb02987.x.
|
| 1520 |
Growth-inhibitory effects of TGFL3-SEB chimeric protein on colon cancer cell line.Biomed Pharmacother. 2019 Feb;110:190-196. doi: 10.1016/j.biopha.2018.11.025. Epub 2018 Nov 22.
|
| 1521 |
Epigenetic drift towards histone modifications regulates CAV1 gene expression in colon cancer.Gene. 2016 Apr 25;581(1):75-84. doi: 10.1016/j.gene.2016.01.029. Epub 2016 Jan 19.
|
| 1522 |
PTB-associated splicing factor (PSF) is a PPAR-binding protein and growth regulator of colon cancer cells.PLoS One. 2013;8(3):e58749. doi: 10.1371/journal.pone.0058749. Epub 2013 Mar 13.
|
| 1523 |
INPP4B is an oncogenic regulator in human colon cancer.Oncogene. 2016 Jun 9;35(23):3049-61. doi: 10.1038/onc.2015.361. Epub 2015 Sep 28.
|
| 1524 |
Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer.FASEB J. 2017 Sep;31(9):3816-3830. doi: 10.1096/fj.201601225RR. Epub 2017 May 18.
|
| 1525 |
The 6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.Cancer Lett. 2013 Jan 28;328(2):325-34. doi: 10.1016/j.canlet.2012.10.004. Epub 2012 Oct 13.
|
| 1526 |
Absence of the Tks4 Scaffold Protein Induces Epithelial-Mesenchymal Transition-Like Changes in Human Colon Cancer Cells.Cells. 2019 Oct 29;8(11):1343. doi: 10.3390/cells8111343.
|
| 1527 |
The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.Int J Clin Exp Pathol. 2015 Aug 1;8(8):9097-104. eCollection 2015.
|
| 1528 |
SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.BMC Cancer. 2010 Oct 4;10:525. doi: 10.1186/1471-2407-10-525.
|
| 1529 |
Lack of somatic mutation in the coding sequence of SIAH1 in tumors hemizygous for this candidate tumor suppressor gene.Int J Cancer. 2000 Sep 15;87(6):794-7.
|
| 1530 |
The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.J Biol Chem. 2019 Jul 12;294(28):10833-10845. doi: 10.1074/jbc.RA118.007083. Epub 2019 May 28.
|
| 1531 |
Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors.Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4760-5. doi: 10.1073/pnas.0831000100. Epub 2003 Apr 3.
|
| 1532 |
Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.Apoptosis. 2011 Jan;16(1):35-44. doi: 10.1007/s10495-010-0538-0.
|
| 1533 |
Atypical role of sprouty in p21 dependent inhibition of cell proliferation in colorectal cancer.Mol Carcinog. 2016 Sep;55(9):1355-68. doi: 10.1002/mc.22379. Epub 2015 Aug 21.
|
| 1534 |
Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells.Biomed Pharmacother. 2012 Oct;66(7):563-7. doi: 10.1016/j.biopha.2012.05.004. Epub 2012 Jun 19.
|
| 1535 |
Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G347-55. doi: 10.1152/ajpgi.00403.2010. Epub 2011 May 19.
|
| 1536 |
DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma.Cancer Sci. 2003 Aug;94(8):692-8. doi: 10.1111/j.1349-7006.2003.tb01504.x.
|
| 1537 |
Insight into the role of PIKK family members and NF-B in DNAdamage-induced senescence and senescence-associated secretory phenotype of colon cancer cells.Cell Death Dis. 2018 Jan 19;9(2):44. doi: 10.1038/s41419-017-0069-5.
|
| 1538 |
Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.Oncogene. 2016 Feb 4;35(5):549-57. doi: 10.1038/onc.2015.127. Epub 2015 Apr 27.
|
| 1539 |
Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression.Int J Oncol. 2017 Jan;50(1):252-262. doi: 10.3892/ijo.2016.3774. Epub 2016 Nov 18.
|
| 1540 |
SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.Anat Rec (Hoboken). 2013 Oct;296(10):1568-75. doi: 10.1002/ar.22737. Epub 2013 Jul 22.
|
| 1541 |
Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation.Br J Pharmacol. 2008 Sep;155(2):198-209. doi: 10.1038/bjp.2008.268. Epub 2008 Jun 30.
|
| 1542 |
Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of -catenin.FASEB J. 2012 Nov;26(11):4685-95. doi: 10.1096/fj.12-212282. Epub 2012 Aug 8.
|
| 1543 |
Sorting nexin 1 down-regulation promotes colon tumorigenesis.Clin Cancer Res. 2006 Dec 1;12(23):6952-9. doi: 10.1158/1078-0432.CCR-06-0317.
|
| 1544 |
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors.Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14717-22. doi: 10.1073/pnas.95.25.14717.
|
| 1545 |
Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer.Exp Mol Med. 2018 Apr 6;50(4):1-10. doi: 10.1038/s12276-017-0001-1.
|
| 1546 |
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.EMBO Mol Med. 2014 Jul;6(7):882-901. doi: 10.15252/emmm.201303799.
|
| 1547 |
MicroRNA-645 is an oncogenic regulator in colon cancer.Oncogenesis. 2017 May 15;6(5):e335. doi: 10.1038/oncsis.2017.37.
|
| 1548 |
Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.Mol Pharmacol. 2005 Aug;68(2):317-29. doi: 10.1124/mol.105.011825. Epub 2005 May 9.
|
| 1549 |
Interleukin-6 increases expression of serine protease inhibitor Kazal type 1 through STAT3 in colorectal adenocarcinoma.Mol Carcinog. 2016 Dec;55(12):2010-2023. doi: 10.1002/mc.22447. Epub 2015 Dec 14.
|
| 1550 |
Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.Oncotarget. 2015 Jun 20;6(17):15095-110. doi: 10.18632/oncotarget.3822.
|
| 1551 |
SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.Oncogene. 2016 Jun 9;35(23):2991-3003. doi: 10.1038/onc.2015.366. Epub 2015 Oct 12.
|
| 1552 |
Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1.Mol Cancer. 2014 Jan 24;13:11. doi: 10.1186/1476-4598-13-11.
|
| 1553 |
SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.Am J Transl Res. 2018 Feb 15;10(2):483-490. eCollection 2018.
|
| 1554 |
Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.Am J Physiol Cell Physiol. 2014 Feb 1;306(3):C250-62. doi: 10.1152/ajpcell.00091.2013. Epub 2013 Nov 27.
|
| 1555 |
The splicing factor SRSF6 is amplified and is an oncoprotein inlung and colon cancers.J Pathol. 2013 Mar;229(4):630-9. doi: 10.1002/path.4129.
|
| 1556 |
SSBP1 Upregulation In Colorectal Cancer Regulates Mitochondrial Mass.Cancer Manag Res. 2019 Dec 2;11:10093-10106. doi: 10.2147/CMAR.S211292. eCollection 2019.
|
| 1557 |
The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.Cancer Res. 1996 Oct 15;56(20):4766-72.
|
| 1558 |
Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas.Br J Cancer. 2003 Jun 16;88(12):1909-13. doi: 10.1038/sj.bjc.6600942.
|
| 1559 |
Effect of StarD13 on colorectal cancer proliferation, motility and invasion.Oncol Rep. 2014 Jan;31(1):505-15. doi: 10.3892/or.2013.2861. Epub 2013 Nov 20.
|
| 1560 |
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.Mol Carcinog. 2013 Feb;52(2):155-66. doi: 10.1002/mc.21841. Epub 2011 Nov 28.
|
| 1561 |
Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer.Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9608-E9617. doi: 10.1073/pnas.1712946114. Epub 2017 Oct 23.
|
| 1562 |
Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):E1312-20. doi: 10.1073/pnas.1110428108. Epub 2011 Oct 31.
|
| 1563 |
Aberrant expression of sonic hedgehog pathway in colon cancer and melanosis coli.J Dig Dis. 2013 Aug;14(8):417-24. doi: 10.1111/1751-2980.12060.
|
| 1564 |
Butyrate mediated regulation of RNA binding proteins in the post-transcriptional regulation of inflammatory gene expression.Cell Signal. 2019 Dec;64:109410. doi: 10.1016/j.cellsig.2019.109410. Epub 2019 Sep 2.
|
| 1565 |
Over-expression of small ubiquitin-related modifier-1 and sumoylated p53 in colon cancer.Cell Biochem Biophys. 2013;67(3):1081-7. doi: 10.1007/s12013-013-9612-x.
|
| 1566 |
Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells.Exp Cell Res. 2015 Nov 1;338(2):214-21. doi: 10.1016/j.yexcr.2015.09.016. Epub 2015 Sep 25.
|
| 1567 |
SYNJ2 variant rs9365723 is associated with colorectal cancer risk in Chinese Han population.Int J Biol Markers. 2016 May 28;31(2):e138-43. doi: 10.5301/jbm.5000182.
|
| 1568 |
Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition.Oncoimmunology. 2017 Jan 3;6(2):e1274476. doi: 10.1080/2162402X.2016.1274476. eCollection 2017.
|
| 1569 |
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.BMC Gastroenterol. 2017 Sep 15;17(1):104. doi: 10.1186/s12876-017-0659-9.
|
| 1570 |
Characterization of the HDAC1 complex that regulates the sensitivity of cancer cells to oxidative stress.Cancer Res. 2009 Apr 15;69(8):3597-604. doi: 10.1158/0008-5472.CAN-08-4368. Epub 2009 Apr 7.
|
| 1571 |
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.Gastroenterology. 2013 Apr;144(4):799-807.e24. doi: 10.1053/j.gastro.2012.12.020. Epub 2012 Dec 22.
|
| 1572 |
Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.Oncogene. 2010 Dec 9;29(49):6464-74. doi: 10.1038/onc.2010.370. Epub 2010 Aug 30.
|
| 1573 |
Detection of DNA hypermethylation in sera of patients with Crohn's disease.Mol Med Rep. 2014 Feb;9(2):725-9. doi: 10.3892/mmr.2013.1840. Epub 2013 Dec 3.
|
| 1574 |
Molecular dynamics of interaction of Sesamin and related compounds with the cancer marker -catenin: an in silico study.J Biomol Struct Dyn. 2019 Mar;37(4):877-891. doi: 10.1080/07391102.2018.1442250. Epub 2018 Mar 12.
|
| 1575 |
A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.Oncogene. 2009 Nov 26;28(47):4133-46. doi: 10.1038/onc.2009.271. Epub 2009 Sep 14.
|
| 1576 |
Prevention of Wogonin on Colorectal Cancer Tumorigenesis by Regulating p53 Nuclear Translocation.Front Pharmacol. 2018 Nov 23;9:1356. doi: 10.3389/fphar.2018.01356. eCollection 2018.
|
| 1577 |
C8orf4 is a transforming growth factor B induced transcript downregulated in metastatic colon cancer.Int J Cancer. 2004 Aug 10;111(1):72-5. doi: 10.1002/ijc.20235.
|
| 1578 |
Knockdown of TCTN1 Strongly Decreases Growth of Human Colon Cancer Cells.Med Sci Monit. 2017 Jan 26;23:452-461. doi: 10.12659/msm.899595.
|
| 1579 |
Serological identification of Tektin5 as a cancer/testis antigen and its immunogenicity.BMC Cancer. 2012 Nov 14;12:520. doi: 10.1186/1471-2407-12-520.
|
| 1580 |
Association between colonic screening, subject characteristics, and stage of colorectal cancer.Am J Gastroenterol. 2005 Nov;100(11):2531-9. doi: 10.1111/j.1572-0241.2005.00319.x.
|
| 1581 |
TET1 suppresses colon cancer proliferation by impairing -catenin signal pathway.J Cell Biochem. 2019 Aug;120(8):12559-12565. doi: 10.1002/jcb.28522. Epub 2019 Mar 1.
|
| 1582 |
The mitochondrial retrograde signaling regulates Wnt signaling to promote tumorigenesis in colon cancer.Cell Death Differ. 2019 Oct;26(10):1955-1969. doi: 10.1038/s41418-018-0265-6. Epub 2019 Jan 18.
|
| 1583 |
TFF2-CXCR4 Axis Is Associated with BRAF V600E Colon Cancer.Cancer Prev Res (Phila). 2015 Jul;8(7):614-9. doi: 10.1158/1940-6207.CAPR-14-0444. Epub 2015 Apr 21.
|
| 1584 |
Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III.J Biol Chem. 2001 Jan 12;276(2):1555-63. doi: 10.1074/jbc.M004553200.
|
| 1585 |
Human thrombospondin 2 inhibits proliferation of microvascular endothelial cells.Int J Oncol. 2002 Feb;20(2):339-42.
|
| 1586 |
Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.Mol Oncol. 2015 Jan;9(1):167-78. doi: 10.1016/j.molonc.2014.07.017. Epub 2014 Aug 20.
|
| 1587 |
Ca(2+)/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration via ERK1/2 and p38 pathways.World J Gastroenterol. 2017 Sep 7;23(33):6111-6118. doi: 10.3748/wjg.v23.i33.6111.
|
| 1588 |
Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.Cancer Sci. 2017 Apr;108(4):744-752. doi: 10.1111/cas.13187. Epub 2017 Apr 12.
|
| 1589 |
MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.Int J Oncol. 2016 May;48(5):2135-43. doi: 10.3892/ijo.2016.3430. Epub 2016 Mar 9.
|
| 1590 |
The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer.Cancer Biol Ther. 2014 Sep;15(9):1198-207. doi: 10.4161/cbt.29500. Epub 2014 Jun 11.
|
| 1591 |
Identification of specific modules and significant genes associated with colon cancer by weighted gene coexpression network analysis.Mol Med Rep. 2019 Jul;20(1):693-700. doi: 10.3892/mmr.2019.10295. Epub 2019 May 24.
|
| 1592 |
Tumor suppressor gene NGX6 induces changes in protein expression profiles in colon cancer HT-29 cells.Acta Biochim Biophys Sin (Shanghai). 2012 Jul;44(7):584-90. doi: 10.1093/abbs/gms042. Epub 2012 May 30.
|
| 1593 |
Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy.Oncogenesis. 2017 Sep 18;6(9):e378. doi: 10.1038/oncsis.2017.77.
|
| 1594 |
TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.Cancer Biol Ther. 2014 Mar 1;15(3):297-304. doi: 10.4161/cbt.27308. Epub 2013 Dec 12.
|
| 1595 |
SCC-S2 is overexpressed in colon cancers and regulates cell proliferation.Tumour Biol. 2012 Dec;33(6):2099-106. doi: 10.1007/s13277-012-0469-1. Epub 2012 Aug 12.
|
| 1596 |
A novel inflammatory regulator TIPE2 inhibits TLR4-mediated development of colon cancer via caspase-8.Cancer Biomark. 2014;14(4):233-40. doi: 10.3233/CBM-140402.
|
| 1597 |
Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism.Biochem Biophys Res Commun. 2010 Jan 8;391(2):1274-9. doi: 10.1016/j.bbrc.2009.12.058. Epub 2009 Dec 17.
|
| 1598 |
DcR3 regulates the growth and metastatic potential of SW480 colon cancer cells.Oncol Rep. 2013 Dec;30(6):2741-8. doi: 10.3892/or.2013.2769. Epub 2013 Oct 1.
|
| 1599 |
The study on specific umbilical blood Dc vaccine for Beige nude mice loaded human colorectal carcinoma to induce anti-tumor immunity.Eur Rev Med Pharmacol Sci. 2017 May;21(10):2364-2371.
|
| 1600 |
High expression of Tob1 indicates poor survival outcome and promotes tumour progression via a Wnt positive feedback loop in colon cancer.Mol Cancer. 2018 Nov 17;17(1):159. doi: 10.1186/s12943-018-0907-9.
|
| 1601 |
Targeting PRPK Function Blocks Colon Cancer Metastasis.Mol Cancer Ther. 2018 May;17(5):1101-1113. doi: 10.1158/1535-7163.MCT-17-0628. Epub 2018 Feb 26.
|
| 1602 |
Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation.Tumour Biol. 2016 Sep;37(9):12477-12483. doi: 10.1007/s13277-016-5103-1. Epub 2016 Jun 23.
|
| 1603 |
The clinical significance and biological function of tropomyosin 4 in colon cancer.Biomed Pharmacother. 2018 May;101:1-7. doi: 10.1016/j.biopha.2018.01.166. Epub 2018 Feb 22.
|
| 1604 |
Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-kappaB-dependent pathway.Oncogene. 2004 Mar 11;23(10):1885-95. doi: 10.1038/sj.onc.1207312.
|
| 1605 |
Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/Fos protein signaling pathway.J Biol Chem. 2012 Jul 27;287(31):25881-92. doi: 10.1074/jbc.M112.359521. Epub 2012 Jun 8.
|
| 1606 |
An acellular tissue matrix-based drug carriers with dual chemo-agents for colon cancer growth suppression.Biomed Pharmacother. 2019 Sep;117:109048. doi: 10.1016/j.biopha.2019.109048. Epub 2019 Jun 8.
|
| 1607 |
TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer.Oncotarget. 2016 Dec 27;7(52):86755-86765. doi: 10.18632/oncotarget.13550.
|
| 1608 |
Role of the focal adhesion protein TRIM15 in colon cancer development.Biochim Biophys Acta. 2015 Feb;1853(2):409-21. doi: 10.1016/j.bbamcr.2014.11.007. Epub 2014 Nov 15.
|
| 1609 |
Increased expression of TRPS1 affects tumor progression and correlates with patients' prognosis of colon cancer.Biomed Res Int. 2013;2013:454085. doi: 10.1155/2013/454085. Epub 2013 May 26.
|
| 1610 |
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.Blood. 2018 Jun 21;131(25):2789-2802. doi: 10.1182/blood-2017-09-806679. Epub 2018 Apr 13.
|
| 1611 |
Over-expression of the testis-specific gene TSGA10 in cancers and its immunogenicity.Microbiol Immunol. 2004;48(4):339-45. doi: 10.1111/j.1348-0421.2004.tb03515.x.
|
| 1612 |
Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles.BMC Cancer. 2018 Nov 1;18(1):1058. doi: 10.1186/s12885-018-4952-y.
|
| 1613 |
Ultrasensitive NIR-SERRS Probes with Multiplexed Ratiometric Quantification for In Vivo Antibody Leads Validation.Adv Healthc Mater. 2018 Feb;7(4). doi: 10.1002/adhm.201700870. Epub 2017 Dec 1.
|
| 1614 |
miR663aTTC22V1 axis inhibits colon cancer metastasis.Oncol Rep. 2019 Mar;41(3):1718-1728. doi: 10.3892/or.2019.6969. Epub 2019 Jan 16.
|
| 1615 |
ARMc8 indicates aggressive colon cancers and promotes invasiveness and migration of colon cancer cells.Tumour Biol. 2015 Nov;36(11):9005-13. doi: 10.1007/s13277-015-3664-z. Epub 2015 Jun 18.
|
| 1616 |
Up-regulated expression of l-caldesmon associated with malignancy of colorectal cancer.BMC Cancer. 2012 Dec 17;12:601. doi: 10.1186/1471-2407-12-601.
|
| 1617 |
A functional variant of IC53 correlates with the late onset of colorectal cancer.Mol Med. 2011;17(7-8):607-18. doi: 10.2119/molmed.2010.00192. Epub 2011 Mar 2.
|
| 1618 |
Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression.J Clin Invest. 2014 Dec;124(12):5398-410. doi: 10.1172/JCI76614. Epub 2014 Oct 27.
|
| 1619 |
Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer.Cell Physiol Biochem. 2017;44(3):897-906. doi: 10.1159/000485357. Epub 2017 Nov 24.
|
| 1620 |
Differential roles of EPS8 in carcinogenesis: loss of protein expression in a subset of colorectal carcinoma and adenoma.World J Gastroenterol. 2012 Aug 7;18(29):3896-903. doi: 10.3748/wjg.v18.i29.3896.
|
| 1621 |
DNA methylation biomarker candidates for early detection of colon cancer.Tumour Biol. 2012 Apr;33(2):363-72. doi: 10.1007/s13277-011-0302-2. Epub 2012 Jan 12.
|
| 1622 |
FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.Oncotarget. 2017 Jan 17;8(3):5048-5056. doi: 10.18632/oncotarget.13790.
|
| 1623 |
Hypermethylation of the GATA gene family in esophageal cancer.Int J Cancer. 2006 Nov 1;119(9):2078-83. doi: 10.1002/ijc.22092.
|
| 1624 |
The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.J Biol Chem. 2013 Dec 13;288(50):35637-50. doi: 10.1074/jbc.M113.472076. Epub 2013 Oct 25.
|
| 1625 |
Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells.PLoS One. 2013 Sep 9;8(9):e73593. doi: 10.1371/journal.pone.0073593. eCollection 2013.
|
| 1626 |
A core matrisome gene signature predicts cancer outcome.Br J Cancer. 2018 Feb 6;118(3):435-440. doi: 10.1038/bjc.2017.458. Epub 2018 Jan 23.
|
| 1627 |
Brush border myosin Ia has tumor suppressor activity in the intestine.Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1530-5. doi: 10.1073/pnas.1108411109. Epub 2012 Jan 18.
|
| 1628 |
The effect of linker type and recognition peptide conjugation chemistry on tissue affinity and cytotoxicity of charged polyacrylamide.J Control Release. 2017 Jul 10;257:102-117. doi: 10.1016/j.jconrel.2016.06.038. Epub 2016 Jun 30.
|
| 1629 |
3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans.Cancer Res. 2012 Mar 15;72(6):1467-77. doi: 10.1158/0008-5472.CAN-11-3073. Epub 2012 Jan 26.
|
| 1630 |
Polymorphisms of the apoptosis-associated gene DP1L1 (deleted in polyposis 1-like 1) in colon cancer and inflammatory bowel disease.J Cancer Res Clin Oncol. 2010 Jun;136(6):795-802. doi: 10.1007/s00432-009-0719-9. Epub 2009 Nov 19.
|
| 1631 |
Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity.Am J Pathol. 2011 Mar;178(3):1009-20. doi: 10.1016/j.ajpath.2010.11.047.
|
| 1632 |
Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.Biochem Pharmacol. 2012 Apr 1;83(7):849-57. doi: 10.1016/j.bcp.2012.01.007. Epub 2012 Jan 13.
|
| 1633 |
Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype.Mol Carcinog. 2012 Sep;51(9):746-53. doi: 10.1002/mc.20843. Epub 2011 Aug 30.
|
| 1634 |
Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents.Comput Biol Chem. 2018 Jun;74:294-303. doi: 10.1016/j.compbiolchem.2018.04.006. Epub 2018 Apr 10.
|
| 1635 |
Ets1 and heat shock factor 1 regulate transcription of the Transformer 2 gene in human colon cancer cells.J Gastroenterol. 2013 Nov;48(11):1222-33. doi: 10.1007/s00535-012-0745-2. Epub 2013 Jan 30.
|
|
|
|
|
|
|
